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Tissue engineering of any tissue type requires the combination of a supporting 
scaffold, a range of biological factors and a suitable source of cells. This source of 
cells must satisfy a number of criteria: 
 
 The ability to form all of the mature/specialised cell types found in the target 
tissue. 
 
 Readily obtainable. 
 
 Readily maintainable in the laboratory without requiring excessive resources 
or time. 
 
For intestinal tissue engineering there are a number of issues associated with the use 
of tissue derived stem cells particularly quantity of normal tissue available (from the 
patient) and maintenance and expansion of the cells when cultured in vitro. Using 
embryonic stem cells offers a potential alternative strategy but methods must be 
established to efficiently differentiate the cells towards the desired fate. Many 
strategies for differentiating embryonic stem cells are based upon treatment with 
growth factors in vitro. There is a (logistical) limit to the degree of complexity that 
these systems can achieve and therefore a limit to the number of differentiation 
signals that occur during in vivo development that can be mimicked. In recent years 
using embryonic tissue to provide signals to undifferentiated cells has proved a 
successful method of directing the differentiation of naïve cells towards a particular 
fate (with the choice of tissue determined by the desired target cell type). 
 
The aims of this thesis were to explore the potential of differentiating embryonic stem 
cells towards the intestinal progenitor fate using a combination of in vitro cell culture 
treatment with the growth factor ActivinA and ex vivo coculture with embryonic 
chick gut tissue.  Previous studies [Kubo et al 2004, Tada et al 2005, Yasunaga et al 
 
2005, D’Amour et al 2005, MacClean et al 2007] have shown that ActivinA 
treatment will induce embryonic cells to more efficiently differentiate to definitive 
endoderm, the germ layer from which the intestines (and other visceral organs) arise.  
These techniques were applied to the Columnar Epithelial Epiblast murine embryonic 
stem cell line and cell differentiation was then evaluated at the molecular level using 
Reverse TranscriptionPolymerase Chain Reaction, immunocytochemistry and 
Western blotting.  ActivinA treatment produced an upregulation of definitive 
endoderm markers at both the mRNA and proteomic levels compared to the control 
conditions.  However the cell population produced retained expression of pluripotent 
markers and showed some expression of markers of other cell lineages. 
 
Further studies [Sugie et al 2005, Fair et al 2003, Van Vranken et al 2005, Coleman et 
al 2007, Krassowska et al 2006] have shown that coculture of embryonic stem cells 
with early stage embryonic tissue can induce the formation of particular tissue types; 
the tissue must be selected based on proximity to the target cell type during 
development.  This exposes the embryonic stem cells to the signals that prompt 
differentiation towards the target tissue during normal development.  With gut tissue 
much signalling occurs between the different tissue layers that make up the whole 
organ both during development and in adult tissue. Ex vivo coculture of murine 
embryonic stem cells with embryonic chick gut tissue was used to direct their 
differentiation to the intestinal epithelial stem cell fate.  Before the coculture was 
carried out various experiments were carried out to establish if the proposed protocol 
was viable e.g. defining how long chick gut tissue explants could survive in culture. 
 
Once this had been established coculture experiments were undertaken and cell 
differentiation was then evaluated at the molecular level using Reverse Transcription
Polymerase Chain Reaction, immunocytochemistry and Western blotting.  The cells 
showed some expression of intestinal epithelial stem cell markers at both the mRNA 
and proteomic levels following coculture.  The cells were also assessed at a 
physiological/functional level by evaluating their ability to form a functional intestinal 
epithelial barrier.  This was achieved using an in vitro coculture model with intestinal 
subepithelial myofibroblasts by measuring transepithelial resistance, permeability to 
protein and morphology in a simple tissue model coculture.  The cells did not display 
 
the morphological or physiological characteristics associated with intestinal epithelial 
cells in the model system. 
 
Overall this work has shown that coculturing pluripotent mES cells with embryonic 
chick gut tissue can induce differentiation towards the ISC fate.  Pretreating the cells 
with growth factors in vitro did not seem to enhance this differentiation but there was 
scope to refine these techniques.  Following the differentiation protocols the cells did 
not display the desired physiological characteristics but again there was scope to 
refine the techniques particularly with regard to selecting cells positive for the 
expression of the chosen molecular markers.  These techniques show promise but do 
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Apc Adenomatous polyposis coli 
APES 3Aminopropyltriethoxysilane 
ASC Adult stem cells 
α1MEM α Modified Eagles Media 
BCA Bicinchoninic acid 
Bmi11 BMI1 polycomb ring finger oncogene 
BMPs Bone Morphogenic proteins 
bp base pair 
BrdU 5bromodeoxyuridine 
BSA Bovine Serum Albumin 
β1MCPE βMercaptoethanol 
CBC Crypt base columnar 
CD133 Cluster of differentiation 133 
CDP CCAAT displacement protein 
Cdx1/2Caudal type homeobox 1/2  
CEE Columnar Epithelial Epiblast 
cES cell Cynomolgus monkey embryonic stem cell 
CFU colony forming unit 
ChGA Chromogranin A 
CM Conditioned media 
COX Cyclooxygenase enzyme 
CRESIP Colonrepressive element of the SI promoter 
CXCR4 Chemokine CXC motif Receptor 4 
DAB Diaminodenzidine 
DABCO 14 Diazabicyclo222octane 
 
DBA Dolichos Biflorus Agglutinin 
DE Definitive Endoderm 
DMEM Dulbecco’s Modified Eagle’s Media 
DMSO Dimethylsulphoxide 
DPX Distyrene, Plastisier & Xylene 
DTT Dithiothreitol 
EBs Embryoid bodies 
ECM Extracellular matrix 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor  
EM Eagle’s Media 
Eph Ephrins 
Epi Ant Epithelial Antigen 
ES Cell Embryonic Stem Cell 
EtBr Ethidium Bromide 
Eth D11 Ethidium D1 Homodimer 
EVOM Epithelial Voltometer 
FACS Fluorescence Activated Cell Sorting 
FBS/FCS Foetal Bovine Serum/Foetal Calves Serum 
FGF Fibroblast Growth Factor 
FITC Fluorescein isothiocyanate 
FoxA2 Forkhead Box A2 
FSH Follicle Stimulating Hormone 
GAPDH Glyceraldehyde 3phosphate dehydrogenase 
GATA GATA Binding protein  
GFP Green Fluorescent Protein 
GI Gastrointestinal 
GM Genetically modified 
GM1CSF Granulocyte macrophage colony stimulating factor 
GPR49 Gprotein receptor 49 
Gsc Goosecoid 
H & E Haematoxylin & Eosin 
HBSS Hank’s Balanced Salt Solution 
HDAC Histone Deacetylase 
 
hES cell Human Embryonic Stem Cell 
HGF Hepatocyte Growth Factor 
HMG High mobility group 
HNF Hepatic Nuclear Factor  
HRP Horse Radish Peroxidase 
HSA Hepatic Specific Antigen 
IBS Irritable Bowel Syndrome 
ICM Inner Cell Mass 
IL Interleukin 
ILGF2 Insulinlike Growth Factor 2 
IMS Industrial Methylated Spirit 
iPS cell Induced pluripotent stem cell 
ISC Intestinal (Epithelial) Stem Cell 
ISEMF Intestinal subepithelial myofibroblast 
IVF In vitro Fertilisation 
KGF Keratinocyte Growth factor 
L1Glut LGlutamine 
LDL Low Density Lipoprotein 
Lgr5 Leucinerichrepeatcontaining Gproteincoupled receptor 5 
LIF Leukaemic Inhibitory Factor 
M1CSF Macrophage colony stimulating factor 
MEF Mouse/Murine Embryonic Fibroblast 
MEM Modified Eagles Media 
mES cell Murine Embryonic Stem Cell 
MSCs Mesenchymal Stem Cells 
Msi11 Mushashi1 
Mt2 Metallothionein2 




PAC Puromycin Nacetyltranferase 
PAS Periodic Acid Schiff 
PBS Phosphate Buffered Saline 
 
PCS Portacaval shunt 
PDGFRα Platelet derived growth factor receptor α 
Pdx1 Pancreatic and duodenal homeobox 1 
Pen/Strep Penicillin and Streptomycin 
PET Polyethylene Terephthalate 
PF Protein free 
PFA Paraformaldehyde 
PGA Polyglycolic acid 
PGD Preimplantation genetic diagnosis 
PGP9.5 Protein Gene Product 9.5 
PI3K Phosphatidylinositol 3Kinase 
PLA Polylatic acid 
PMSF Phenylmethanesulphonylfluoride 




qPCR Quantitative/RealTime PCR. 
RA Retinoic acid 
RPM Revolutions per minute  
RT1PCR Reverse Transcription  Polymerase Chain Reaction 
SAGE Serial Analysis of Gene Expression 
SBR Small bowel resection 
SBS Short Bowel Syndrome 
SCs Stem cells 
SCID Severely compromised immunodeficient 
SDF11 Stromal derived factor1 
SEM Standard Error of the Mean 
Shh Sonic Hedgehog 
SMCs Smooth Muscle Cells 
SMαA Smooth Muscle α Actin 
SM1MHC Smooth Muscle Myosin Heavy Chain 
SNL Sto Neo Leukaemic 
Sox Sex Determining Region Box  
 
SR Serum Replacement 
SSEA Stage specific embryonic antigen 
TBE TrisBorate EDTA 
TBS Tris Buffered Saline 
TCP Tissue Culture (treated) Plastic 
TEM Transmission Electron Microscopy 
TER Transepithelial resistance 
TGF1β Transforming Growth Factorβ 
Tm Melting temperature 
TMCC Tissue model coculture 
TRITC Tetramethylrhodamine isothiocyanate 
TSSC Tissue Specific Stem Cells 
TTBS TweenTris Buffered Saline 
TTF1 Thyroid transcription factor 1 
TTR Transthyretin 
VLA Very late activation 
YFP Yellow fluorescent protein 
 
 
Note: With gene and protein names when referred to in italics this indicates the gene 
only whilst the PROTEIN will be referred to in capitals. When in normal text this 









The field of tissue engineering utilises a combination of engineering materials, known 
as scaffolds, cells and biochemical reagents, such as growth factors, to produce tissue 
structures outside of the body [Langer and Vacanti, 1993, Ikada, 2006].  Scaffolds, as 
the name suggests, form the framework around which the tissue structure can form.  
The specific architecture and composition of the scaffold can be designed to influence 
and aid the growth and differentiation of the tissue.  The cellular component forms the 
foundation of the new biological material as the cells grow and divide.  Biochemical 
factors fulfil a number of functions including directing the differentiation of the cells, 
stimulating growth and aiding cellular interaction with the scaffold.  Biological 
agents, such as growth factors (e.g.  Bone Morphogenic Proteins (BMPs) [Kanczler et 
al 2010], Transforming Growth Factorβ (TGFβ) [Miyanishi et al 2006]), and 
hormones (e.g. Insulin [Kellner et al 2001]) and chemical agents, such as steroids (e.g. 
Dexamethasone [Tanaka et al 2004]) can be used for these applications. 
 
There are two main approaches followed in experimental tissue engineering strategies 
(Figure 1.1).  The first uses cell free scaffolds, usually impregnated with growth 
factors, as an aid to in vivo tissue regeneration and repair and would be of use in 
clinical situations only.  The second approach combines cells with scaffolds and 
growth factors to generate tissue structures outside the body, usually using a culture 
system known as a bioreactor (Figure 1.2). 
 
The first strategy is useful for repairing damage to part of a tissue where the wound is 
too extensive for the body’s natural healing process to cope by itself, for example 
damage to diseased joints or nonunion breaks to bones (breaks that exceed the size 
that the bone can selfrepair) [Yang et al 2004], and has more immediate potential for 
use in some clinical work [Braddock et al 2001].  The second strategy is still very 
much at the research stage of development but is advancing rapidly [Ikada 2006] with 
some ‘products’ recently reaching the clinic e.g. TE bladder [Atala et al 2006] and TE 
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[Verbridge et al 2010], and developmental processes.  For example, engineered 
intestine could be used to examine how readily drug candidates can cross the 
intestinal epithelial barrier and enter the circulation or to examine the progression of 
diseases such as Crohn’s disease (and the effectiveness of potential treatments) [Day 
2006].  This could incorporate replacing some animal experiments with tests carried 
out using tissue engineered constructs [www.nc3rs.org.uk, Holmes et al 2009]. 
 
 
Figure 1.2: Bioreactors (spinner flasks) containing scaffolds in culture media. 
 
The supply of cells can be a rate limiting step in tissue engineering strategies as many 
cell types, such as intestinal epithelium (see Section 1.2.4) [Gupta et al 2006, Day 
2006], are slow growing and/or difficult to culture in vitro.  Factors such as potential 
rejection of tissue engineered organs produced using allogenic cells must also be 
considered.  Therefore any techniques by which a reliable, suitable cell source can be 





The mucosa of the GI tract consists of a variety of layers including an epithelial layer 
with a highly complex structure and organisation.  It forms the lining of the intestinal 
lumen and in turn is surrounded by outer layers of submucosa and smooth muscle 
(Figure 1.3) that is responsible for digestive transit (peristalsis).  The intestinal 
epithelium is a columnar epithelial layer and is responsible for digestion, nutrient and 
liquid absorption and immune defence.  In the small intestine the epithelium has a 
characteristic cryptvillous architecture with numerous microvilli protruding into the 
lumen of the small intestine interspersed with small invaginations into the intestinal 
wall known as Crypts of Lieberkuhn.  In the small intestine a number of different cell 
types (Figure 1.4) with a variety of functions arise from the small population of 
intestinal epithelial stem cells (ISC).  Stem cells are also responsible for maintaining 
the cell complement in the large intestinal epithelium but the majority of research into 
ISC has been carried out in the small intestine.  The spatial niche occupied by the 
stem cells is well defined with differentiating progeny becoming more specialised as 
they migrate away from it.  The generally accepted theory of how this occurs is 
outlined below (Figures 1.5 and 1.6) [Cheng and LeBlond 1974, Clevers et al 2009]. 
 
The ISC reside at the base of the Crypts of Lieberkuhn; as the stem cells divide one 
daughter cell takes on a stem cell fate (ensuring the selfrenewal of the ISC 
population) whilst the other begins to migrate up the wall of the Crypt of Lieberkuhn.  
At first this second daughter cell continues to divide, forming the transitamplifying 
cells.  As the cells migrate further up the crypt wall and out onto the villus surface 
they differentiate (and cease to proliferate) into either the absorptive enterocytes or 
secretory cell types (Goblet or Enteroendocrine) as shown in Figure 1.4.  The 
exceptions to this pattern are the Paneth cells (that only occur in the small intestine); 
they remain in the base of the Crypts of Lieberkuhn after they have differentiated 
[Crosnier et al 2006]. 
 
Differentiated cells continue to migrate up the crypt/villi until they die by apoptosis 
and are sloughed off into the intestinal lumen.  The mechanism of epithelial renewal 
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axis.  This is also shown by the fact that the loss of particular Eph receptors (EPHB) is 
associated with the start of invasive behaviour in colorectal cancer [Mariadson et al 
2005]. 
 
Different patterns of integrin expression (specifically the very late activation (VLA) 
family of integrins) and the subsequent interactions with surrounding cells along the 
basement membrane also play a role in controlling differentiation and migration along 
the cryptvillus axis [Beaulieu 1992]. 
 
The intestinal epithelium contains various cell types that are intermixed with each 
other throughout the cryptvillous architecture.  As the variety of differentiated cell 
types all arise from the ISC there must be a mechanism for specifying the correct 
number of each type of cells is produced.  Wnt signalling is important in specifying 
the secretory cell types in the gut lineage [MoriAkiyama 2007].  If Wnt signalling is 
blocked enterocytes will differentiate normally but all classes of secretory cells are 
lost.  Overexpression of Wnt leads to incomplete differentiation in all types of cells 
with a marked increase in the number of Paneth cell precursors [Crosnier et al 2006]. 
 
Secretory cell precursors seem to inhibit their neighbours from also adopting a 
secretory fate via Notch signalling (Figure 1.5).  Partial inactivation of the Notch 
pathway results in an increase in the number of goblet and enteroendocrine cells 
whilst constitutive activation of Notch leads to a drastic reduction in all three 
secretory cell types.  This signalling (and resulting fate commitment) occurs whilst 
the cells are still in the crypts and still dividing.  Secretory precursors express Delta 
enabling them to activate Notch in their neighbours [Stanger et al 2005]. 
 
The blocking of Notch signalling doesn’t just cause a predominance of secretory cells 
to form; it also results in loss of proliferation at the crypt base i.e.  the stem cell 
population also differentiates.  Overexpression of Wnt is not enough to reverse this so 
it appears stem cells are dependent on Wnt and Notch to drive proliferation (and 
prevent differentiation).  Wnt signalling appears to activate Notch in the crypt base 
and it is this small region of Notch+/Wnt+ signalling that maintains the stem cell 





























The overexpression of Notch (through a gain of function mutation in mice) gives rise 
to a number of (reversible) defects in embryonic gut morphogenesis which suggest 
Notch plays a key role in regulating the ratio of secretory and absorptive cell types in 




Figure 1.6: The location of the various cell types within the small intestinal crypt
villous structure [Crosnier et al 2006]. 
 
 
The dynamics of how the ISC maintain the intestinal epithelium have also been 
investigated in mice [Bjerknes and Cheng 1999].  By causing a (chemically 
introduced) mutation in a particular gene locus (Dlb1) that produces a marker in the 
affected cells at random throughout the intestinal epithelium and then tracing the 
clones of the mutated cells, the lineages of the various cell types could be identified.   
 
The results showed that there were ‘long lived’ progenitors capable of forming all the 
cell types in the epithelium (the ISC), ‘relatively long lived’ cells (a lifespan measured 
in months) that were either mucus cell progenitors or columnar cell progenitors and 
‘short lived’ cells that only produced one or two daughter cells.  Analysis of 
branching crypts showed that clones were localised to one crypt.  Clones were also 
shown to be widely dispersed despite the fact that the intestinal epithelial contains 





The GI tract, along with the rest of the viscera, arises from the (definitive) endoderm 
(DE) germ layer during development.  The development and differentiation of the GI 
epithelium and other intestinal structures is controlled by a variety of regulatory 
mechanisms.  These include some epigenetic mechanisms where genes are silenced or 
activated according to the state of the chromatin/DNA [Tou et al 2004].  Class I 
Histone Deacetylases (HDACs) play an important role in mammalian gut 
development illustrated by the fact that overexpression of HDACs causes 
misexpression of a number of intestinal epithelial developmental markers including 
Apo1a and metallothionein2 (Mt2) [Tou et al 2004]. 
 
As mentioned above Wnt signalling plays a key role in maintaining the ISC niche in 
adult intestine and is restricted to the base of the Crypts if Lieberkuhn but it is also a 
key component in the development of the intestinal epithelium [Kim et al 2007].  
TOPGAL and LacZ reporter constructs were used to identify the location of Wnt 
expression in developing mouse embryos.  Wntreporter expression is first seen in the 
intestine as villi begin to form at around embryonic day 14.  General patterns of 
expression similar to those observed in the adult intestine develop rapidly in the villi 
 
whilst transcripts that localise to adult crypts are found in the intervillus cells (from 
which the Crypts of Lieberkuhn will eventually arise). 
 
Postnatal Wnt expression only becomes apparent three days post partum in the 
intervillus regions whereas it is elevated in the villi in late gestation and immediately 
following birth.  This does not correspond with what was expected and may be caused 
by incongruities in timing between reporter activity and real Wnt signalling or indicate 
a sensitivity threshold for detecting activity [Kim et al 2007]. 
 
The environment in the intestine continues to change post partum following the 
switch from in utero/parenteral nutrition to ingestion of food.  In mammals these 
changes take on an extra stage as the change from suckling to solid food takes place.  
In mice there is a complex pattern of expression of key transcription factors and 
enzymes which shows both temporal and spatial variation [Fang et al 2006]. 
 
The (temporal and spatial) expression of Sucraseisomaltase is partially controlled by 
the novel regulatory elements such as CCAAT displacement protein (CDP aka Cux) 
[Boudreau et al 2002].  This element represses the expression of Sucraseisomaltase 




The discovery of characteristic (putative) markers for GI stem cells has been a key 
development in this field as previously the ISC were only identified by their 
(supposed) location at the +4 cell position at the base of the Crypts of Lieberkuhn.  
MUSASHI1 (MSI1) is a RNA binding protein first observed in neural progenitor 
cells where it is involved in asymmetric cell division – the mechanism by which ISC 
are believed to proliferate.  It should therefore only be expressed in the proliferative 
compartment of the intestinal epithelium i.e. the ISC and their immediate daughters 
the transit amplifying cells.  Antibody staining against MSI1 protein showed this to 
be the case in mice [Potten et al 2003].   
 
 
BDF1 mice were dosed with radiation (1 – 14 Gy) and the small intestine collected up 
to 12 days later.  Nonirradiated neonatal and adult small intestine and colon tissue 
samples and a range of small intestinal adenomas were also analysed.  MSI1 (at the 
predicted location at the base of the crypts) expression was evident in neonatal (two 
day old) and adult samples as well as those regenerating after radiation damage.  The 
adenoma samples were also strongly positive for MSI1.  Some human tissue samples 
(from both the small and large intestine) were also examined but the antibody staining 
was weak and therefore clear results were not obtained [Potten et al 2003]. 
 
The antibody staining in mice was followed up with in situ hybridisation and qPCR 
investigation of Msi1 expression.  The in situ hybridisations showed Msi1 mRNA 
expression in the same locations as the positive MSI1 antibody staining.  The qPCR 
analysis showed elevated levels of Msi1 expression in tumours compared with 
normal tissue.  This suggests Msi1 levels are elevated in more rapidly proliferating 
cells within the intestinal epithelium, be they cancerous cells or the ISC and their 
immediate progeny [Potten et al 2003]. 
 
In recent years a number of other markers for ISCs have been discovered.  Leucine
richrepeatcontaining Gproteincoupled receptor five (Lgr5), otherwise known as 
Gprotein receptor 49 (GPR49), is a Wnt target whose expression is restricted to the 
ISC at the base of the intestinal crypts [Barker et al 2007].  Lgr5 was initially selected 
from a panel of Wnt target genes because of its (spatial) expression pattern, 
specifically that its expression was confined to the putative ISC loci at the base of the 
Crypts of Lieberkuhn when analysed by in situ hybridisation.  Lgr5 was also shown to 
be expressed in intestinal adenomas in Apcmin mice indicating it is expressed in 
rapidly proliferating cancer cells.  Using an Lgr5LacZ reporter knock in construct 
(which gives a blue colouration for positive expression) the expression of Lgr5 was 
examined further [Barker et al 2007]. 
 
In adult mice expression was seen in scattered cells in the brain, eye, reproductive 
organs and mammary glands.  In the small intestine expression was restricted to the 
base of the crypts with three  four positive cells in each crypt interspersed amongst 
the Paneth cells.  The morphology of the Lgr5+ cells was distinct from that of the 
Paneth cells so they were referred to as Crypt Base Columnar (CBC) cells.  They were 
 
also (frequently) positive for the expression of the proliferation marker Ki67.  
Through 5bromodeoxyuridine (BrdU) pulse labelling the cycling time of the cells 
was established as approximately 24 hours.  A further Green Fluorescent Protein 
(GFP) reporter construct was introduced and the same expression pattern was seen as 
with the LacZ reporter construct.  A further inducible CreLacZ reporter was used to 
permanently label Lgr5+ cells and their progeny to allow lineage tracing.   
 
The initial location of the labelled cells was not the +4 position, the previously 
hypothesised locus for the ISC, but (as stated above) interspersed amongst the Paneth 
cells.  The CBC cells showed much reduced sensitivity to radiation doses than those 
cells in the +4 position.  However the labelled CBC cells were capable of 
repopulating the intestinal epithelium as the cell population turned over [Bjerknes and 
Cheng 1999].  One day after induction just a few labelled cells were observed at the 
bases of the crypts but after a further one, five, 35 and 60 days the percentage of the 
cells (in 200 crypts) that carried the permanent label were 22%, 39%, 25% and 36%.  
The cells at 60 days were also positive for markers of Goblet cells (Periodic Acid 
Schiff (PAS)), Paneth cells (PAS expressed at the base of the crypt) and 
Enteroendocrine cells (Synaptophysin, a membrane glycoprotein) as well as 
demonstrating the morphological character of enterocytes.  These cell types were 
present in similar ratios in labelled crypts as compared with unlabelled adjacent 
crypts.  The Lgr5+ CBC cells demonstrate all the properties indicative of the ISC in 
the small intestine.  Similar analysis was carried out on the epithelium of the colon 
generating almost identical observations.  This suggests that Lgr5+ expression is 
characteristic of ISC throughout the intestinal epithelium [Barker et al 2007]. 
 
BMI1 polycomb ring finger oncogene (Bmi1), a member of the Polycomb gene 
family, plays an important role in self renewal of a number of Adult Stem Cell (ASC) 
populations, particularly haematopoietic [Park et al 2003] and neural stem cells [Park 
et al 2003 (2)] where it distinguishes stem cell maintenance from progenitor 
proliferation.  It was also found to be expressed in the ISCs in the epithelium of the 
small intestine [Sangiorgi & Capecchi 2008].  This study localised the expression of 
Bmi1 in the intestine to cell position four in the base of the crypts using a genetically 
modified (GM) mouse carrying an inducible Cre reporter gene in the Bmi1 locus that 
 
would generate a permanent fluorescent signal in cells that were positive for Bmi1 
(LacZ or Yellow fluorescent protein (YFP)) [Sangiorgi & Capecchi 2008]. 
 
Some cells retained expression of BMI1 as they differentiated and migrated up the 
wall of the crypt but the Bmi1 transcript was only present in cells at the base of the 
crypt.  Bmi1 expression did not appear to be uniform along the length of the small 
intestine.  Crypts in the 10 cm nearest the pylori showed the highest number of Bmi
1+ crypts with a gradual decrease further along the small intestine.  This suggests that 
not all ISC express Bmi1.  One month after the reporterBmi1 constructs had been 
induced the labelled progeny of the Bmi1+ cells were examined to identify which 
cell fates they had differentiated to.  The Bmi1+ lineage included all of the 
differentiated (secretory) cell types present in the intestinal epithelium (Figure 1.3), 
Paneth cells that expressed lysozyme, Goblet cells that expressed Dolichos Biflorus 
Agglutinin (DBA, a cell surface protein) and Enteroendocrine cells that expressed 
Chromogranin A (ChGA) [Sangiorgi & Capecchi 2008]. 
 
Crypts that were positive for Bmi1 remained so up to 12 months after reporter 
induction.  This persistence of expression is an indicator of selfrenewal, a key 
property of stem cell populations.  Bmi1+ cells were also shown to be present in 
intestinal adenomas.  Disrupting Bmi1+ cells had a significant impact on the animals 
in question.  Mice where disruption was induced over several days died.  On 
examination the intestines of these mice were full of dead cells.   
 
Mice where a single disruption was induced survived but were slow to gain mass.  
The intestines of these mice initially showed several areas devoid of crypts but these 
areas were gradual ‘repopulated’ by surrounding tissue over time.  This data indicates 
that Bmi1 positive cells are required for crypt maintenance which is another key 
feature of ISC.  Although Bmi1 does not appear to be expressed in every crypt it does 
seem to be a good marker for the ISC [Sangiorgi & Capecchi 2008]. 
 
Other potential markers can be used to help identify the differentiation of ISCs from 
mES cells such as Epithelial Antigen (EpiAnt) and Cluster of differentiation (CD) 
133.  EpiAnt encodes a homophilic cell surface adhesion molecule that is expressed 
widely throughout all epithelial cells.  CD133 is a glycoprotein, also known as 
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Prominin1 (PROM1).  It forms part of a transmembrane glycoprotein complex that 
localises to cellular protrusions [Corbeil et al 2000].  It is expressed in a wide range of 
adult stem cell/progenitor populations [Yin et al 1997, Corbeil et al 2000, Shmelkov 
et al 2005, Kordes et al 2007] including putative colonic stem cells [Samuel et al 
2008] and is conserved in structure across a number of mammalian species [Corbeil 
2001]. 
 
ISC potentially share some similarities from cancer initiating cells in the intestine.  
Cancer initiating cells in the colon have been shown to be CD133+ [RicciVitiani et al 
2006].  When tumours were examined c.2.5% of the cells were found to be CD133+.  
These cells had the capacity to initiate tumours when injected into SCID mice (eight  
10 weeks from injection until termination) whereas CD133 cells did not.  In some 
respects these cells acted like stem/progenitor cells.  A small fraction of the total 
tumour mass consisted of cells responsible for the maintenance and growth of the 
tumour in the same way that many adult tissues are maintained by a small population 
of ASC [RicciVitiani et al 2006]. 
 
Other important intestinal markers such as Cdx1 are also associated with intestinal 
cancers [Bonhomme et al 2008].  Cdx1 (and its paralogue Cdx2) is a homeobox gene 
and is involved in anterioposterior embryo patterning.  It is expressed in the intestinal 
epithelium throughout life and often shows altered expression in many 
adenocarcinomas (with loss of expression being most common with overexpression 
seen rarely).  The effects of loss of function and overexpression of Cdx1 in mice were 
investigated with particular reference to intestinal development and intestinal cancers.   
 
Neither loss of nor overexpression of Cdx1 had any effects on intestinal development 
or morphology although it did produce an inverse proportional effect on Cdx2 
activity.  The incidence of tumours was also unaffected but overexpression of Cdx1 
did increase the severity of tumours in some cases.  These results indicate that Cdx1 is 
redundant in intestinal development; whilst it does have a significant function this is 
replicated by other mechanisms [Bonhomme et al 2008]. 
 
The homeobox gene Cdx2, which is a homologue of the Drosophila gene Caudal, 
plays a key role in the control of GI tract patterning and intestinal epithelial 
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development [Beck et al 1999] and is a tumour suppressor in the colon [Bonhomme et 
al 2003].  These properties make it a potential molecular marker for intestinal 
epithelium.  In Cdx2+/ mice multiple Cdx2 lesions that did not contain normal 
intestinal epithelial structures developed [Beck et al 1999].  Examination of 98 
animals showed that these polyplike lesions formed as two distinct types of 
epithelium developed in the intestine; normal (Cdx2+) and a more gastric epithelial
like layer (Cdx2).  Where the two tissue types met intercalary growth occurred, in 
effect filling in the gaps which resulted in the formation of lesions.  Cdx2 expression 
is vital to the correct formation of intestinal epithelium to the extent that 
haploinsufficiency results in serious tissue malformation [Beck et al 1999]. 
 
It was found that Cdx2 expression is reduced in tumours of the colon [Bonhomme et 
al 2003].  To investigate this Cdx2+/ and wildtype mice were treated with the 
mutagen Azoxymethane and then analysed for the incidence of intestinal tumours.  
Three months following Azoxymethane treatment Cdx2+/ animals displayed 
increased tumour (adenocarcinomas) formation confined to the distal colon (spatially 
distinct from Cdx2’s field of activity in correct intestinal patterning); this was not 
observed in wildtype animals.  The haploinsufficient animals also showed reduced 
cell apoptosis following radiation treatment of the tumours; the tumours in Cdx2+/ 
animals did not respond to treatment as favourably as those in wildtype animals 





It has proved to be quite challenging to culture intestinal epithelium in vitro/ex vivo 
which has hindered the development of model systems to study developmental 
processes and diseases such as intestinal cancers.  The proliferating component of the 
tissue, the ISC and the transit amplifying cells, constitute a very small proportion of 
the total tissue mass so isolating them can be difficult.  Even when they are isolated 
ISC prove to be slow growing and do not survive for many passages in vitro (around 
14 days) [Dekaney et al 2005].   Much GI tissue engineering has been carried out by 
culturing intact crypts/small tissue masses (known as organoids that can be 
maintained in culture (see Section 1.5) [Evans et al 1992, Tait et al 1995, Choi and 
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Vacanti 1997, Choi et al 1998].  In recent years some success has been achieved in 
maintaining intestinal epithelium in vitro [Perreault & Beaulieu 1998, Dekaney et al 
2005, Quinlan et al 2006]. 
 
Primary foetal intestine from between 15  20 weeks post fertilisation was washed and 
the epithelium separated by nonenzymatic dissociation [Perreault & Beaulieu 1998].  
The dissociated epithelium was transferred to primary culture in Dulbecco’s Modified 
Eagle’s Media (DMEM), 5% Foetal Calf Serum (FCS), human epidermal growth 
factor (EGF) and insulin on tissue culture plastic (TCP) that had been Collagen I 
coated.   
 
The cells initially proliferated well and reached confluence after three  four days.  
After seven days the culture contained both goblet and absorptive cells that 
demonstrated a range of the functional characteristics associated with in vivo 
intestinal epithelium.  Mucins and enzymes such as lactase were expressed (evaluated 
by antibody staining), the cells formed tight junctions and the rate of 
proliferation/DNA synthesis was negligible.  This showed that the isolated epithelium, 
and the different cell types within it, was maintaining its functional characteristics in 
vitro as well as remaining viable [Perreault & Beaulieu, 1998].  
 
The identification of putative markers has allowed the isolation and study of murine 
ISC in vitro [Dekaney et al 2005].  A cell fraction was isolated from either whole 
mucosa or epithelium of the jejunum and a population of cells that was negative for 
CD45 and other surface markers but that exhibited Msi1 expression was isolated and 
maintained in vitro for up to 14 days.  CD45+ and dead cells were excluded and the 
isolated cell population was selectively sorted by FACS against a range of 
haematopoietic stem cells markers.   
 
A population of cells that exhibited Msi1 expression was isolated from both whole 
intestine and epithelium only samples.  These cells were maintained in vitro and 
remained viable at seven days when they still excluded Trypan blue but by 14 days 
most of the cells had undergone apoptosis.  These results demonstrate that whilst it is 
possible to isolate a putative population of intestinal progenitor cells it is difficult to 
maintain those cells in vitro for any significant duration.  Intestinal epithelial cells 
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have a limited lifespan in vivo as they differentiate and migrate up the villi before 
being sloughed off into the intestinal lumen after around four  five days.  ISC also 
require a complex array of signalling (detailed in Section 1.2.1) to maintain the stem 
cell niche that is not replicated under in vitro culture conditions [Dekaney et al 2005]. 
 
Embryonic mouse intestinal explants were maintained on fibronectin coated 
coverslips for a number of days [Quinlan et al 2006].  The explants maintained the 
expression of the key intestinal marker, the transcription factor cdx2 as well as 
columnar epithelial and smooth muscle markers.  The explants also began to show 
later markers of intestinal epithelial development (and of the specialised cell types 





A stem cell is defined as a cell that is both multipotent (able to form multiple cell 
types) and selfrenewing (each time a stem cell divides at least one of its daughter 
cells will also be a stem cell).  Embryonic stem (ES) cells are derived from the inner 
cell mass (ICM) of preimplantation (eight cell stage/three – four days post
fertilisation) blastocysts (Figure 1.7).  When generating human embryonic stem cell 
(hES) lines the cells are taken from embryos (following informed consent) that have 
not met quality control standards for use in clinical in vitro fertilisation (IVF) 
treatments and are donated for research use. 
 
They were first generated from mouse embryos in 1981 by two separate research 
groups, one at the University of Cambridge and one at the University of California, 
San Francisco respectively [Evans and Kaufmann 1981, Martin 1981] (it was Gail 
Martin who coined the phrase embryonic stem cell), and from human embryos in 
1998 at the University of Wisconsin, Madison [Thomson et al 1998]. 
 
Evans and Kaufmann’s technique involved blocking the implantation of the embryo 
to allow the ICM to increase in size whilst remaining in the uterus for four – six days.  
This was achieved by removing the mothers’ ovaries and dosing her with 
progesterone.  Following their removal from the uterus the embryos were cultured in 
vitro on MitomycinC inactivated fibroblast cells (see Section 2.1.2) where they 
formed cylinder shaped structures.  These were then dissociated into single cells that 
were cultured on inactivated fibroblasts to generate clonal cell lines with pluripotent 
characteristics [Evans and Kaufmann 1981]. 
 
Martin’s technique involved removing the embryo around three days postfertilisation 
and then culturing it overnight.  The ICM was then removed and cultured on 
inactivated fibroblasts.  After one week of culture colonies of cells grew out of the 
ICM and these were used to establish clonal cell lines with pluripotent characteristics 
[Martin 1981]. 
 
Generating hES cell lines requires human embryos and so there are ethical 
considerations as well as technical ones when it comes to the generation and use of 
hES cell lines.  The embryos were cultured to the blastocyst stage at which point the 
 
ICM was isolated.  Following isolation the ICM were plated on inactivated (by 
irradiation) MEF and after (up to) 15 days in culture any outgrowths were dissociated 
into small clumps that were replated on irradiated MEF.  Uniform colonies were 
identified and replated following enzymatic dissociation (with Collagenase IV). This 
protocol was based on a technique first used to generate ES cells from other primate 
species [Thomson et al 1995].  Five hES cell lines were established from five 
different embryos with lines H1, H13 and H14 being XY (normal) karyotype and 
lines H7 and H9 being XX (normal) karyotype [Thomson et al 1998]. 
 
ES cells have two defining properties.  Firstly, they are pluripotent which means that 
they are capable of differentiating into any of the cell types found in the body 
including those of the germ line (Figure 1.7).  Pluripotent ES cells must be 
distinguished from totipotent cells, that can form any cell type found within the body 
and those found in extraembryonic structures, and multipotent (adult/tissue specific) 
stem cells (see below).  Secondly, ES cells have the capacity for selfrenewal; they are 
capable of propagating themselves and therefore maintaining a population of stem 
cells indefinitely. 
 
ES cells also have a number of characteristics that can be examined experimentally.  
They express a panel of pluripotency marker genes including Octamer4 (Oct4) and 
nanog as well as various Stage Specific Embryonic Antigen (SSEA) sugar epitopes 
[Draper et al 2002, Lanctot et al 2007].  They are capable of teratoma formation when 
injected in vivo in their undifferentiated state; they will form tumours along with a 
population of selfrenewing stem cells [Cao et al 2007]. ES cells can contribute to 
chimaeras [Robertson et al 1986]; chimaera formation involves injecting a population 
of donor ES cells into a recipient early stage embryo.  The injected ES cells will 
contribute to the tissues of the developing organism (usually a mouse).  The donor 
cells can sometimes be observed phenotypically, for example if the donor cells were 
from a brown mouse with the recipient being white you might see patches of brown 
and white fur, or karyotypically by using donor cells from a male mouse in a female 
recipient and looking for the Y chromosome carrying cells.  The donor cells can also 
be furnished with a fluorophore label, e.g.  GFP, to allow tracing using a microscope 
[Lakshmipathy et al 2004]. 
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ES cells proliferate rapidly and will continue to divide indefinitely in an 
undifferentiated state under the appropriate in vitro culture conditions.  They express 
a characteristic profile of molecular markers, as mentioned above, although some 
variations exist between different cell lines [Nieden et al 2001, Nagano et al 2005, 
Nunomura et al 2005].  During long term culture some mutations will occur but the 
core molecular profile (and therefore the key characteristics of the cells) should 
remain consistent [Berrill et al 2004, Palmqvist et al 2005].  For murine ES (mES) 
cell culture a protein known as Leukaemic Inhibitory Factor (LIF) is required to 
maintain the cells in an undifferentiated state [Ogawa et al 2006].  This can either be 
added to the culture media or the cells can be grown on a ‘feeder’ layer of cells that 
secrete LIF; for some mES cell lines a combination of the two approaches is used (see 
Section 2.1.1).  Feeder layer cells also provide extracellular matrix (ECM) 
components that help the ES cells adhere to the culture vessel.  Removal of LIF from 
the culture media will allow differentiation to be initiated.  A number of pathways, 
such as Grb2Mek signalling that represses Nanog, then become active [Hamazaki et 
al 2006]. 
 
For hES cells either feeder layers to provide ECM components or an ECM substitute 
such as MatriGel© (an ECM protein mixture produced by EngelbrethHolmSwarm 
mouse sarcoma cells marketed by BD Biosciences®) are always required.  A variety 
of factors such as βFibroblast Growth Factor (FGF) and BMPs are used to maintain 
the cells’ pluripotency.  Generally hES cell lines are slower to proliferate and more 
difficult to maintain than mES cell lines.  There are some significant differences 
between mES and hES cells beyond the factors required to maintain them in a 
pluripotent state in culture [Ginis et al 2004]. 
 
If the factors that suppress ES cell differentiation are removed from the culture media 
the ES cells will begin to randomly differentiate.  This is enhanced if they are 
aggregated into structures known as embryoid bodies (EBs) [Abe et al 1996].  EBs 
were formed in suspension culture and following seven   eight days of formation the 
EBs resembled a primitive yolk sac as seen in postimplantation embryos.  At this 
stage the expression of the endodermal markers αFetoprotein (AFP) and 
Transthyretin (TTR) were examined by Northern blotting, in situ hybridisation and 
Reverse Transcription – Polymerase Chain Reaction (RTPCR).  The expression of 
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the selected markers was strong in all the samples examined indicating that a 
significant number of cells had been directed towards the endodermal fate by 
aggregation into EBs [Abe et al 1996]. 
 
In the first 12 hours of differentiation as EBs a number of key factors involved in 
transcription, intracellular signalling were upregulated compared to controls when 
assessed using DNA Microarrays [HailesellasseSene et al 2007].  The EBS were 
generated by allowing ES cells to form multicellular aggregates in suspension culture.  
The factors that inhibit differentiation were removed in suspension culture.  The 
removal of this inhibition allowed the formation of patches of similarly differentiating 
cells; this is most easily observed when cardiomyocytes are formed as groups of 
beating cells [Kehat et al 2001, De Smedt et al 2008].   Some cell surface molecules 
are early differentiation markers in mES cells, e.g.  5T4 antigen [Ward et al 2003] and 
therefore are potentially useful as indicators of loss of pluripotency.  Some factors 
seem to be common between hES and mES cells when the switch from pluripotent to 
differentiating occurs, e.g.  Lamin AC [Constantinescu et al 2006]. 
 
Recently it has been shown that it is possible to generate a hES cell line without 
destroying the embryo.  In IVF treatments a single cell is extracted at the eightcell 
stage to conduct genetic tests, known as preimplantation genetic diagnosis (PGD).  If 
this cell is allowed to divide one cell can be used for the tests whilst the other can be 
used to generate a hES cell line [Klimanskaya et al 2006].  Multiple biopsies were 
taken from a number of embryos (which were not cultured further) and the single 
isolated blastomeres were allowed to grow overnight.  In total 19 samples gave ES 
like outgrowths with two stable hES cell lines being established.  These lines 
proliferated in an undifferentiated state for more than eight months and maintained the 
expression of a number of pluripotency markers including Oct4, SSEA3 and SSEA
4 [Klimanskaya et al 2006]. 
 
Ethical concerns led to research into characterising the pluripotent character of ES 
cells which in turn has led to the development of techniques to produce ESlike cells 
by treating skin cells with a combination of signalling factors.  These cells, termed 
Induced Pluripotent Stem (iPS) cells, have been shown to have many of the 
fundamental characteristics of ES cells (detailed above) and in the future may offer an 
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alternative to using ES cells.  They were first generated from mouse cells in 2006 
[Takahashi and Yamanaka 2006] and from human cells in 2007 [Yu et al 2007, 









Mouse skin cells were retrovirally transfected with Oct3/4, Sex determining region 
box (SOX) 2, cMyc, and Klf4 and then cultured under antibiotic selection for Fbx15 
to isolate the transfected cells [Takahashi and Yamanaka 2006].  This first iPS cell 
line showed some aberrant characteristics, namely a failure to produce chimaeras and 
further changes were made to the protocols by the original research group plus a 
number of other researchers [Takahashi and Yamanaka 2006, Takahashi et al 2007, 
Wernig et al 2007, Maherali et al 2007], specifically using a different marker, nanog, 
for selection purposes. 
 
iPS cells have the added potential bonus of offering a patient specific cell source for 
tissue engineering.  This would reduce the risk of rejection of transplanted tissue 
engineered organs to an absolute minimum as the cells should be recognised by the 
hosts’ immune system as self.  iPSlike cells have also been generated from adult 
human testis using similar methods [Conrad et al 2008].  Recently iPS cells have been 







ASC, sometimes called tissue specific stem cells, have many advantages from the 
tissue engineering standpoint.  Whilst they remain (largely) undifferentiated they are 
limited in the number of cell types they can form, usually to just those found in a 
single tissue type (although there are some exceptions such as haematopoietic stem 
cells).  The problems with using tissue specific ASC are associated with their isolation 
and maintenance in culture.  The ASC populations are often embedded deep in their 
respective tissues and only constitute a small fraction of the total cell number within a 
tissue.  This means that extracting and isolating the stem cells can be technically 
difficult.  Maintaining ASC in culture can also be problematic as they are often 
dependant on signalling from the surrounding tissues in vivo and once extracted from 
the in vivo tissue are programmed to undergo apoptosis.  This can mean that 
generating sufficient numbers of cells for in vitro tissue engineering applications is 
not straightforward. 
 
With ES cells the logistical challenges are different and there are also significant 
ethical concerns surrounding their use.  If a small sample of ES cells was taken from 
an individual and stored it would be a potential source for any cell based therapies 
they needed in their lifetime.  This can be achieved by the process known as ‘Cord 
Banking’ where a sample of pluripotent cells are taken from the umbilical cord 
following birth and cryogenically stored in anticipation of those cells being useful in 
future medical treatments [Harris et al 2007]. These cells would be immunogenically 
matched to the individual (‘self’) so there would be no risk of rejection as there is 
with donated organs.  The cells would also have the potential to develop into any type 
of cell providing that techniques to drive their differentiation towards the desired fate 
were available; the pluripotency of ES cells is an attractive feature but ways need to 
be developed to reproducibly and reliably differentiate them towards the desired cell 
fate. 
 
As detailed in Section 1.3 most techniques for doing this involve the generation of 
embryoid bodies. This technique is not always reliable and is not very efficient as the 
ES cells will randomly differentiate along multiple different pathways within the 
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aggregate.  If a specific cell type is desired it must be identified and isolated from the 
total population. 
 
The yield of a particular cell type may be enhanced by the addition of certain growth 
factors.  Once the cells have differentiated the desired cell type may be selected and 
purified providing an appropriate panel of markers is available.  The in vitro effects of 
eight different growth factors on the differentiation of hES cells (H9 clone) was 
examined [Schuldiner et al 2000].  hES cells were cultured on feeder layers in an 
undifferentiated state before being aggregated and cultured as EBs in suspension for 
five days.  The cells were then disaggregated using trypsin and replated in monolayer 
on fibronectin coated TCP.  The cells were then cultured with one of βFGF, TGFβ1, 
ActivinA (ActA), BMP4, Hepatocyte Growth Factor (HGF), EGF, Neural Growth 




Figure 1.8: Generation of embryoid bodies to produce differentiated cells from ES 
precursors [Schuldiner et al 2000]. 
 
The cells were then analysed for the expression of a range of markers of 
differentiation to the three germ layers by RTPCR.  Firstly the expression of the 
receptors for each of the growth factors used was analysed.  The expression of some 
of the receptors were negative/low in undifferentiated ES cells but were positive in 
five day EBs and in cells cultured in monolayer for 10 days after aggregation.  This 
indicated that the cells were receptive to the influence of the selected growth factors 
in the differentiation culture.  The expression of a panel of germlayer markers by the 
cells was then analysed.  The selected ectodermal markers were NFH (brain 
lineages), keratin (skin) and DβH (adrenal).  The selected mesodermal markers were 
enolase (muscle), CMP (bone), renin kallikrein (both renal), WT1 (urogenital), 
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cActin (cardiac), δ and βglobin (both haematopoietic).  The selected endodermal 
markers were albumin, α1AT (both hepatic), amylase, pdx1, insulin (all pancreatic) 
and AFP (definitive and visceral endoderm).  Although many of these conclusions 
have been challenged by later studies [D’Amour et al 2005] the methodology used 
here has remained an excellent template for later experimental work. 
 
Once the desired precursor cells have been isolated/generated they can be taken 
forward for functional analysis [Sinha et al 2006] and eventually be used in tissue 
engineering.  Transgenic mES cells that carried a Puromycin resistance gene driven 
by a Smooth Muscle αActin (SMαA) or Smooth Muscle Myosin Heavy Chain (SM
MHC) promoter were differentiated by aggregation into EBs.  The EBs were 
generated by the hanging droplet method with an initial formation period of three 
days and then a further three days in suspension culture.  The cells were then cultured 
in selective media to isolate the Puromycin resistant Smooth Muscle Cell (SMC)like 
cells.  These cells were analysed for the expression of SMC markers by 
immunofluorescence, FACS and RTPCR.  The ESderived cells expressed all the 
SMC markers tested at comparable levels with established SMC cell lines.  The 
markers tested included SMMHC, Myocardin and Calponin.  The physiological 
characteristics of the ESderived cells were also examined.  They demonstrated an 
ability to increase Ca2+ levels in response to depolarisation or vasoconstrictor 
treatment; a function that forms part of the mechanism by which contraction is 
induced [Sinha et al 2006]. 
 
The cells were seeded on strips of collagen gel to form artificial muscle fibres.  The 
contractile strength of these artificial constructs was compared to ex vivo muscle 
tissue fibres when treated with vasoactive agonists with the two sample sets proving 
comparable.  The ESderived cells showed a molecular profile and various 
physiological properties that were highly similar to established lines of SMCs.  
However the ESderived cells retained significant tumuorogenic potential when 
injected in vivo into mice that were genetically compatible to the original mES cell 
line used (D3).  Teratomas formed in a high number of injection sites in a variety of 
tissues where the generated SMCs had been integrated.  This problem was eliminated 
by extending selective culture for an additional three days before the cells were 
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injected to remove any fraction of the cell population that retained its pluripotent 
character [Sinha et al 2006]. 
 
In vitro directed ES cell differentiation towards a specified cell type has been 
particularly successful in a number of areas including osteogenesis [Buttery et al 
2001, Sottile et al 2003], pancreatic islet cells [Lumelsky et al 2001], cardiomyocytes 
[Kehat et al 2001], neural precursors and motor neurons [Zhang et al 2001, Wichterle 
et al 2002] and haematopoietic cells [Chadwick et al 2003]. 
 
ES cell differentiation towards the osteoblast fate was enhanced by treatment with 
ascorbic acid, βglycerophosphate, and/or dexamethasone/RA in serum containing 
media or by coculture with foetal murine osteoblasts [Buttery et al 2001].  
Differentiation was assessed based on the formation of (mineralised) bone nodules, 
where around 50 cells are embedded in a matrix of CollagenI and osteocalcin.  
Dexamethasone combined with ascorbic acid and βglycerophosphate produced a 
sevenfold increase in bone nodule frequency (compared to ES cells cultured alone) 
when added to the cultures after 14 days.  Coculture with foetal murine osteoblasts 
produced a fivefold increase in bone nodule frequency [Buttery et al 2001].   
 
hES cells have also been directed towards the osteogenic fate by in vitro treatments 
with growth factors [Sottile et al 2003].  Cell differentiation was assessed by 
examining the expression of osteogenic markers including osteocalcin, bone 
sialoprotein, osteopontin, and CollagenI as well as observing the formation of bone 
nodules (that contained hydroxyapatite) in culture. 
 
ES cells were directed towards bone and cartilage precursors via growth factor 
treatment [Kawaguchi et al 2005].  Initially the ES cells were aggregated into EBs and 
treated with RA.  This suppressed mesodermal differentiation but enhanced the 
differentiation of neural crest which can also contribute to mesenchymal cell fates.  
Further treatment with BMP4 produced osteogenic precursors whilst treatment with 
TGFβ produced chondrogenic precursors [Kawaguchi et al 2005]. 
 
Growth factor treatment can induce ES cell differentiation towards osteoblast, 
cartilage or adipogenic fates [Nieden et al 2005].  BMP2 combined with insulin, 
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ascorbic acid and TGFβ produced an increase in markers of cartilage differentiation 
including Sox9 (and reduced the expression of markers of other fates).  Adding β
glycerophosphate and Vitamin D3 prompted these cells to differentiate towards the 
osteoblast fate whilst some cells expressed markers of adipogenic fates [Nieden et al 
2005]. 
 
Tissue specific ECM was used to direct the differentiation of mES cells towards 
osteogenic fates [Evans et al 2010].  ES cells were aggregated into EBs then 
dissociated and cultured on (denuded) ECM prepared from the MOT3E1 osteogenic 
cell line.  ECM prepared from the (nonosteogenic) A549 cell line and Type I 
Collagen were used as controls.  Mineralisation and expression of osteogenic markers 
were increased on the MOT3E1 matrix compared to controls.  The osteoinductive 
effect was lost when the ECM was heated or treated with Trypsin suggesting that the 
specific protein compliment found in the ECM was responsible for the osteogenic 
effects [Evans et al 2010]. 
 
Other factors, including Simvastatin, have also been shown to enhance the osteogenic 
potential of mES cells in vitro [Pagkalos et al 2010].  Simvastatin concentrations of 
0.1 nM were sufficient to provide an osteoinductive effect (in the absence of other 
factors) measured both by alizarin red staining and expression of osteocalcin and 
osterix.  Higher (micromolar) concentrations of Simvastatin proved to be cytotoxic 
[Pagkalos et al 2010]. 
 
ES cell differentiation has been directed towards pancreatic cell lineages via a nestin
positive intermediate stage by culture in serum free media and treatment with basic 
FGF (bFGF) [Lumelsky et al 2001].  Cell differentiation was monitored by observing 
the expression of key molecular markers of pancreatic differentiation.  Whilst most of 
the selected nestin positive cells developed into neurons the expression of the DE 
markers Gata4 and HNF3β (FoxA2) and the (early) pancreatic transcription factor 
pdx1 was assessed by RTPCR in the initial stages of the differentiation protocol.  In 
the latter stages of the differentiation protocol the expression of (murine) Insulin I and 
II, Islet Amyloid Polypeptide and (the islet α cell marker) Glucagon was also 
monitored [Lumelsky et al 2001]. 
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The cells first expressed Gata4, HNF3β and pdx1 following aggregation into EBs 
however at this point the expression of the pluripotency markers Oct4 and alkaline 
phosphatase was maintained.  Expression of Gata4 and HNF3β was maintained at 
the end of the differentiation protocol at which point all of the pancreatic markers 
were also expressed.  Immunocytochemistry showed similar expression of the 
selected pancreatic markers.  Around 31% of the cells stained positive for insulin.  
The cells released insulin when stimulated with high glucose levels and also produced 
other pancreatic hormones.  These cells organised into islet (of Langerhans) like 
structures in vitro that were also observed following injection in vivo in diabetic mice 
where the structures also showed good vascularisation [Lumelsky et al 2001]. 
 
Treating mES cells with PI3K inhibitors produced pancreatic βlike cells [Hori et al 
2002(2)].  Following treatment the cells aggregated into Islet of Langerhanslike 
structures in vitro and produced insulin in a glucosedependant fashion.  When 
transplanted into diabetic mice all recipients survived and exhibited reduced weight 
loss and improved glycaemic control compared to untreated diabetic mice.  Analysis 
of the grafts following removal from the recipients (that subsequently ‘relapsed’ and 
died) showed no evidence of tumour formation with the ES derived cells retaining 
their differentiated characteristics [Hori et al 2002(2)]. 
 
Insulin producing cells have also been derived from hES cells [Segev et al 2004].  ES 
cells were aggregated into EBs then plated in media supplemented with fibronectin, 
insulin, selenium and transferrin, then media supplemented with bFGF, N2 and B27.  
Finally bFGF was replaced with Nicotinamide and the glucose concentration was 
reduced.  The cells were then dissociated and placed in suspension culture.  These 
cells formed clusters producing insulin and glucagon that exhibited elevated 
expression of pancreatic genes compared to controls [Segev et al 2004]. 
 
ES cells have also been differentiated towards the pancreatic lineage by coculture 
with primary hepatocytes [Banerjee et al 2011].  ES cells were differentiated to 
definitive endoderm by coculture with primary hepatocytes.  These cells were then 
further differentiated by culture on Matrigel with media supplemented with Shh 
inhibitors and RA.  >70% cells showed expression of Pdx1, a key pancreatic 
transcription factor, with a number of markers of pancreatic endocrine cells, including 
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Ngn3 and beta2, also upregulated.  These cells were then cocultured with endothelial 
cells which induced upregulated expression of Insulin 1 in 60% of the population.  
These ES derived cells began to secrete insulin [Banerjee et al 2011]. 
 
Cardiomyocytes have been generated from hES cells by aggregation into EBs and 
subsequent selection of those cells that began to spontaneously contract [Kehat et al 
2001].  Spontaneously contracting areas appeared in c.8% of the EBs. Cell 
differentiation was further assessed by antibody staining of the contracting regions 
and RTPCR for various cardiac markers including cardiac myosin heavy chain, 
desmin and cardiac troponin I.  Intracellular Ca2+ levels showed variation that 
corresponded with a contraction/relaxation cycle [Kehat et al 2001]. 
 
Cardiomyocytes have also been generated from IPS cells.  Human IPS cells (see 
Section 1.3) were differentiated towards the cardiomyocyte fate by aggregation into 
EBs alongside ES cells differentiated in the same fashion.  Contracting cells appeared 
in both conditions at a similar time and both displayed upregulation of some cardiac 
markers.  Pluripotency markers (Oct4 and nanog) were downregulated in both 
conditions but less so in the IPS cells (probably because both Oct4 and nanog were 
among the transgenes activated to induce pluripotency in the cells).  Both ES and IPS
derived cardiomyocytes proliferated at a similar rate.  Both sets of cells also displayed 
characteristics of a number of cardiac cells with evidence of sarcomere components 
(analysed by immunocytochemistry) and appropriate electrophysiological activity 
[Zhang et al 2009]. 
 
A number of studies have directed ES cells towards neuronal fates [Zhang et al 2001, 
Reubinoff et al 2001].  hES cells were directed towards the neural precursor fate by 
aggregation into EBs and treatment with FGF2. This population of cells was isolated 
and allowed to further differentiate (in FGF2 culture) giving rise to a number a neural 
cell types including neurons and astrocytes.  These cells were introduced into the 
brains of neonatal mice where they incorporated in a number of brain regions forming 
neurons and astrocytes without any teratoma formation [Zhang et al 2001].  Similar 
results were also obtained in other studies where neural progenitors capable of 
forming astrocytes, neurons and oligodendrocytes when transplanted in neonatal 
mouse brain were generated [Reubinoff et al 2001]. 
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ES cells differentiated towards the neuronal fate in vitro acquired the characteristics 
of particular subsets of cells following in vivo implantation [Peljto et al 2011].  
Evidence reviewed in this study suggested that ESderived neuronal cells contained 
populations of spinal (motor) neurons and cortical neurons [Peljto et al 2011]. 
 
hES cells have also been differentiated towards haematopoietic lineages by a 
combination of aggregation into EBs and treatment with Cytokines and BMP4 
[Chadwick et al 2003].  The addition of Cytokine factors for the first 10 days of 
culture as EBs proved particularly effective at enhancing differentiation towards the 
haematopoietic progenitor fate as determined by the positive expression of the cell 
surface marker CD45 [Chadwick et al 2003]. 
 
WNT3a and BMP4 enrich the differentiation of haematopoietic cells from hES cells 
in vitro [Wang and Nakayama 2009].  WNT3a increased levels of both haemogenic 
and angiogenic activity whilst BMP4 enriched angiogenic activity in ES derived cells 
indicated by a population of PDGFR+/KDR+ cells.  Addition of BMP inhibitors 
blocked the differentiating effects of WNT3a with the same effect observed with 
WNT inhibitors and BMP4 [Wang and Nakayama 2009]. 
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Replicating the tissue structure of the GI tract in vitro would be useful for drug 
screening, disease modelling and ultimately as an alternative to donor derived 
transplants.  The condition Short Bowel Syndrome (SBS) arises when most of the 
length of the small intestine is lost, either as a result of massive resection to treat 
gastrointestinal cancer or as a consequence of conditions such as Crohn’s disease.  
Radiotherapy used to treat cancer located in the pelvis or abdomen also often leads to 
radiation injuries to the intestine and a loss of the epithelial cell population.  If less 
than 50 cm of small intestine is left (equating to a 75% loss) the patient will be unable 
to absorb sufficient nutrients to stay alive and will therefore be dependent on 
parenteral nutrition.  Surgical intervention to slow the passage of material to the gut or 
to increase the surface area is possible but ultimately a transplant is required.   
 
Aside from the usual complications associated with transplant procedures, intestinal 
grafts have a very low success rate.  There are a large number of white blood cells 
found in the intestine which increases the risk of rejection whilst the large number of 
bacteria found in the gut increase the chances of postoperative infection.  Initial graft 
failure occurs frequently and even when successful there is a high rate of subsequent 
rejection due to the complex nature of the GI immune system.  Tissue ischemia and 
leaks from anastomosis sites are also common because of the complex nature of the 
surgery meaning that long term patient outlook is poor (although it is much improved 
compared with 10 years ago) with one year survival rates being 72% and five year 
survival rates being 50% (US statistics for 2010) 
[www.surveillance.cancer.gov/statistics/types/survival.html].  Survival rates in the 
UK (and W.Europe) are slightly lower than in the USA [www.cancerresearchuk.org]. 
 
Cancers of the intestine are one of the most common types of cancer in the Western 
world with cancers of the small intestine accounting for 0.5% of all cancers diagnosed 
in the USA [www.oncolink.com].  38606 patients were diagnosed with colorectal 
cancer in the UK in 2007 accounting for 13% of new cancer diagnosis 
[www.cancerresearchuk.org].  Intestinal cancers have a very high patient mortality 
rate due to the frequent occurrences of primary metastasis to the liver.  The far less 
severe but more frequent condition Irritable Bowel Syndrome (IBS) also affects many 
patients.  There are a number of types of inflammatory bowel diseases, such as 
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Crohn’s disease and ulcerative colitis.  These conditions can be contributing factors to 
the development of gastrointestinal cancers [MedlinePlus, www.nlm.nih.gov] and can 
require severe surgical intervention themselves.  Tissue engineered models could 
prove useful in studying the causes and progression of these diseases, for example 
investigation of microflora/gut interactions in IBS. 
 
Tissue engineered intestine could also be a very useful tool in pharmaceutical testing.  
One of the ‘gold standards’ for new medicines is that they should be orally dosable 
and therefore any candidate drug must be shown to survive transit through the 
digestive system and be absorbed through the intestinal wall into the blood stream.  
Much of the required testing is currently carried out on animals and using Caco2 cells, 
which are a human cancer cell line, but tissue engineered models would provide an 
alternative allowing the numbers of animals used in drugs trials to be substantially 
reduced and providing model tissues that more closely resemble the in vivo 
environment allowing for more meaningful data to be generated.  Such model systems 
would also be useful in studying diseases of the intestine.  New EU directives on the 
use of animals in research are clear that pursuing alternatives to the use of live 
animals in experiments should be one of the top priorities for all member states.  The 
Home Office, the government department responsible for regulating scientific 
research in the UK, has a series of guidelines and directives to facilitate this 
[http://scienceandresearch.homeoffice.gov.uk/animalresearch, Animals (Scientific 
Procedures) Act 1986]. 
 
Most current cell based GI tissue engineering is based upon growing small intestinal 
epithelial crypts in (primary) culture.  Tissue fragments are enzymatically digested 
into multicellular aggregates, known as organoids.  These organoids (which contain 
the intact crypts), first isolated from neonatal rat intestine, consist of a layer of 
epithelium (including the GI stem cells which can now be identified by staining for 
Msi1, or one of the other ISC markers detailed in Section 1.2.3) interspersed with 
small numbers of (mesenchymal) stromal cells [Evans et al 1992].  The presence of 
the stromal cells appears to be important in maintaining the stem cell niche. 
 
Small intestinal epithelial cells were maintained in vitro for up to one month 
following isolation from suckling rats [Evans et al 1992].  The small intestines of six 
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day old (male and female) Wistar rats were removed following sacrifice of the 
animals by cervical dislocation.  The tissue was cleaned and cut into sections of 
approximately 1 mm3 in size. The tissue was then further broken down by a variety of 
enzymatic treatments including Trypsin, Collagenase, Dispase, 1 mM EDTA in 
Hanks Balanced Salt Solution (HBSS) and Weiser solution [Flint et al 1991]. 
 
Using either Collagenase only or a combination of Collagenase and Dispase (at 20°C 
with agitation) gave the best outcome with regard to further culture of the cells 
following disaggregation.  Collagenase treatment produced small clumps of cells that 
adhered well to the culture vessel and demonstrated good further proliferation.  
Collagenase/Dispase treatment produced the organoid structures described above, 
where the spatial organisation of the whole tissue structure was maintained, that also 
demonstrated good attachment and further proliferation.  Cell numbers were assessed 
using the crystalviolet assay and proliferation was assessed by pulse labelling with 
tritiated thymine.  The cells were also stained with a range of antibodies to establish 
which cell types were present in the cultures [Flint et al 1991]. 
 
A number of media preparations were tested based on either DMEM or modified EM 
supplemented with FCS (between 2.5 – 10% (v/v)).  The cells grew best in fresh 
media preparations rather than those prepared from concentrated stocks, where almost 
no growth was seen.  Antibody staining showed that the vast majority (>90%) of the 
isolated cells were epithelial.  The remaining 10% consisted of smooth muscle cells 
with some myofibroblast like and endothelial cells.  Where higher concentrations of 
serum were present the smooth muscle cells tended to surround the clusters of 
epithelial cells [Flint et al 1991]. 
 
The epithelial cells were identified by positive staining for Cytokeratin eight with 
some weaker staining for Cytokeratins 18 and 19.  After some time in culture 
following isolation as the epithelial cells spread out the Cytokeratin reaction became 
weaker and the cells began to express Vimentin.  The nonepithelial cells showed no 
reactivity to the Cytokeratin antibodies. Smooth muscle cells were positive for SMαA 
expression; endothelial cells showed positive reactivity to OX43 antibody and also 
displayed the ability to take up Low Density Lipoprotein (LDL), a functional 
characteristic of endothelial cells; myofibroblast cells showed positive reactivity to a 
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Desmin antibody.  There were also some cells that displayed the morphology 
associated with neuronal cells such as dendrites [Flint et al 1991]. 
 
The serum concentration used in the culture media affected a number of significant 
experimental variables.  Firstly, the serum concentration affected the growth of the 
isolated cells; a minimum concentration (>1%) was required to maintain the intestinal 
epithelial cells following isolation and the cells showed increased growth at 10% 
serum compared with 2.5% serum.  Secondly, the serum concentration affected the 
growth of smooth muscle cells in the culture; at serum concentrations >2.5% the 
growth of smooth muscle cells was reduced and those that were present grew around 
the outside of the clusters of epithelial cells whilst at lower concentrations the cell 
types grew separately.  The coating of the culture vessel had an effect on the 
morphology of the cultured cells but did not appear to have any influence of their 
proliferation; using either complete ECM or (dried) collagen coating of the TCP 
vessel improved the attachment of the cells [Flint et al 1991]. 
 
These organoid units have been shown to develop into small intestine like structures 
that can be maintained in culture and used in further tissue engineering studies [Tait et 
al 1995, Choi and Vacanti 1997, Choi et al 1998].  The enzymatic activity and 
nutrient absorption/transport capacity of engineered mucosa was examined following 
ISC transplantation in rats [Tait et al 1995].  ISC transplantation was used to 
regenerate damaged intestinal epithelium in rats and 25 days after transplantation 
morphologically normally tissue had formed.  The functional characteristics of this 
tissue were evaluated by examining its nutrient transport ability and brush border (the 
microvillus covered intestinal epithelial surface) enzymatic activity.  The activity of a 
panel of enzymes including lactase, sucrase, aminopeptidase N, and alkaline 
phosphatase activity was determined by incubation with enzyme specific substrates.  
Nutrient transport was assessed using labelled (C14) glucose.  The results were 
compared with those from age matched control tissue samples and the level of activity 
was found to be similar [Tait et al 1995]. 
 
Small intestinal organoids [Evans et al 1992  see above] from six day old Lewis rats 
have been combined with biodegradable polymer scaffolds to produce tissue 
engineered intestine [Choi and Vacanti 1997].  These were combined with scaffolds 
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made of Polyglycolic acid (PGA) fibres of 15 µm in two different arrangements, 
either as 1 cm2 sheets or in a tubular conformation with an internal diameter of 5 mm.  
The average pore size in the scaffolds was 250 µm.  The organoids were seeded at a 
density of between 6400 – 22000 organoids per scaffold and allowed to attach for two 
hours prior to implantation into adult syngeneic (closely related to the donors) Lewis 
rats.  Unseeded sheet scaffolds were implanted as controls whilst some of the seeded 
tubular scaffolds were cultured in vitro overnight or for seven days prior to 
implantation.  The implants were recovered (following recipient sacrifice) between 
one and 12 weeks post implantation.  Following recovery the implants were fixed, 
wax embedded and sectioned (5 Xm sections) for histological assessment and 
antibody staining to identify particular cell types (antiαActin for smooth muscle 
cells and antilysozyme for Paneth cells) [Choi and Vacanti 1997]. 
 
Samples from both scaffold conformations (that had been implanted shortly after 
seeding) at two, six and eight weeks showed cysts with neomucosal growth.  The 
neomucosa consisted of columnar epithelium with invaginations that represented 
protocrypts and villi containing both goblet and Paneth cells (positive staining for 
lysozyme).  This epithelial layer was surrounded by vascularised tissue, fibroblasts, 
smooth muscle cells (indicated by positive staining for αActin), ECM and degrading 
polymer.  Those scaffolds that had been cultured in vitro prior to implantation did not 
display any neomucosal formation.  The controls showed evidence of some 
vascularisation but also stimulated a foreign body reaction/inflammation.  The 
implants generated tissue that morphologically resembled intestinal epithelium as well 
containing some of the specific cell types associated with it [Choi and Vacanti 1997]. 
 
The functional properties of engineered intestinal epithelial tissue [Choi and Vacanti 
1997] were examined [Choi et al 1998].  Some modifications were made to the 
protocol summarised above.  The PGA scaffolds were sprayed with 5% polylactic 
acid (PLA) and some of the scaffolds were coated with Collagen I.  The implants 
were recovered between two and 14 weeks post implantation.  The morphological and 
histological analysis gave similar results as above but in addition the expression of the 
brush border enzymes sucrase and lactase was shown by fluorescent microscopy 
using enzyme specific substrates.   
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The expression pattern of Laminin was also established with the basolateral pattern 
suggesting that cell polarity had been established.  The Transepithelial resistance 
(TER) of the engineered tissue was similar to native adult intestinal mucosa 
establishing that they had similar electrophysiological properties.  The implants had 
generated tissue that grew and survived in vivo and replicated the structure, molecular 
and physiological properties of native intestinal tissue [Choi et al 1998]. 
 
Further studies have indicated that engineered intestinal tissue integrates well with the 
native tissue when transplanted following intestinal resection [Kim et al 1999, Kim et 
al 1999 (2), Gricksheit et al 2004, Perez et al 2002].  Tissue engineered intestine was 
transplanted into adult Lewis rats and the effects on tissue regeneration were 
examined [Kim et al 1999].  Rat intestinal epithelial organoid units [Evans et al 1992] 
were seeded onto biodegradable polymer tubes [Choi and Vacanti 1997] and 
transplanted into adult Lewis rats.  The first group of animals had the seeded scaffolds 
implanted with no subsequent intervention.  The second group of animals had the 
implants anastomised to the native small bowel three weeks after implantation.  The 
third group were treated as the second but prior to implantation had had a small bowel 
resection. 
 
All three groups demonstrated cysts with neomucosal growth that resembled intestinal 
epithelium surrounded by vascularised tissue.  The anastomosis sites were all patent 
(the tissue was linked with an open lumen).  There were increased numbers of crypt 
and villi that were larger in size along with increased mucosal surface area in the 
animals where the implants had been anastomised in comparison to the animals where 
the scaffolds were just implanted. The same difference was apparent between animals 
where the implant had been anastomised and a small bowel resection had been carried 
out compared with the animals where the implant had been anastomised with no 
resection.  These results show that the scaffolds seeded with intestinal organoids can 
regenerate intestinal tissue and that anastomosis and small bowel resection act as 
stimuli for this regeneration [Kim et al 1999]. 
 
These techniques were further refined by examining which methods gave the most 
significant tissue regeneration [Kim et al 1999 (2)].  Some modifications were made 
to the protocol above with the inclusion of different experimental groups of animals.  
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The groups used were a control group where seeded scaffolds were implanted with no 
further intervention.  Group two animals were implanted following a 75% small 
bowel resection (SBR).  Group three animals were implanted following a portacaval 
shunt (PCS) where the hepatic portal vein is connected to the inferior vena cava.  
Group four animals were implanted following a partial (75%) hepatectomy – a partial 
resection of the liver.   
 
The formation of neointestinal crypts was monitored in vivo by ultrasonography three, 
seven and 10 weeks after implantation.  The implants were recovered 10 weeks after 
implantation.  Cysts formed in all the animals but were larger in the SBR group at 
seven and 10 weeks.  Histological analysis showed that the tissue was well 
vascularised with a neomucosal layer lining the lumen.  This layer had the crypt
villous architecture as in the native intestinal epithelium.  The crypts/villi were larger 
and more numerous and the mucosal surface area was greater in the SBR group 
compared with all the others.  The PCS group of animals displayed a greater number 
of larger crypts than the control group.  As with the previous study these results show 
that the scaffolds seeded with intestinal organoids can regenerate (well vascularised) 
intestinal tissue and that SBR, and to an extent PCS, act as stimuli for this 
regeneration [Kim et al 1999 (2)]. 
 
The functional properties of implanted engineered tissues, such as the immune cell 
complement, have been investigated [Perez et al 2002].  Immune defence is a key 
function of the intestine and therefore engineered tissue must demonstrate the same 
immune responses as native tissue.  Engineered intestine, generated in a similar 
fashion to the studies above using scaffolds seeded with organoids, was implanted in 
rats.  Some animals were implanted only whilst the other group had the implants 
anastomised to native tissue.  Samples from the engineered tissue (cysts) and native 
tissue were harvested between three and 56 weeks post implantation and screened for 
immune cell specific antigens by immunohistochemistry.   
 
The selected antigens were CD3 for T cells, CD32 for B cells, CD56 for NK cells and 
CD68 for macrophages.  Cell morphology was also examined using computer based 
analysis.  The anastomised implants showed a comparable immune cell complement 
to native tissue in the lamina propria and intraepithelial space 20 weeks after 
 
implantation.  In the mucosal layer the density of immune cells was less than in native 
tissue at both 10 and 20 weeks after implantation but the difference was less at 20 
weeks.  This data indicated that engineered tissue produced a similar complement of 
immune system cells to native tissue but these populations were restored due to tissue 
infiltration some time following implantation [Perez et al 2002]. 
 
The extent to which engineered tissue could replace the intestine following massive 
resection has also been examined [Gricksheit and Vacanti et al 2004].  In rats, the 
introduction of engineered small intestine significantly improved recovery after 
substantial resection of the small intestine.  Animals that received the engineered 
tissue lost body mass faster than the controls at first and reached their lowest body 
mass first.  They then showed much faster body mass gain and reached 98% of their 
preoperative body mass after 40 days compared with only 76% of preoperative body 
mass for animals who had not received any engineered tissue implant [Gricksheit and 
Vacanti et al 2004].  This data suggests that the engineered tissue integrated with the 
recipient at a systemic level and could contribute to recovery by significantly 
accelerating tissue regeneration.  
 
Some strategies have used cell free scaffolds to provide a framework for natural 
regeneration of the intestine.  In dogs inserting a collagen based scaffold allowed the 
regeneration of the epithelial layer of the small intestine [Hori et al 2001] but not the 
smooth muscle surrounding it.  The same scaffold seeded with mesenchymal stem 
cells (MSCs) also allowed some regeneration of the smooth muscle responsible for 
peristalsis [Hori et al 2002].   
 
A variety of types of scaffolds have been used in similar strategies.  A collagen 
sponge scaffold seeded with SMCs was implanted in dogs where the intestine had 
been resected [Nakase et al 2006].  The SMCs used were autologous having been 
isolated from the stomach wall of the animal patient previously.  After 12 weeks the 
seeded scaffolds showed the formation of a substantial epithelial layer with 
surrounding muscle tissue.  The control scaffolds which were not seeded with SMCs 
showed some epithelial formation but only a very thin layer of surrounding muscle 
was present [Nakase et al 2006]. 
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It has been shown in mice that introducing mES into a radiation damaged intestinal 
tract (simulating a postradiotherapy environment) can lead to a degree of 
repopulation [Kudo et al 2007].  The intestines of female nude mice were irradiated 
with a single 30 Gy dose and then a population of male derived mES cells was 
transplanted into the damaged intestine.  The intestines were then removed 13 or 27 
days following treatment and assessed for the presence of Ychromosome derived 
material by RTPCR.  The colonisation of the irradiated intestine and differentiation 
of the cells towards intestinal epithelial fates was assessed by histological methods 
and immunohistochemical analysis for SSEA1, SMαA and cytokeratin AE1/3.   
 
There was no improvement in the survival rate of the mice who received a cell 
transplant following irradiation compared to those irradiated mice that did not receive 
a transplant.  Proliferating (donor) cells, which were positive for Ychromosome 
DNA, were found to be present both 13 and 27 days after transplantation whilst in 
nontransplanted mice no proliferating cells were observed.  Histological staining and 
analysis showed cryptlike structures were evident after 13 days in the transplanted 
mice although some undifferentiated cells were also present.  There was positive 
reactivity to SSEA1 after 13 and 27 days which fitted with the observation that some 
cells remained undifferentiated.   
 
Positive reactivity was observed for both SMαA and cytokeratin suggesting that some 
of the transplanted mES cells were beginning to differentiate towards either the 
fibroblast or epithelial fates within the environs of the irradiated intestine.  This was 
not seen in the animals that had been irradiated but had not received a mES transplant.  
This study shows that undifferentiated cells may be stimulated to differentiate and 
become incorporated into damaged or regenerating tissue in vivo.  This shows that 
mES cells are receptive to signalling from the microenvironment into which they have 
been transplanted [Kudo et al 2007]. 
 
Gut like structures were generated in vitro from mES cells [Yamada et al 2002].  EB3 
mES cells were differentiated by aggregation into EBs using the hanging droplet 
method.  Following six days of culture the EBs were plated on gelatin coated 10 cm 
Petri dishes to allow further growth.  Some of the outgrowths formed gut like 
structures developing a lumen and demonstrating some mechanical activity within a 
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3D dome formation.  These were examined to see if they displayed the 
electrophysiological responses associated with gut function and evaluated for smooth 
muscle markers by immunohistochemistry.   
 
A number of the cellular clusters that formed demonstrated electrophysiological 
activity consistent with peristaltic patterns.  Several of the clusters gave positive 
expression of the interstitial cell marker CKIT, a cytokine receptor also known as 
CD117, and those that demonstrated electrophysiological activity also gave positive 
expression of a neuron specific Ubiquitin Cterminal Hydrolase,  Protein Gene 
Product 9.5 (PGP9.5).  The clusters also displayed spatial organisation similar to that 
found in the intestinal wall with an inner epithelial layer surrounded by smooth 
muscle cells [Yamada et al 2002]. 
 
mES cells were capable of forming gut associated structures that derive from all three 
germ layers [Torihashi et al 2006].  ES cells were aggregated into EBs using the 
hanging droplet method for six days and then replated to allow further growth.  The 
cells were examined for markers of gut structures by immunohistochemistry and 
morphologically by electron microscopy between two and 28 days (EB2 – EB28) 
after replating.  Gut like structures were transplanted under the kidney capsule of 
seven week old female severely compromised immunodeficient (SCID) mice.  Three 
weeks after transplantation the animals were sacrificed and the kidney tissues 
examined by RTPCR and immunohistochemistry.   
 
Potential gutlike structures were first observed at E4/5 with weak contractions 
observed in these structures at E10 with the contractions noticeably stronger at 
E14/15.  Immunohistochemical analysis showed the expression of ID2 in 
endoderm/epithelial formation before E10 with SMαA expressed in the surrounding 
smooth muscle layers from E15.  Germ layer markers such as FoxA2 were also 
expressed.  The structures began to appear more like gut structures from a 
morphological view with protovilli evident.   
 
Following transplantation the gut like structure grew in size to between three and five 
times their pretransplantation size.  Blood vessels and nerve fibres from the host had 
invaded the implanted structures.  The structures retained marker expression and in 
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some cases where early (E6) structures were implanted had gained gut marker 
expression during the three week implantation period.  Other gut markers such as 
Cdx2 were also being expressed.  In some cases the structures were maintained in vivo 
for an extended time period of 42 days.  There was no sign of teratoma formation 
even from the early stage implants.  These methods provide a way of generating small 
sections of intestinal tissue from mES cells and demonstrate the potential for ES cells 
to generate intestinal tissue given the correct stimuli [Torihashi et al 2006]. 
 
An alternative approach is to produce populations of cells that can form one part of 
the cellular compliment in the GI tract e.g.  the epithelial layer only.  For example it 
has been shown that human MSCs will form epithelial like cells in vitro [Paunescu et 
al 2007].  Human MSCs isolated from bone marrow were cultured with EGF, HGF, 
Keratinocyte Growth Factor (KGF) and Insulinlike Growth Factor 2 (ILGF2) for 
between seven  14 days.  When the cells exhibited a change in morphology to a more 
rounded shape the expression of the epithelial markers Cytokeratin 18 (by qPCR) and 
Cytokeratin 19 (by immunocytochemistry) was assessed.  Untreated MSCs did not 
exhibit positive expression of either marker but following growth factor treatment 
both markers were expressed in the cultured cells.  A number of MSC marker genes 
were also downregulated in the treated cells indicating that the MSCs exposed to the 
growth factor cocktail were differentiating towards the epithelial fate [Paunescu et al 
2007]. 
 
All GI tissue engineering carried out thus far has involved in vivo techniques and 
tissue derived material.  This places limits on the applications that such tissue could 
be used for, particularly potential clinical uses.  For any tissue engineered product to 
be sanctioned for human clinical use (e.g. a nondonor derived transplant) all the steps 
and material used would have to be of nonanimal origin.  It further highlights the 






The growth factor ActA is a member of the TGFβ superfamily of signalling 
molecules (see Figure 3.1.1, Section 3.1).  It acts by binding to Type I and II Activin 
receptors on the cell surface which then activate SMAD 2 & 3 molecules which in 
turn interact with the DNA a transcriptional response activating genes involved in the 
specification of DE as well as genes involved in gonadal growth and placental 
formation. 
 
It has been known for some years that Activin (and Inhibin) recombinant protein can 
influence the differentiation of multipotent cells [Broxmeyer et al 1988].  Activin 
enhances the release of Follicle Stimulating Hormone (FSH) in vitro whilst Inhibin 
inhibits it.  Human multipotent bone marrow cells were exposed to either ActA or 
InhibinA in vitro and the effects on cell differentiation were assessed by various 
colony forming unit (CFU) assays.  The BFUE assay assesses the erythroid colonies 
(at the proerythroblast stage), the CFUGEMM assay assesses the formation of 
myeloid multipotent progenitor cells (granulocyte, erythrocyte, monocyte, and 
megakaryocyte) and the CFUGM assay assesses the formation of granulocyte or 
macrophage progenitors.   
 
In bone marrow cells ActA enhanced BFUE colony formation twofold over 
controls and CFUGEMM colony formation sevenfold over controls.  InhibinA 
showed a significant suppressing influence on BFUE and CFUGEMM colony 
formation.  Both molecules seemed to act via a nondirect mechanism as the addition 
of certain intermediate signalling factors added to or suppressed the effects of the two 
growth factors.  Neither molecule produced significant effects in the CFUGM assay.  
Treating multipotent bone marrow cells with ActA seems to enhance the 
differentiation of various haematopoietic progenitors whilst treatment with InhibinA 
has the opposite effect [Broxmeyer et al 1988]. 
 
The response of undifferentiated cells to Activin is known to be concentration 
dependant as in development the effects of Activin signalling are reduced over 
distance from signal source – as the concentration gradient falls. ActA is dispersed 
by passive diffusion [Gurdon et al 1994]. 
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More recently it has been shown that ActA can induce ES cells (both human and 
murine) to differentiate towards the definitive endodermal lineage [Kubo et al 2004, 
Tada et al 2005, Yasunaga et al 2005, D’Amour et al 2005, MacClean et al 2007].  
This work is discussed in detail in Section 3.1.  The definitive endoderm (DE) is the 
germ layer that gives rise to the GI tract and other visceral organs during development 
(Figure 1.9).  It is distinct from the visceral endoderm that gives rise to a number of 
extraembryonic structures.  The other two germ layers are the mesoderm, that gives 
rise to the skeleton and muscles (including the smooth muscle surrounding the 
intestine and cardiac muscle), and the ectoderm, that gives rise to the nervous system 
(including the brain) and the skin. 
 
This differentiation can be monitored by observing the expression of key marker 
genes at both the mRNA and protein levels.  By comparing the levels of expression of 
these markers expressed by cells cultured in the presence of ActA with a number of 
control conditions the relative efficiencies with which the cells differentiate towards a 
particular fate can be determined.  A variety of endodermal markers have been 
identified (summarised in Section 3.1.2). 
 
Chemokine CXC motif Receptor 4 (CXCR4), also known as Fusin, is an alpha
chemokine cell surface receptor specific for stromal derived factor1 (SDF1) [Kucia 
et al 2004].  It plays a role in embryo implantation and is important in the mechanism 
of HIV infection.  GATA Binding protein 4 (GATA4) is a member of a family of zinc 
finger transcription factors that bind a core GATA motif [Liew et al 2005].  The co
expression of the transcription factors Sex Determining Region Box 17 (Sox17) 
[KaniaAzuma et al 2002, Tam et al 2003] and Forkhead Box A2 (FoxA2) [Ang et al 
1993], also known as Hepatic Nuclear Factor 3β (HNF3β), indicates the production 
of definitive endoderm.  The expression of HNF factors in the absence of Sox17 is an 
indication of visceral rather than definitive endoderm [Duncan et al 1994].  HNF4 
expression is found in embryonic gut and nephrons but is also expressed in a number 
of extraembryonic structures.  In Sox17null mutant mice endoderm derived 
structures, particularly the gut, are reduced [KaniaAzuma et al 2002].  It is important 
to distinguish this from visceral endoderm which only contributes to extraembryonic 





Figure 1.9: Development of the early embryo & formation of the 3 germ layers 
(endoderm, mesoderm & ectoderm) at gastrulation.  ES cells are generated from 
Blastocysts. 
 
The Sox gene family are transcription factors that bind to the minor groove of the 
DNA double helix and contain a high mobility group (HMG) box binding motif 
[Lefebvre et al 2007, Shivdasani 2002].  They are highly conserved across all 
eukaryotes.  Sox17 is a member of the SoxF subfamily along with Sox7 and Sox18.  
FoxA2 is a transcription factor and contains a winged helix DNA binding domain as 
do the closely related FoxA1 (HNF3α) and FoxA3 (HNF3γ) [Friedman and Kaestner 
2006, Kaestner 2010]. 
 
Other TGFβ family members, such as Nodal, may also play a role in DE and 
mesoderm differentiation of ES cells in vitro [Takenaga et al 2007].  Nodal signalling 
plays a role in the specification of mesoderm and DE during gastrulation.  By 
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generating an ES cell line with a Tetracycline inducible promoter regulating Nodal 
expression, the effects of Nodal on the differentiation of the ES cells were readily 
observable by RTPCR analysis of key marker gene expression.  Initially upregulated 
Nodal expression enhanced differentiation towards the mesodermal and DE germ 
layers indicated by the expression of markers such as Gsc and FoxA2.  Continued 
elevated Nodal expression resulted in teratoma formation and the maintenance of the 
expression of pluripotency markers such as Oct3/4.   
 
If Nodal expression was downregulated following an initial period of elevated 
expression this lead to further differentiation towards the gut lineage indicated by the 
expression of markers such as pancreatic and duodenal homeobox 1 (Pdx1) and 
Albumin 1.  Neural/ectodermal markers, such as βtubulin III, were downregulated in 
the Nodal expressing cells.  Nodal expression can be used to initiate ES cells to 
differentiate into mesoderm and DE but for further maturation to occur Nodal 
signalling must be downregulated.  Sorting the cells by FACS using cell surface 
markers such as CXCR4 showed that the differentiation of ES towards the 
mesodermal and DE fates was highly efficient. 
 
Some other TGFβ family members were upregulated in the upregulated Nodal 
expressing cells and therefore some of the differentiation effects may not be directly 
caused by Nodal activity.  These Nodal expressing cells also initiated mesoderm/DE 
differentiation in unaltered ES cells when they were cultured together or Nodal cell 
CM was used.  Treatment with 100 ng/ml recombinant Nodal protein did not produce 







For tissue engineering to continue to advance from the research environment into 
clinical application it is crucial to have a readily available cell source for a variety of 
tissues.  ES cells provide an attractive option to tissue engineers for a number of 
reasons but particularly due to their pluripotent nature.  However this ability to take 
on multiple fates can also be something of a weakness as researchers need to generate 
pure populations containing one cell type, or rather the cell types found in a single 
tissue.   
 
Reproducibly and reliably specifying a particular fate for ES cells is therefore one of 
the primary challenges facing regenerative medicine.  The primary aim of this project 
is to generate intestinal progenitors from ES cells in sufficient numbers for intestinal 
epithelial tissue engineering applications (a significant proportion of the ES cells 
introduced into the differentiation conditions should end up specified as the desired 
cell type). 
 
One way of achieving controlled ES cell differentiation is to replicate the conditions 
under which a particular tissue develops naturally.  In the case of the GI epithelium 
this development involves a complex pattern of signalling with the overlying smooth 
muscle layer (that is derived from the mesoderm) that surrounds the epithelial layer 
(that is derived from the endoderm); artificially replicating the array of signals 
involved in this process would be highly complicated.  Recent reports have 
demonstrated that ES cells can be induced to differentiate to tissue specific lineages 
by creating a microenvironment that possesses the early signalling events that drive 
ES cell differentiation. 
 
Such microenvironments have been established in vitro using embryonic tissue from 
the developing mouse or chick to promote pulmonary epithelial [Van Vranken et al 
2005], photoreceptor [Sugie et al 2005], haematopoietic [Krassowska et al 2006] and 
hepatic [Fair et al 2003] differentiation respectively.  By coculturing mES cells or 
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hES cells with early embryonic chick gut tissue early signalling factors would be 
present and may therefore provide an environment that is able to direct ES cell 
differentiation towards the endodermal and hence gut lineages.   
 
A number of studies have been conducted [D’Amour et al 2005, MacClean et al 2007, 
Kubo et al 2004, Tada et al 2005, Yasunaga et al 2005] to show that fairly simple cell 
culture treatments can favour the formation of DE, the germ layer from which the 
gastrointestinal epithelium arises, from ES cells.  By combining these in vitro 
treatments with the coculture of ES cells with early chick gut tissue the ES cells 
should be directed to differentiate toward the intestinal fate. 
 
 
Hypothesis: The differentiation of murine and human ES cell into intestinal 
progenitors can be directed specifically by signalling from the gut mesenchymal 
microenvironment of the developing chick. 
 
 
Based on this hypothesis it is proposed to establish methodologies to derive intestinal 
stem cell/progenitor populations in vitro in a controlled fashion for future tissue 
engineering research projects.  To test the hypothesis, gut tissue from chick embryos 
will be isolated at various stages of development.  The tissue will be maintained in 
culture and ES cells (both undifferentiated and those that have been differentiated 
towards DE using in vitro stimulation) will be injected into the mesenchymal tissue 
surrounding the gut organoid. 
 
Following culture, the cells will be extracted from the tissue and purified using flow 
cytometry and profiled using RTPCR, immunocytochemistry and western blotting 
for markers of definitive endoderm and intestinal epithelial differentiation.  If the cells 
display the molecular characteristics of intestinal precursors they will be functionally 
evaluated by culturing them in a model coculture system with intestinal subepithelial 
myofibroblasts (ISEMFs) [Beltinger et al 1999] to examine if they organise and 




Therefore the main aims of this project are to:  
 
 Establish the viability of early embryonic chick gut tissue in culture measuring 
any degradation of tissue quality and viability that occurs over time. 
 
 Replicate previously described procedures for differentiating mES (& hES) 
cells to DE in vitro to determine the method is consistent for the Columnar 
Epithelial Epiblast (CEE) mES cell line being used in our laboratories. 
 
 To coculture mES cells with early chick gut tissue and show that the injected 
cells can be recovered and purified and that they are differentiating into 
gastrointestinal epithelial progenitors and/or differentiated intestinal cells. 
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CEE mES cells (between passages 15  30) [Buttery et al 2001, Gothard et al 2010] 
were maintained on (LIF producing) Sto Neo Leukaemic feeder cells (inactivated 
mouse fibroblasts, SNLs) [Williams et al 1988] at 37°C, 5% CO2 in air in T25 tissue 
culture treated plastic (TCP) flasks (Nunc, UK) that had been gelatin (Sigma, UK) 
coated.  The cocultures were maintained in a monolayer in DMEM (Gibco, UK) 
supplemented with 10% (v/v) FCS (Sigma, UK), 2 mM LGlut (Sigma, UK), 1% (v/v) 
antibiotics and antimycotics (ABAM, Sigma, UK), 100 XM βMercaptoethanol (β
MCPE, Sigma, UK) and LIF (Sigma, UK) at 5 x 10³ units/ml (referred to as mES 
complete media, see Section 6.4 for full media ‘recipes’). 
 
When the cells reached c.80% confluence they were passaged by treatment with 
0.25% (v/v) Trypsin (Sigma, UK) in 0.02% (w/v) EDTA (Sigma, UK).  Please note 
that all Trypsin treatments were carried out using this formulation referred to as 
Trypsin/EDTA henceforth.  The media was removed from the flask and the cells were 
washed with Phosphate Buffered Saline (PBS, Sigma, UK) to remove any residual 
proteins from the media that might inactivate the Trypsin and to remove nonviable 
cells.  Trypsin/EDTA (3 ml) in PBS that had been prewarmed was added to each 
flask for a few seconds (until cells could be seen lifting off the bottom of the flask).  
The cell suspension was transferred to a 15 ml centrifuge tube and aspirated up and 
down to generate a single cell suspension.  mES complete cell media (6 ml) was 
added to each tube to inactivate the Trypsin.  The cell suspension was centrifuged at 
200 g for five minutes to pellet the cells.  The supernatant was discarded and the cells 
were resuspended in 4  20 ml of fresh mES complete media.  Cell suspension (1 ml) 
was seeded into 4 ml of mES complete media in a fresh flask and incubated. 
 
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Confluent T75 cell culture treated flasks (Nunc, UK) of SNL Fibroblasts were treated 
with 1 ml of 0.1 mg/ml MitomycinC (Sigma, UK, final concentration 0.01 mg/ml) 
This chemical causes the cell cycle to arrest by blocking DNA synthesis and nuclear 
division preventing further proliferation of the cells whilst maintaining cell viability 
[Tomasz 1995].  The cells were then incubated with MitomycinC for two hours at 
37°C in 5% CO2 in air after which time the flasks were washed three times with PBS 
then treated with Trypsin/EDTA to dissociate the cells.  The cells were then 
transferred to a 15 ml Falcon tube containing SNL complete media (as mES complete 
media above but LIF, see Section 6.4) supplemented with 10% (v/v) FCS to 
inactivate the Trypsin.  The cell suspension was then centrifuged at 200 g for five 
minutes.  The supernatant was then removed and the pellet resuspended in SNL 
complete media (2 ml).  A cell count was carried out using an Improved Neubauer 
Haemocytometer. 
 
SNL complete media (5 ml) was added to gelatin coated cell culture flasks (see 
Section 2.1.3 below) and the cells seeded at 8 x 104 cells/ml (4 x 105 cells/flask).  The 
flasks were then gently agitated to ensure an even distribution of the cells and 
incubated overnight at 37°C, 5% CO2 in air to allow the SNL cells to adhere to the 
cell culture surface before being seeded with mES cells.  The flasks remained usable 
for two weeks after preparation; maintenance of fibroblast morphology and 




Gelatin was made up at 2% (w/v) solution and stored at 4°C.  This was diluted to 
0.1% (v/v) in PBS (5 ml gelatin in 95 ml PBS) and filtered; 3 ml was then added to a 
cell culture flask or 1 ml per well of a six well TCP plate (Nunc, UK).  The flasks or 
plates were then left for at least two hours at room temperature; excess gelatin 
solution was removed before cell seeding. 
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Collagen IV (Fluka, UK; used to enhance mES cell adherence to the TCP surface 
[Khoshnoodi et al 2008]) was made up at 0.5% (w/v) solution in acidified water and 
stored at 4°C.  This was diluted to 0.01% (v/v) in PBS, filtered (using a 0.2Xm filter) 
and 1 ml added per well of a six well TCP plate. The plates were left for at least two 
hours at room temperature before being seeded with cells. 
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CEE mES cells that had been maintained as described in Section 2.1.1 for between 15 
 25 passages were washed with PBS (3 ml) and treated with Trypsin/EDTA (2 ml) to 
generate a single cell suspension; the concentration of the cell suspension was 
determined by counting with a Neubauer improved haemocytometer. The CEE mES 
cells were seeded (5 x 104 – 1 x 106 cells/ml) in nonTCP six well plates in DMEM 
supplemented with 1% (v/v) FCS, 1% (v/v) Penicillin/Streptomycin (Pen/Strep, 
Sigma, UK, 100U Penicillin and 100 ng Streptomycin per ml) and 1% (v/v) LGlut (2 
mM). The plates were then placed in agitated culture at 37°C, 5% CO2 in air (on an 
orbital plate shaker set at 15 rpm) for a minimum of six hours. The media was 
supplemented further to gain a final concentration of 10% (v/v) FCS (by the addition 
of 90 Xl FCS per ml of media/ 180 Xl per well) and the plates were transferred to 
static culture at 37ºC, 5% CO2 in air for a minimum of two days. 
 
When media changes were required, based on the colour change of the Phenol red pH 
indicator in the media [Rahat and Reich 1983], standard SNL complete media (10% 
(v/v) FCS) was used. Phenol red is yellow at pH ≤ 6.8, red between pH 6.8 – 8.2 and 
pink at pH ≥ 8.2.  If any specific growth factors were to be used the media was 
supplemented with them at the required concentration (details given in the methods 
sections of the relevant results chapters). To reseed the cells in monolayer the EBs 
were washed with PBS then treated with prewarmed Trypsin/EDTA (3 ml) to 






2.2.1i Cultured cells 
At the designated timepoints for each experiment media was removed from the cells 
in culture which were then washed three times with PBS (3 ml).  The cells were then 
detached/disaggregated by treatment with Trypsin/EDTA that had been prewarmed 
to 37°C.  The cell suspension was then transferred to a 15 ml centrifuge tube and 
neutralised by the addition of DMEM supplemented with 10% (v/v) FCS and the cell 
suspension was centrifuged at 200 g for five minutes to pellet the cells.  The 
supernatant was removed and the cells were resuspended in lysis buffer; either Tri
reagent (Sigma, T9424) or RNeasy MiniPrep kit RLT buffer (Qiagen, 74101) were 
used.  The samples were then stored at 80°C until required. 
 
2.2.1ii Tissue samples 
Samples were washed thoroughly with PBS.  Larger tissue pieces were manually 
broken up using sterile forceps prior to enzymatic digestion.  The tissue pieces were 
broken down using a dispasecollagenase digestion media (DMEM, 1% (v/v) FCS, 
1% (w/v) AB/AM, 1% (w/v) LGlut, 75 U/ml collagenase XI, Sigma, 20 µg/ml 
dispase, Sigma).  The explants were transferred to fresh nonTCP six well plates 
containing the digestion media and incubated for two  three hours at 37°C on a 
shaker.  The cell suspension produced from the dispasecollagenase digest was 
pelleted by centrifugation at 200 g for five minutes, then washed with PBS and 
repelleted before being resuspended in lysis buffer as detailed above in Section 2.2.1i.  






2.2.2i RNA sample preparation using Trireagent. 
Samples lysed in trireagent were purified by ethanol precipitation.  The samples were 
thawed and allowed to stand at room temperature for five minutes.  Chloroform (that 
did not contain isoamyl alcohol or other additives) was added to each sample at a 
 	
volume of 0.2 ml per 1 ml of Trireagent used in the lysis of the sample.  The sample 
was covered, shaken vigorously and then allowed to stand at room temperature for 
between two  15 minutes prior to centrifugation at 12000 g for 15 minutes at 4°C.  
The sample separated into three distinct phases; a (red) organic phase at the bottom 
containing protein, a narrow interphase band containing DNA and a (colourless) 
aqueous phase uppermost containing RNA.   
 
The aqueous phase was transferred to a fresh tube and 0.5 ml of isopropanol was 
added per 1 ml of trireagent used in the original sample preparation.  The sample was 
well mixed and allowed to stand at room temperature for five  10 minutes and then 
centrifuged at 12000 g for 10 minutes at 4ºC; the RNA formed a pellet at the bottom 
and side of the tube.  The supernatant was removed and the sample was washed in (at 
least) an equal volume of 75% (v/v) ethanol in water per volume of trireagent used in 
the original sample preparation.  The sample was vortexed and then centrifuged at 
7500 g for five minutes at 4°C.  Most of the supernatant was removed and then the 
pellet was allowed to air dry (in a flow hood).  The pellet was then resuspended in an 
appropriate volume of nuclease free water. 
 
2.2.2ii RNA sample preparation using RLT buffer. 
Samples lysed in RLT buffer were thawed and then purified using RNeasy 
MiniKit/columns (all the buffers used are components in the kit, Qiagen) according to 
the manufacturer’s instructions.  The sample was homogenised by adding an equal 
volume of 70% (v/v) ethanol.  The sample was mixed and then transferred to an 
RNeasy column in a 2 ml tube.  This was centrifuged at ≥8000 g for 15 seconds and 
the flow through discarded.  RW1 buffer (700 Xl) was added to the column which was 
centrifuged at ≥8000 g for 15 seconds and the flow through discarded.  RPE buffer 
(500 Xl) was then added to the column which was centrifuged at ≥8000 g for 15 
seconds and the flow through discarded.  A further 500 Xl of buffer RPE was added to 
the column which was centrifuged at ≥8000 g for two minutes and the flow through 




The column was transferred to a fresh 2 ml tube and centrifuged at full speed (13000 
g) for one minute.  The column was then transferred to a 1.5 ml collection tube.  
RNase free water (50 Xl) was added to elute the RNA from the column.  This was 
then centrifuged at ≥8000 g for one minute.  The elution step was then repeated to 
give a final sample volume of 100 Xl.  The RNA content of all the purified samples 
were then quantified using a NanoDrop spectrophotometer (Thermo Scientific) and 






At the designated time points for each experiment (details given in individual results 
chapters) media was removed from the cells in culture which were then washed with 
PBS.  The cells were then fixed by treatment with 4% (w/v) Formalin (Sigma, 
HT501128) for 20 minutes at room temperature.  The cells were then washed three 
times with PBS and then stored at 4°C under PBS until required.  The plates were 
sealed with Parafilm to prevent desiccation.  See Chapter Four, sections 4.2.13 and 




2.2.4i Western blot sample collection from cultured cells 
At the designated timepoints for each experiment media was removed from the cells 
in culture which were then washed three times with PBS (3 ml).  The cells were then 
detached/disaggregated by treatment with Trypsin/EDTA that had been prewarmed 
to 37°C.  The Trypsin was then neutralised by the addition of DMEM supplemented 
with 10% (v/v) FCS and the cell suspension was centrifuged at 200 g for five minutes 
to pellet the cells. 
 
2.2.4ii Western blot sample collection from tissue samples 
Samples were washed thoroughly with PBS.  Larger tissue pieces were manually 
broken up.  The tissue pieces were broken down using a dispasecollagenase digestion 
media (DMEM, 1% (v/v) FCS, 1% (w/v) ABAM, 1% (w/v) LGlut, 75 U/ml 
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collagenase XI, 20 µg/ml dispase).  The explants were transferred to fresh nonTCP 
six well plates containing the digestion media and incubated for two  three hours at 
37°C on a shaker.  The cell suspension produced from the dispasecollagenase digest 






Cells or tissue samples (as collected in sections 2.2.4i and 2.2.4ii) were suspended in 
freshly prepared lysis buffer (1% (v/v) Triton X100, 20 mM Tris HCl, 150 mM 
NaCl) containing 1:1000 EDTAfree protease inhibitor cocktail (Boehringer 
Mannheim, Germany), 1 mM Phenylmethanesulphonylfluoride (PMSF) and 1 mM 
EDTA in deionised water (dH2O).  The samples were then lysed on ice for 30 
minutes.  The lysate was centrifuged at 14000 g for 10 minutes and the supernatant 
containing the solubilised protein was collected and then stored at 80°C until 
required.  The protein content was determined by the Bicinchoninic acid (BCA) assay 
or using the NanoDrop spectrophotometer. 
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The BCA assay (aka the Smith assay) [Smith et al 1985] was carried out using a 
QuantiPro® BCA assay kit (Sigma, UK) according to the manufacturers’ instructions.  
A series of protein (Bovine Serum Albumin (BSA)) standard solutions were prepared 
(0 – 10 mg/ml total protein) to produce a standard curve including blanks.  A volume 
of each sample (40 Xl) was combined with 40 Xl of the reaction mixture in a flat 
bottomed 96 well plate and incubated for one hour at 37°C in the dark.  The 
absorbance reading at 560 nm was then determined using a KC4 plate reader 
(BioTek).  A standard curve was generated by plotting protein concentration (Xaxis) 
against absorbance at 560 nm (Yaxis) using the data from the known standard 
solutions. The absorbance values for the unknown samples were then used to 
determine their protein content using the equation of the straight line generated from 




Primers were designed using Ensemble (www.ensembl.org) for sequence information 
and Primer 3 (http://frodo.wi.mit.edu/).  Sequences were then checked using BLAST 
(www.ncbi.nlm.nih.gov) to ensure that they were specific for the desired gene only.  
GAPDH primers that had previously been designed within the Tissue Engineering 
group were used as a ubiquitously expressed control to confirm the RT stage of the 
reaction had worked.  The primers were then ordered from MWGOperon. 
 
Reaction conditions for each primer pair were optimised using RNA prepared from 
undifferentiated mES cells, embryoid bodies, early stage mouse embryos and total 
mouse RNA (Applied Biosystems UK, AM7800) for the murine primers.  Chick 
primers were optimised using RNA generated from whole chick embryos (at various 
stages of development), decapitated embryos and excised gut tissue.  Full primer 
details can be found in the relevant experimental chapter methods section (Section 
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RT and PCR reactions were carried out on a Px2 Thermal Cycler (Thermo Electron 
Corporation) in thin walled 200 Xl PCR reaction tubes (Qiagen, 114028100).  In the 
RT reaction, 1 Xg of total RNA was used for each sample.  This was added to the 
reaction mixtures detailed in Table 2.1A below.  Reaction Mixture One was incubated 
at 65°C for 10 minutes to denature any secondary RNA structures.  Reaction Mixture 
Two was then added and the total mixture was incubated at 55°C for two hours.  The 
temperature was then raised to 85°C for 10 minutes to denature the reverse 
transcriptase enzyme, halting the reaction.  The cDNA product was then stored at 
20°C until required. 
 
The product from the RT reaction was used as the template in the PCR reaction 
mixtures outlined in Table 2.1B.  Aliquots of Master Mix One and Two (enzymes and 
buffers from Roche, dNTPs from Sigma, UK) were mixed and 5 Xl of template was 
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added.  These were then run on a PCR program with the general parameters of an 
initial denaturation incubation of 10 minutes at 94°C.   This was followed by n cycles 
(see Table 3.2.4 and 4.2.1 for primer pair details) at 94°C for 30 seconds, X°C for 30 
seconds (see Table 3.2.4 and 4.2.1 for primer pair details) and then 72°C for one 
minute.  This was followed by a final extension incubation of 10 minutes at 72°C.  






Agarose gels were prepared by melting 2% (w/v) high grade agarose (Sigma, UK) in 
TrisBorate EDTA (TBE, Sigma, UK) electrophoresis buffer in a microwave.  This 
was allowed to cool to approximately 60°C before Ethidium Bromide (EtBr) was 
added to the molten gel.  The molten gel was poured into a gel tray, combs inserted in 
place and the gel allowed to set. Once the gel had set, it was transferred to an 
electrophoresis tank filled with TBE buffer.  The samples were mixed with 1 Xl 
loading buffer (Sigma, UK) per 9 Xl of sample.  Each sample (10 Xl) was then loaded 
into a separate well in the gel.  A ladder consisting of known fragment sizes (see 
Figure 2.1) was also loaded into a well.  An electric current (100 mV, 100 mA) was 
then passed across the gel.  The negatively charged DNA migrates towards the 
positive terminal.  The fragments separate according to size as smaller fragments are 
able to move faster through the gel matrix.  After 20 – 30 minutes the current was 
stopped and the gel removed from the tank and imaged using a UV transilluminator. 
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Figure 2.1: 100 base pair (bp) fragment PCR ladder. 
 
Following imaging the bands obtained were (subjectively) scored on a scale of one – 
seven based upon relative size (pixel count) and brightness (pixel intensity).  A 
guideline to these scores can be found in Section 6.4. 
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The expression of proteins of interest within samples was analysed using the 
appropriate antibodies against the products of the genes of interest at the protein level 
by either fluorescence or enzymatic immunocytochemistry.  Details of the primary 
antibodies used are given in Table 2.2. 
 
2.2.10i Fluorescence immunocytochemistry 
Fixed samples (as prepared in Section 2.2.3) were washed in PBS.  The samples were 
then permeabilised by treatment with 0.1% (v/v) Triton X100 for one hour at 4°C, 
nonspecific protein binding sites were blocked with 2% (w/v) BSA in PBS for one 
hour before being incubated overnight at 4°C in primary antibody (Santa Cruz 
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biotechnology, see Table 2.2) diluted 1:200 in PBS including the appropriate blocking 
serum (i.e. serum from the animal species in which the secondary antibody was 
raised).  The samples were then washed in PBS before being incubated in 
fluorescently tagged secondary antibodies overnight at 4°C.  The samples were then 
washed in PBS and all proteins immobilised by treatment with 4% (w/v) 
Paraformaldehyde (PFA) in PBS for five minutes at room temperature.  The samples 
were washed with PBS and then incubated with DAPI for 60 seconds and then 
washed with PBS again.  Finally the samples were mounted using a fluorescence 
preserving mounting agent such as 2.5% (w/v) Polyvinylacetate (PVA)/14 
Diazabicyclo222octane (DABCO) or Vectashield (Vector Labs, H1000).  The 
samples were then visualised using a Nikon fluorescence microscope. 
 
2.2.10ii Enzymatic immunocytochemistry 
The fixed samples were washed in PBS.  The samples were then permeabilised by 
treatment with 0.1% (v/v) Triton X100 for one hour at 4ºC.  The cells were then 
treated with 1  3% (v/v) Hydrogen Peroxide (H2O2) for one hour at room temperature 
to quench any endogenous peroxidase activity.  The cells were then washed in PBS 
and nonspecific protein binding sites blocked by treatment with 0.5% (w/v) Saponin 
in PBS for 10 minutes at 37°C.  The samples were then incubated overnight at 4°C in 
primary antibody in 0.05% (w/v) Saponin in PBS plus appropriate blocking serum. 
 
The cells were then washed with PBS and incubated overnight at 4°C in biotinylated 
antiprimary secondary antibody (Sigma, UK).  The samples were then washed with 
PBS and incubated in a 1 Xg/ml solution of Horse Radish Peroxidase (HRP)
Streptavidin conjugate in 1% (w/v) blocking reagent (Diaminodenzidine (DAB) 
histochemistry kit, Invitrogen, D22187) for one hour.  The samples were then washed 
with PBS and incubated in 1 mg/ml DAB in PBS containing 0.03% (v/v) H2O2 for 
between 10 seconds and five minutes (until a significant colour change was 
observed).  The samples were washed with PBS and then incubated with DAPI for 60 
seconds and then washed with PBS again.  The samples were then visualised using a 
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on the filter paper.  A nitrocellulose membrane was then placed on top of the gel with 
another filter paper and two more pads added on top of that.  The blotting tank was 
then placed in the gel tank with the Nitrocellulose membrane towards the positive 
(red) terminal.  The blotting tank and the reservoirs were filled with 1X Transfer 
Buffer and the blotting process run at 25 V, 125 mA and 17 W for 90 minutes. 
 
If the transfer was successful the coloured bands from the prestained standards were 
seen on the membrane.  This was blocked in TweenTris Buffered Saline (TTBS, 
15mM TrisHCl, 150mM NaCl, 0.01% (v/v) Tween 20 at pH 7.6) containing 1% (w/v) 
BSA for 30 minutes.  This was then rinsed in TTBS and incubated overnight in TTBS 
containing 0.1% (w/v) BSA plus primary antibody.  The membrane was then washed 
three times in TTBS 0.1% (w/v) BSA (a total duration of 10 minutes) and incubated 
for one hour in TTBS 0.1% (w/v) BSA plus the appropriate antiprimary secondary 
antibody (AntiRabbitHRP conjugate from Invitrogen, G21234 & AntiGoatHRP 
conjugate from Invitrogen, R21459).  The membrane was then washed three times in 
TTBS 0.1% (w/v) BSA and once with Tris Buffered Saline (TBS).  Detection solution 
(Sigma, T05655ml) was added for 15 minutes to allow the colour to develop.  
Positive expression was indicated by a band at the expected molecular weight 





Single cell suspension samples were sorted for positive expression of GFP using a 
BeckmanCoulter Altra Flow Sorter (http://genomics.nottingham.ac.uk).  This work 
was carried out in the University of Nottingham’s Central FACS Facility (based in the 
QMC, Nottingham) with expert assistance from Dr Adrian Robbins and Miss Nina 
Lane.  The sorted cells were then either returned to culture or used to prepare RNA or 

















The differentiation of particular cell types during development and in mature tissue 
maintenance is a complicated and multistaged process.  Therefore directing the 
differentiation of pluripotent mES cells into ISC is unlikely to be simple.  By 
deconstructing the process by which the ISC (and all the cells in the intestinal 
epithelium) arise during development it is possible to identify certain steps that might 
be replicable in vitro.   
 
As discussed in Section 1.2 the intestinal epithelium and all the other visceral organs, 
such as the lungs, originate from the definitive endoderm germ layer that is formed, 
along with the ectoderm and the mesoderm, at gastrulation (Chapter One, Figure 1.9).  
A number of studies have shown that it is possible to direct the differentiation of both 
mES [Kubo et al 2004, Tada et al 2005, Yasunaga et al 2005] and hES cells 
[D’Amour et al 2005, MacClean et al 2007] towards the DE germ layer fate using 




The growth factor ActA is a member of the TGFβ superfamily of signalling 
molecules (Figure 3.1.1).  It acts by binding to Type I and II Activin receptors on the 
cell surface which then activate SMAD 2 and 3 molecules which in turn interact with 
the DNA producing a transcriptional response activating genes involved in the 
specification of DE as well as placental formation and gonadal growth.  As discussed 
in Section 1.3 there are significant differences between hES and mES cells. It is 
therefore encouraging that ActA treatment seems to induce the same response in cells 
from both species as it suggests that the mechanism of action is highly conserved. 
 
The further differentiation potential of the cells following the in vitro treatments was 
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To initiate DE differentiation GFPBrachyury mES cells were aggregated into EBs 
for 2.5 days then cultured in IMDM media with 15% SR or aggregated for two days 
then cultured with IMDM media with 15% SR plus ActA (at a range of 
concentrations).  Expression of DE markers (such as FoxA2 and Sox17) was enhanced 
by reduced serum levels compared to controls when evaluated by RTPCR and 
immunostaining. 
 
The expression of GFP (representative of Brachyury) was reduced in low serum/SR 
conditions.  ActA treatment induced upregulated expression of both endodermal 
(FoxA2 and Sox17) and mesodermal (Brachyury) markers (see Section 3.1.2 below).  
These cells were further differentiated to initiate the hepatic (endodermally derived) 
and haematopoietic progenitor (mesodermally derived) fates.  The cells that 
differentiated towards the hepatic fate showed upregulated expression of a variety of 
hepatic markers including AFP and albumin.  The cells which had been exposed to 
reduced serum levels showed a corresponding reduction in haematopoietic potential 
reflecting the observed reduction in mesodermal markers.  Some of the treated cells 
were transplanted into the kidney capsules of SCID mice.  After three to four weeks 
the kidneys were removed and analysed.  The cells had formed some endoderm 
derived structures such as gut epitheliallike and bronchial epitheliallike cells.  Some 
mesoderm derived structures had also developed such as skeletal muscle [Kubo et al 
2004]. 
 
Both the DE and mesoderm arise from a common precursory germ layer known as the 
mesendoderm.  Characterising the changes that occur during the specification of the 
germ layers is required if these processes are to be manipulated [Tada et al 2005].  A 
GFPGsc mES cell line was established to investigate this as Gsc expression is 
indicative of mesendoderm formation.  Selective in vitro culture of these mES cells in 
serum free SFO3 media with the TGFβ family members Activin and Nodal initiated 
the formation of mesendoderm as indicated by the positive expression of GscGFP 
along with Ecadherin and Platelet derived growth factor receptor α (PDGFRα).  This 
population then split into two fractions, one of which remained positive for all three 
markers whilst the other retains only GscGFP and Ecadherin expression.  The latter, 
PDGFRα negative, population gave rise to DE whilst the former, PDGFRα positive, 
population gave rise to the mesoderm.  These populations were also examined for the 
 	
expression of markers of endoderm (FoxA2 and Sox17) or mesoderm (Vegfr2) 
formation by RTPCR analysis.  These markers showed upregulation in the selective 
culture conditions when compared to controls [Tada et al 2005]. 
 
Using selective in vitro culture conditions mES cells (carrying reporter genes) have 
also been differentiated towards the DE fate [Yasunaga et al 2005].  These cells were 
then assessed for cell surface markers that distinguished DE cells.  These markers 
were then used to assess the differentiation of (genetically) unmanipulated mES cells 
that had been cultured in the selective conditions.  A GFPGsc mES cell line also 
carrying the CD25 reporter gene at the Sox17 locus was generated.  Sox17 is 
expressed both in the DE and also in the visceral endoderm.  Cells which are positive 
for the expression of both marker genes can therefore be identified as being of the DE 
lineage.  Culturing cells in SFO3 serum free media with 10 ng/ml ActA gave a high 
proportion of Gsc+ cells.  A further six days of culture in the continued presence of 
ActA gave an cell population that was nearly 100% Gsc+ with around a quarter of the 
cells also being Sox17+.  Although no specific conditions seemed to induce visceral 
endoderm a high proportion of Gsc/Sox17+ cells were observed in cultures seeded in 
SFO3 media alone.  These cell populations were purified by FACS and their 
complement of cell surface markers was determined using Microarray experiments.  
Of the markers expressed by DE but not visceral endoderm only CXCR4 had a 
suitable antibody available so this marker was selected, along with Ecadherin, to 
distinguish the DE fraction from the mesoderm fraction following selective culture of 
unmanipulated mES cells [Yasunaga et al 2005]. 
 
The specific differentiation of DE from hES cells can also be achieved using the 
growth factor ActA [D’Amour et al 2005].  hES cells were cultured in RPMI media 
plus Glutamax with Penicillin and Streptomycin with varying concentrations of 
(defined) FBS with ActA present at 100 ng/ml.  The serum concentration in the 
culture media appeared to influence the differentiation to DE.  The selected 
(definitive) endodermal markers (Sox17, FoxA2, Gsc) showed the highest levels of 
expression after five days of culture under low serum (0.5% FBS) conditions with 
ActA treatment.  Markers associated with visceral endoderm (Sox7) were not 
upregulated under these conditions.  Single cell analysis of the cells for SOX17 
showed that around 80% of the cells differentiated to the DE fate.  These cells were 
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then sorted by selection for CXCR4 by FACS giving an almost pure DE cell 
population.  The cells were examined for further differentiation potential by 
implantation in the kidney capsule of SCID mice where they remained in vivo for five 
weeks.  The cells had organised into small structures which were analysed for the 
expression of intestinal (CDX2 and villin) and hepatic (Hepatic Specific Antigen, 
HSA) markers and compared with the expression levels seen in primary tissue.  The 
implanted cells showed comparable expression of these markers with primary tissue 
when evaluated by immunohistochemistry [D’Amour et al 2005]. 
 
This study was taken further [MacClean et al 2007] where other specific conditions 
for improving the efficiency of differentiation to the DE fate were examined.  ActA 
induction of DE from hES cells (and the effects of other members of the TGFβ 
family of signals) was found to be more efficient when PI3K signalling was 
suppressed.  When PI3K inhibitors including LY294002 and AKT1II were added to 
hES cells in normal maintenance culture (where the cells should remain 
undifferentiated) changes to the cells morphology and molecular profile began to 
occur.  Ecadherin and the pluripotency markers CD9 and Oct4 were downregulated 
and T and Sox17 showed upregulation.  This suggests that PI3K signalling plays a 
role in hES cell selfrenewal. 
 
Further investigation highlighted that those genes that showed upregulated expression 
were those associated with the formation of mesendoderm (T and MIXL1) and then 
DE (FoxA2, Sox17, Gsc, GATA4 and GATA6) indicating that the differentiation that 
was occurring was towards a specific set of cell fates.  To confirm this hypothesis the 
expression of CXCR4 and Sox17 were examined by immunostaining and flow 
cytometry.  LY294002 treatment generated a cell population that was 70  80% 
SOX17+ and greater than 80% CXCR4+ after five days.  Of the cells that were 
SOX17+, greater than 95% were also FOXA2+ indicating that it was DE being 
formed.  This is supported by the data that shows that the cells differentiate to DE via 
the, T+, mesendoderm intermediate.  AKT1II (another PI3K inhibitor) treatment also 
produced an increase in the transcripts of the DE marker genes.  The observations 
were reproducible in a number of hES cell lines (H1, BG01 and BG02). 
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The hES cell derived DE generated by LY294002 treatment were expression profiled 
using Affymetrix® GeneChips© and compared with the expression profile of hES 
cell derived DE generated by ActA treatment.  A number of genes (75) showed 
significant (10 fold) increases in expression in both conditions.  These included all of 
the key DE markers including Sox17, FoxA2, CXCR4, Gsc and GATA4.  A number of 
the other upregulated genes had been previously associated with murine embryonic 
endoderm [MacClean et al 2007].  Further investigation showed that ActA/Nodal 
signalling was required in the low PI3K signalling conditions for DE differentiation to 
occur.  A range of inhibitors to TGFβ signalling factors were added to the hES 
culture along with LY294002.  Inhibitors of BMPs (e.g.  Chordin) had no effect but 
inhibitors of Nodal/Activin (e.g.  Follistatin) blocked the effects of LY294002.  
Specific blocking of the Nodal receptor, Cripto, using LeftyA did not block the 
effects of PI3K suppression.  This suggests that Activin in the MEFCM stimulates 
differentiation to DE when PI3K signalling is suppressed.  This suggests that PI3K 
plays a role in the selfrenewal of hES cells by blocking differentiation stimuli from 
Activin/Nodal signalling [MacClean et al 2007]. 
 
To determine the minimum signalling requirements of the culture system the MEF
CM was substituted with unconditioned media and 20% SR with or without Activin 
or Nodal.  In the absence of any other signalling factors in the media LY294002 
suppression of PI3K was insufficient to initiate DE differentiation.  The addition of 
ActA or Nodal to the culture produced an upregulation in Sox17 expression 
comparable to that seen in the MEFCM conditions.  This could explain why in 
previous studies have shown more efficient DE differentiation in low serum 
conditions, where PI3K signalling may be reduced [MacClean et al 2007]. 
 
The hES cell derived DE cells generated by PI3K suppression with LY294002 were 
transplanted into the kidney capsule of SCID mice.  After six weeks the grafts 
displayed high levels of a range of endodermal lineage markers when they were 
immunostained.  These included hepatic markers (AFP and HSA), lung/thyroid 
markers (Thyroid transcription factor 1, TTF1) and intestinal (epithelial) markers 
(gastrin and villin).  The control grafts from untreated hES cells did not show 
expression of any of these markers in all but one sample.  The qPCR analysis showed 
that albumin and FABP1 were expressed 10 fold higher in the treated cells than in the 
 	
naïve hES cells.  The hES cell derived DE showed considerably increased 
differentiation into further DE lineages than untreated hES cells [MacClean et al 
2007].   
 
Whilst these studies suggest that ActA has a similar effect on both hES and mES 
cells it is not certain that the mechanism of action will be the same.  As discussed in 
Section 1.3 there are significant differences between hES and mES cell lines so it is 
possible that the mechanism by which they differentiate in these studies is not the 
same.  This is encouraging in some regards as it suggests that the effects of ActA are 
fairly universal and therefore similar results should be obtainable using the CEE mES 
cell line. 
 
Other TGFβ family members, such as Nodal, may also play a role in DE and 
mesoderm differentiation of ES cells in vitro. Nodal signalling plays a role in the 
specification of mesoderm and DE during gastrulation [Takenaga et al 2007].  
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As alluded to in the studies discussed above the differentiation of cells towards a 
particular fate can be monitored by observing the expression of key lineage marker 
genes at both the mRNA and protein levels.  A lineage marker is a gene that has 
patterns of expression (both spatial and temporal) that are limited to a particular set of 
cells during development.  In some instances using multiple markers can be useful; if 
coexpression of two factors is indicative of a particular lineage it reduces the chance 
of false positive results e.g. coexpression of Sox17 and FoxA2 is indicative of DE 
formation.  By comparing the levels of expression of these markers expressed by cells 
cultured in the presence of ActA with a number of control conditions the relative 
efficiencies with which the cells differentiate towards a particular fate can be 
determined.  A variety of endodermal markers have been identified [Hou et al 2007].  
By screening the gene expression of the early DE of mice by Serial Analysis of Gene 
Expression (SAGE) a number of novel candidate DE markers were identified along 




CXCR4 has been shown to be a marker of DE formation in mice [Yasunaga et al 
2005] and humans [D’Amour et al 2005].  GATA4 is involved in the differentiation 
of a number of endoderm derived organs [Holtzinger and Evans, 2005, Watt et al 
2007].  The coexpression of the transcription factors Sox17 [KaniaAzuma et al 
2002, Tam et al 2003] and FoxA2 [Ang et al 1993] indicates the production of 
definitive rather than visceral endoderm (that only expresses FoxA2).  It is important 
to distinguish DE from visceral endoderm which only contributes to extraembryonic 
structures and therefore would be of no use in generating intestinal precursors 
[Duncan et al 1994]. 
 
The production of the other two germ layers also needs to be assessed to evaluate how 
much of the differentiation observed is occurring randomly following the removal of 
the factors that suppress differentiation (LIF).  Brachyury (a T domain transcription 
factor) is an early marker of mesoderm [Smith et al 1991] whilst Nestin (a Type VI 
intermediate filament protein) is an early marker of ectoderm [Dahlstrand et al 1995].  
The expression Oct4 [Nichols et al 1998] and Nanog [Pan and Thomson 2007] (both 
are homeodomain transcription factors) can be used to assess if any undifferentiated 
cells remain in the population – they are markers of pluripotency.  Downregulation of 
the pluripotency markers during differentiation culture should also occur and serves 
as an indicator of the efficiency of differentiation. 
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The aims of the experiments in this Chapter were to reproduce the results obtained in 
the literature reviewed above (and in Section 1.6) in the CEE mES cell line. If these 
results can be reproduced in this study it may prove a useful first step towards 
specifying ES derived cells (ISClike cells) suitable for intestinal tissue engineering 
applications. 
 
Specifically the aims are: 
 
 To investigate the effects of serum concentration on the behaviour of CEE 
mES cells in culture with regard to their differentiation towards the DE fate in 
vitro. 
 	
 To investigate the effects of EB aggregation on the differentiation of CEE 
mES cells towards the DE fate in vitro. 
 
 To investigate the effects of treatment with the growth factor ActA on the 
differentiation of CEE mES cells towards the DE fate in vitro. 
 
 Assess the differentiation of the CEE mES cells at the RNA level using RT
PCR analysis and at the proteomic level using immunocytochemistry and 
western blotting. 
 












A number of sources in the literature detailed methods for differentiating ES cells 
towards the DE fate [D’Amour et al 2005, MacClean et al 2007, Kubo et al 2004, 
Tada et al 2005, Yasunaga et al 2005]. These methods were used as the basis for the 
following experimental procedure. CEE mES cells that had been maintained in an 
undifferentiated state (see Section 2.1.1) for between 15 and 25 passages were 
transferred into culture in differentiation media for 120 hours with and without the 
addition of 10 ng/ml ActA (Sigma, UK) in six well tissue culture plates (one plate 
per condition) that had been previously gelatin coated.  For the first 24 hours the cells 
were cultured in differentiation media A (LIF, FCS, see Section 6.4) with or without 
ActA.  For the second 24 hours the cells were cultured in differentiation media B 
(LIF, 0.2% (w/v) FCS, see Section 6.4) with or without ActA.  For the remainder of 
the experiment the cells were cultured in differentiation media C (LIF, 2% (w/v) 
FCS, see Section 6.4) with or without ActA.  Two control plates were also run; one 
where the cells were cultured in (complete) embryonic stem cell media (ES media, 
LIF+, 10% (w/v) FCS) and one where the cells were cultured in LIF ES media (SNL 






Based on the results observed from the above experiments (see Section 3.3.1) and 
sources in the literature [Kubo et al 2004, Tada et al 2005, Yasunaga et al 2005] some 
adaptations to the differentiation culture conditions were made.  CEE mES cells that 
had been maintained in an undifferentiated state (see Section 2.1.1) for between 15 
and 25 passages were transferred into culture in differentiation media (see below) for 
120 hours with or without the addition of 10 ng/ml ActA in 12 well tissue culture 
 	

plates (one plate per condition) that had been previously coated with Collagen IV (see 
Section 2.13).  Three differentiation conditions and two control conditions were used.  
In conditions one and two, cells were cultured in 10% (v/v) SR (Sigma, UK, S0638) 
media for 120 hours; condition two had ActA added.  In condition three, cells were 
cultured in SR media for 72 hours then SNL media (10% (w/v) FCS) for the final 48 
hours.  Conditions four and five were controls (both containing 10% (v/v) FCS as in 
Section 3.2.1i), four being ES media (LIF+) and five being SNL media (LIF) 
cultured for 144 hours.  The media was initially changed after 48 hours and then every 
24 hours thereafter. 
 
Duplicate RNA samples for RTPCR were prepared at 48, 96 and 144 hours using tri
reagent as described in Section 2.2.1 and analysed as described in Sections 2.2.5 and 
2.2.6.  Remaining wells were prepared for immunocytochemistry at 120 or 144 hours 
as described in Section 2.2.2 and analysed as described in Section 2.2.7.  The PCR 
timepoints were evenly spaced along the time course of the experiment to observe 
changes in the mRNA expression of the selected markers throughout. The 
immunocytochemical samples were prepared at the terminal timepoints only as 
initiation of protein expression is slower than mRNA. 
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Part A:  To establish if the coating applied to the TCP prior to cell seeding influenced 
the attachment and proliferation of the cells in the experiment the growth of cells on 
Collagen IV or gelatin coated TCP was compared.  CEE mES cells were seeded at 1 x 
105 cells/ml in SNL media (10% (w/v) FCS) on six well TCP plates that had been 
previously coated with either 0.01% (w/v) Collagen IV or 0.1% (v/v) Gelatin (see 
Section 2.1.3).  Initially the cells were cultured for 120 hours with images taken every 
24 hours to assess the viability & proliferation of the cells.  The experiment was then 
repeated with a lower initial seeding density of 5 x 104 cells/ml and the culture period 




Part B:  The proliferation of cells in either FCS or SR was compared. CEE mES cells 
were seeded at 5 x 104 cells/ml in gelatin coated six well TCP plates.  The cells were 
cultured in media that had been supplemented with either 10% (v/v) FCS or 10% (v/v) 
SR for 72 hours.  Cell counts (n = 3), using an improved Neubauer haemocytometer, 
and images, using a Nikon light microscope, were taken every 24 hours. 
 
Part C:  To establish a suitable initial seeding density CEE mES cells were seeded at a 
range of densities (1 x 104, 5 x 104, 1 x 105, 1.5 x 105, 2 x 105 and 2.5 x 105 cells/ml) 
in SNL media on gelatin coated six well TCP plates for up to 168 hours.  Cell counts 
(n = 3), using an improved Neubauer haemocytometer, and images, using a Nikon 
light microscope, were taken every 24 hours. 
 
Table 3.2.1: Table of optimisation media compositions from Experiment Three, Part 
D detailing basal media used and the supplements added. 
 
 
Part D: Cells were seeded at 5 x 104 cells/ml in a variety of media formulations in 
gelatin coated six well TCP plates for up to 168 hours.  The FCS concentration, the 
basal media and some of the supplements used were changed in the different 
conditions (see Figure 3.2.1 and Section 6.4).  Cell counts (n = 3), using an improved 
Neubauer haemocytometer, and images, using a Nikon Eclipse light microscope, were 
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Table 3.2.2: Summary table of in vitro cell culture conditions from Experiment Four. 
 
 
RNA samples were collected after 48 hours in monolayer culture and every 24 hours 
thereafter (until the end of the experiment) and prepared using a Qiagen kit as 
described in Section 2.2.1 and analysed as described in Sections 2.2.5 and 2.2.6.  
Samples for immunocytochemistry were prepared after 96 and 168 hours in 
monolayer culture as described in Section 2.2.2 and analysed as described in Section 
2.2.7.  The PCR timepoints were evenly spaced along the time course of the 
experiment to observe changes in the mRNA expression of the selected markers 
throughout. The immunocytochemical samples were prepared in the latter part of the 




Following on from the results obtained from the above experiment (Chapter Three, 
Section 3.3.4) CEE mES cells that had been maintained in an undifferentiated state 
(see Section 2.1.1) for between 15 and 25 passages were cultured under a variety of 
conditions in the presence and absence of ActA at 10 ng/ml with 10 % (v/v) FCS. 
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In condition one CEE mES cells were aggregated for three days in the presence of 
ActA in suspension culture seeded at 5 x 105 cells/ml (see Section  2.1.4) in uncoated 
nonTCP six well plates.   The EBs formed were then dissociated by treatment with 
prewarmed Trypsin/EDTA and reseeded in monolayer culture at 1 x 105 cells/ml for 
nine days in the presence of ActA in gelatin coated TCP six well plates.  RNA 
samples were collected after 0, 72, 216 and 288 hours and prepared using a Qiagen kit 
as described in Section 2.2.1 and analysed as described in Sections 2.2.5 and 2.2.6.  
Samples for immunocytochemistry were prepared after 144 and 288 hours as 
described in Section 2.2.2 and analysed as described in Section 2.2.7. 
 
In condition two CEE mES cells were seeded in monolayer culture at 1 x 105 cells/ml 
for nine days in the presence of ActA on gelatin coated TCP six well plates.  RNA 
samples were collected after 0, 72 and 216 hours and prepared using a Qiagen kit as 
described in Section 2.2.1 and analysed as described in Section s 2.2.5 and 2.2.6.  
Samples for immunocytochemistry were prepared after 72 and 216 hours as described 
in Section 2.2.2 and analysed as described in Section 2.2.7. 
 
In condition three CEE mES cells were seeded in monolayer culture at 2.5 x 105 
cells/ml for two days in the presence of ActA on gelatin coated TCP six well plates.  
The cells were then aggregated in suspension culture at 5 x 105 cells/ml for three days 
(see Section  2.1.4) in the presence of ActA in uncoated nonTCP six well plates.  
The EBs formed were then dissociated by treatment with prewarmed Trypsin/EDTA 
and reseeded in monolayer culture at 1 x 105 cells/ml for nine days in the presence of 
ActA on gelatin coated TCP six well plates.  RNA samples were collected after 0, 48, 
120, 288 and 336 hours and prepared using a Qiagen kit as described in Section 2.2.1 
and analysed as described in Sections 2.2.5 and 2.2.6.  Samples for 
immunocytochemistry were prepared after 144, 240 and 336 hours as described in 
Section 2.2.2 and analysed as described in Section 2.2.7. 
 
In condition four CEE mES cells were seeded in monolayer culture at 1 x 105 cells/ml 
for nine days on gelatin coated TCP six well plates.  RNA samples were collected 
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part of the experiment and at the terminal timepoint or close to key points of each 
experiment such as the transition from EBs back to monolayer culture to observe any 
protein expression. 
 






CEE mES cells that had been maintained in an undifferentiated state (see Section 
2.1.1) for 20 passages were seeded in monolayer culture at 2.5 x 105 cells/ml for two 
days in the presence of ActA on gelatin coated TCP six well plates.  The cells were 
then aggregated in suspension culture (see Section  2.1.4) seeded at 5 x 105 cells/ml 
for five days in the presence of ActA in uncoated nonTCP six well plates.  The EBs 
formed were then dissociated by treatment with prewarmed Trypsin/EDTA and 
reseeded in monolayer culture at 1 x 105 cells/ml for nine days in the presence of Act
A on gelatin coated TCP six well plates.  DMEM supplemented with 10% (v/v) FCS 
and 1% (v/v) LGlut, 1% (v/v) ABAM and 100XM βMCPE was used throughout.  
RNA & protein samples were collected after 0, 48, 168, 264 and 384 hours and 
prepared as described in Sections 2.2.1 (Qiagen kit) and 2.2.3 respectively.  RNA 
samples were analysed as described in Sections 2.2.5 and 2.2.6 whilst protein samples 
were analysed by western blotting as described in Section 2.2.8.  Samples for 
immunocytochemistry were prepared after 48, 192, 264 and 384 hours as described in 







Primers were designed as described in Section 2.2.4.  The selected markers for 
Definitive Endoderm were Foxa2, Sox17 (transcription factors) [KaniaAzuma et al 
2002, Tam et al 2003, Ang et al 1993], CXCR4 (cell surface receptor) [D’Amour et al 
2005] and GATA4 [Holtzinger and Evans 2005, Rojas et al 2009].  The selected 
marker for Mesoderm was Brachyury [Smith et al 1991] and the marker for Ectoderm 
was Nestin [Dahlstrand et al 1995].  The selected marker for 
undifferentiated/pluripotent mES cells was Oct4 [Nichols et al 1998].  New primer 
pairs for CXCR4, Oct4 and Brachyury were designed as described in Section 2.2.4.  
Primers for GATA4, Nestin and GAPDH had been previously designed within the 
group.  Primer sequences for Sox17 and FoxA2 were from published literature [Kubo 
et al 2004] (Table 3.2.4).  The primers were then ordered from MWGOperon. 
 











Evidence in the literature suggested that low serum concentrations and the presence of 
ActA induced mES cells to differentiate towards the DE lineage in culture with 
greater efficiency than as EBs in standard cell culture media [D’Amour et al 2005, 
MacClean et al 2007, Kubo et al 2004, Tada et al 2005, Yasunaga et al 2005].  This 
experiment aimed to show that these results could be achieved using the CEE mES 
cell line.  Complete (CEE mES) cell culture media contains around 10% FCS so the 
initial experiment aimed to establish if the CEE mES cell line could tolerate low 
serum (2% or lower) conditions and to observe any discernible effects on their 
differentiation under these conditions. 
When cultured under low serum conditions the CEE mES cell line did not proliferate 
or adhere as it did when cultured in CEE complete cell culture media (10% FCS, 
LIF+/) resulting in almost total cell death and therefore no samples were taken for 





The presence of ActA in serum replacement (SR) media rather than low serum has 
been previously shown to promote differentiation to the DE fate without having a 
negative effect on cellular attachment and proliferation [D’Amour et al 2005, Kubo et 
al 2004, Tada et al 2005, Yasunaga et al 2005].  In this study, the ability to culture 
CEE mES cells in SR media was assessed.  In addition, the effect of using different 
ECM components to coat the culture vessel was also investigated.  
The cells did not appear to attach or proliferate any better in SR complete media 
compared with low serum conditions.  There was no apparent difference between 
cellular attachment on Gelatin or Collagen IV coated TCP (see Appendices, Section 
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on gelatin had reached around 40% confluence (Figure 3.3.3H).  Overall there 
appeared to be no significant differences in cellular attachment or proliferation 






Figure 3.3.4: Graph showing the Log average total cell number of CEE mES cells 
seeded and cultured in 10% (v/v) FCS vs 10% (v/v) SR complete media on Gelatin 
coated TCP over 72 hours in culture (n = 3, error bars show SEM). 
 
Figure 3.3.4 shows that there was no significant difference between the cells grown in 
10% (v/v) SR when compared to 10% (v/v) FCS in terms of their rate of proliferation.  
The cultures were originally seeded at the same density and the total cell number 
remained similar throughout the time in culture.  The data shows that there was very 
little variation between the replicates for either condition particularly at the 48 hour 




There were considerable variations in the number of cells attaching to the culture 

































(Figure 3.3.5).  At the lower seeding densities a scattering of cells across the field of 
view was observed at 24 hours (Figure 3.3.5A – D) whilst cells seeded at higher 
densities, particularly 2.5 x 105 cells/ml (Figure 3.3.5F), already demonstrated a much 
higher degree of confluence.  After 168 hours cells seeded at higher seeding densities 
(Figure 3.3.5J  L) had all reached 100% confluence with all but the lowest seeding 





Figure 3.3.6 illustrates that the mES cells proliferated at varying rates dependant on 
the type of media in which they were cultured when seeded on Gelatin coated TCP.  
The highest cell counts obtained after 72 hours in culture were from the controls, SNL 
and CEE mES complete cell culture media, with in excess of 3 x 106 cells per sample.  
These two media compositions were identical (both contained 10% (v/v) FCS) except 
that CEE mES complete cell culture media was LIF+ (at 1 x 103 units/ml) (LIF 
suppresses differentiation). 
 
The cells grown in SR complete media (FCS) proliferated at a slower rate with each 
sample containing around 2.5 x 106 cells after 72 hours culture in ActA SR complete 
media and approximately 2 x 106 cells in ActA+ SR complete media.  The cells in 
both the DMEM low FCS and αMEM low FCS media proliferated very slowly; this 
data is not shown on the graph.  The cells exhibited moderate proliferation in the 10% 
FCS αMEM complete media with between 1 x 106 – 1.5 x 106 cells per sample.  
Adding ActA to the SR media reduced the rate of cell growth further but the cells 
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Figure 3.3.6: Graph showing the average total number of cells obtained after mES 
cells were cultured for 72 hours on Gelatin coated TCP in a variety of different media 







CEE mES cells were removed from maintenance culture on feeder layers and seeded 
in a range of (feeder free) conditions designed to investigate the effects of treatment 
with the growth factor ActA, aggregation into EBs and serum or SR usage on the 
differentiation of the cells [Kubo et al 2004, Tada et al 2005, Yasunaga et al, 2005].  
In conditions where EBs were generated the cells were aggregated and cultured as 
EBs for 3 days prior to reseeding in monolayer culture for up to 7 days.  Other 
conditions were immediately seeded in monolayer culture for up to 7 days.  RNA 
samples were generated after 48 hours in monolayer culture and every 24 hours 






























Glyceraldehyde 3phosphate dehydrogenase (GAPDH), an enzyme involved in 
glycolysis, was used as a ubiquitous control in the RTPCR analysis to confirm that 
the RT reaction had worked; all samples should have shown positive expression of 
GAPDH.  The strength of the GAPDH bands was then assessed to guide biased 
loading in the selected marker gene PCR reactions (see Sections 2.2.8 and 2.2.9).  All 
the samples generated in condition 6 (EB in SR, ActA) did not contain sufficient 
material for analysis. 
 
PCR expression of all of the selected marker genes was noticeably stronger in the 
conditions where ActA was present (Figure 3.3.8C and F) compared to the control 
conditions (Figure 3.3.8A and B).  Expression of FoxA2 in cells derived from EBs 
(Figure 3.3.8C) and from monolayer derived cells (Figure 3.3.8F) cultured in the 
presence of ActA was strongly upregulated in the later timepoints compared to the 
monolayer control (ActA) conditions (Figure 3.3.8A and B). 
 
In the monolayer derived cells there was some expression of FoxA2 after 48 hours but 
this then disappeared at the 72 and 96 hour timepoints (Figure 3.3.8F).  Weak CXCR4 
expression was observed in the later timepoints in the presence of ActA with none in 
the conditions without ActA.  Sox17 expression followed a similar pattern to that of 
FoxA2 but the level of expression was lower.  However, Oct4 expression was still in 
evidence in all conditions throughout the duration of the experiment. 
 
This data is summarised in Figure 3.3.7.  In the conditions where SR was used (Figure 
3.3.8D, G and H) the cells grew slowly.  Consequently the RNA samples obtained 
were of poor quality and yielded little or no data.  The immunocytochemical images 
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CEE mES cells were removed from maintenance culture on feeder layers and 
transferred into five differentiation conditions designed to examine the effects of 
treatment with the growth factor ActA and aggregation into EBs on the 
differentiation of the cells towards the DE fate.  Given the extremely poor (RNA and 
fixed cell) samples generated in low serum and SR culture conditions in previous 
experiments all culture conditions contained 10% (v/v) FCS.  RNA samples were 
generated (timepoints differ between conditions – see Section 3.2.1v and Figure 
3.3.11) and cells fixed for immunocytochemistry (timepoints differ between 
conditions  see Section 3.2.1v, Figure 3.2.3). 
 
Given the poor cell growth observed in some of the differentiation conditions used 
previously it was decided to evaluate and record the attachment and proliferation of 
the cells throughout the time course of the differentiation experiment by taking light 
microscopy images of the live cell cultures.  The images showed good initial 
attachment and rapid proliferation in all conditions immediately after seeding.  The 
rate of proliferation appeared to slow in the later stages of the experiment. 
 
In condition one (initial three day EB phase, monolayer thereafter, ActA+) numerous 
EBs were formed over the initial 72 hours.  When dissociated and reseeded as a 
monolayer (Figure 3.3.9A and B) the cells attached well and proliferated throughout 
the time course of the experiment.  The proliferation slowed slightly towards the end 
of the time course but at the time the experiment was terminated the cells had formed 
a confluent monolayer.  In condition two (monolayer throughout, ActA+) the cells 
attached well initially and proliferated rapidly throughout the time course (Figure 
3.3.9C and D).  Cell proliferation appeared to slow slightly towards the end of the 
time course but at the time the experiment was terminated the cells had formed an 
overconfluent monolayer. 
 
In condition three (two days in monolayer then three day EB phase, monolayer 
thereafter,  ActA+), where the initial seeding density was higher than the other 
conditions, good attachment and rapid proliferation was seen producing nearly 
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aggregation stage (120 hours).  There was then strong expression of Brachyury after 
268 hours but this had become significantly weaker after 336 hours (final timepoint) 
in culture. 
 
Figure 3.3.12 shows the results of the RTPCR analysis of the RNA samples produced 
from the repeat of in vitro experiment five.  All the GAPDH reactions in all the 
conditions produced strong bands indicating that all of the RT reactions had worked.  
Note that the two series of bands shown for Sox17 represent the PCR reaction carried 
out with a different number of cycles.  Unless specifically stated it is the 35 cycle 
bands that are commented on.  This data is summarised in Section 6.3, Table 6.3.2. 
 
In condition one (Figure 3.3.12A), where the cells had been aggregated and treated 
with ActA throughout, Oct4 expression was maintained throughout the time course 
with the exception of one of the replicates at 216 hours where the reaction appeared to 
have failed.  Oct4 expression was also maintained throughout the time course in 
condition five (Figure 3.3.12A), where the cells had been aggregated but not treated 
with ActA, although the bands were slightly weaker when compared to those 
produced in condition one. 
 
Nanog, another pluripotency marker, was also expressed throughout the time course 
in both condition one and five.  In condition one there was very weak expression of 
Sox17 in one replicate at each time point and strong expression of FoxA2 throughout.  
In condition five there was a very weak band of Sox17 in one of the 72 hour replicates 
but it was not expressed throughout.  Moderate expression of FoxA2 was observed 
throughout the experiment except for one of the 72 hour replicates where the reaction 
appeared to have failed.  In condition one there was weak expression of GATA4 
throughout.  CXCR4 was expressed weakly at 72 hours but then highly expressed after 
216 hours.  It then appeared to fall again with one very weak band and one moderate 
band in the 288 hour samples. 
 
In condition five there are weak bands of GATA4 and CXCR4 expression at 72 hours 
with a weak band present for each gene in one replicate at 216 and 288 hours.  In 
condition one there was a strong band of Brachyury expression in one 216 hour 
replicate but no other expression.  There was weak expression of Nestin throughout 
 	
the time course.  In condition five there was weak expression of Brachyury in one 72 
hour replicate and one 216 hour replicate with a moderate band in one 288 hour 
replicate.  There was weak expression of Nestin after 72 hours with one moderate 
band after 216 hours. 
 
In condition two (Figure 3.3.12B), where the cells had been cultured in monolayer 
and treated with ActA, Oct4 and Nanog expression were maintained throughout.  In 
condition four (Figure 3.3.12B), where the cells were cultured in monolayer without 
ActA treatment, Oct4 expression was maintained throughout but was slightly lower 
than in condition two.  Nanog expression was comparable to that in condition two. 
 
In condition two there was no expression of Sox17 and moderate expression of FoxA2 
whilst in condition four there was very weak expression of Sox17 with moderate 
expression of FoxA2.  In both conditions two and four there were very weak bands for 
both CXCR4 and GATA4 but they were of comparable strength to those observed in 
the negative controls (untreated CEE mES cells).  In condition two there were very 
weak bands for Brachyury in the 216 hour sample with slightly stronger bands seen in 
condition four.  In both conditions weak bands for Nestin were seen in all samples. 
 
In condition three (Figure 3.3.12C), where the cells were cultured in monolayer for 48 
hours then aggregated for 72 hours before being returned to monolayer culture with 
ActA present throughout, there was strong expression of GAPDH in all the 
experimental samples.  Both Oct4 and Nanog were strongly expressed throughout.  
Sox17 was expressed weakly at 264 hours with an increase in expression at 336 hours 
with FoxA2 showing   moderate   expression  at  all  timepoints   although  only  one  
of  the  48  hour duplicates showed expression. 
 
CXCR4 shows expression at the 264 and 336 hour timepoints and GATA4 showed 
weak expression from the 120 hour timepoint onwards.  Brachyury showed moderate 
expression at 264 hours but this had reduced at the 336 hour timepoint.  Nestin 
showed very weak expression at 120 hours with moderate expression at 264 hours.  





















































































































Figures 3.3.13 – 3.3.17 show the fluorescent immunocytochemical results obtained 
from the antibody staining of the fixed cell samples from in vitro experiment five.  
The markers examined are the expressed proteins of some of the marker genes 
examined in the RTPCR analysis.  These are OCT4 as a marker of pluripotency, 
GATA4 and coexpression of SOX17 and FOXA2 as markers of (definitive) 
endoderm and BRACHYURY as a marker of mesoderm.  A secondary control is also 
shown to illustrate the level of background signal and to highlight any nonspecific 
binding of the Fluorescein isothiocyanate (FITC) tagged secondary antibody. 
 
Figure 3.3.13 shows the results from culture condition one (three day EB phase, 
monolayer thereafter, ActA+).  The secondary control at 72 hours showed good 
staining in the DAPI channel with only faint staining in the FITC channel indicating 
that limited nonspecific binding had occurred.  The DAPI stains in the marker 
samples all show a good number of cells in each field of view.  There is little marker 
staining for OCT4 and only weak signal for BRACHYURY which may have been 
caused by background autofluorescence.  FOXA2 and SOX17 both show moderate 
signal across the field of view with a few patches of stronger signal.  The GATA4 
image has strong background signal making it difficult to clearly visualise the image 
although there do appear to be a few patches of genuine signal present. 
 
The secondary control at 288 hours shows a high level of background signal which is 
also present in a number of the marker stains (FOXA2 and GATA4).  The DAPI 
stains also show that there are more cells compared to the earlier timepoint (the cells 
will have continued to proliferate throughout the time course of the experiment).  
There is strong marker signal for OCT4 in the 288 hour sample but much of this 
appears to be background interference (autofluorescence).  There appear to be some 
patches of FOXA2 expression but the levels of background interference make these 
unclear.  There are some clear patches of SOX17 expression.  There are some faint 
patches of signal for BRACHYURY but these may be background signal.  The 
GATA4 image is hard to interpret due to the high background signal but there do 






















 a good cov
samples sh


















ce but the 














 in large cl


























































ee day EB p
nocytoche





















































































































































































l but this i





























 the other 
t 48 hours





ning of the 
nolayer, th





































































































OCT4 is clearly evident at 48 hours.  There is weak signal for SOX17 and FOXA2 
and moderate expression of BRACHYURY.  In the GATA4 sample the level of 
background interference was high and the level of expression is unclear.  At 240 
hours OCT4 expression was present at low levels as was FOXA2.  SOX17 was 
expressed at moderate levels but there is some background interference in the image.   
 
There is no signal in the BRACHYURY sample and, as with the 48 hour sample, the 
level of background signal in the GATA4 sample made the level of actual expression 
unclear.  In the 336 hour timepoint there is moderate signal in the OCT4 image but 
this may be background signal.  The same is true of the FOXA2 image but there are 
some patches of stronger signal which may indicate genuine expression.  There is 
weak expression of SOX17.  The BRACHYURY image is similar to the FOXA2 and 
OCT4 with extensive signal that may be background with some patches of stronger 
signal that indicate real expression.  As with the other timepoints the level of 
background signal in the GATA4 image made any genuine expression difficult to 
identify. 
 
Figure 3.3.16 shows the results from culture condition four (monolayer, no ActA).  
The secondary control sample for the 72 hour timepoint shows moderate levels of 
background signal whilst the control for the 216 hour timepoint shows quite high 
levels of background signal.  There is widespread signal for OCT4 at 72 hours but 
much of this is autofluorescent interference.  There are some localised patches of 
stronger signal that suggest some genuine expression.  There is some background 
signal for FOXA2 and no signal for SOX17 and BRACHYURY.  The background 
interference in the GATA4 image makes any real signal unclear.  At 216 hours there 
is widespread expression of OCT4 and scattered but strong signal for FOXA2 and 
SOX17 expression.  The signal for BRACHYURY is so strong that some must be 
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CEE mES cells were cultured in a modified version of the most promising culture 
condition from experiment five (condition three – two days in monolayer, 3 days as 
EBs then a further nine days in monolayer, ActA+). In this experiment the EB phase 
was extended from three to five days as the selected DE markers showed the strongest 
expression following the EB phase.  Figure 3.3.18 shows the expression of key 
marker genes in RNA samples generated from in vitro experiment six evaluated by 
RTPCR.   
 
All of the experimental samples and controls gave strong bands for GAPDH 
indicating that all the RT reactions had worked well.  Oct4 expression is moderate in 
the 48 hour and 168 hour timepoints, being at a comparable level to the negative 
controls (unmanipulated CEE mES cells).  In the 264 hour and 384 hour replicates 
expression is reduced but still present with the exception of one of the 264 hour 
replicates where expression is still moderate.  This reduction in Oct4 levels is not seen 
in the other conditions.  There are weak bands of CXCR4 expression after 168 hours 
(postaggregation) and very weak bands after 384 hours but no expression in the 
controls.  There are very weak bands of expression of FoxA2 in the mES controls but 
no expression of Sox17.  There are weak bands of FoxA2 expression in the 48 hour, 
264 hour and 384 hour timepoints but they are comparable to the levels in the mES 
controls.  In the 168 hour samples there is moderate expression of FoxA2.  There are a 
few very weak bands of Sox17 expression with the exception of the 168 hour samples 
where there are stronger bands. 
 
There are very weak bands for Brachyury in the mES controls.  There are very weak 
bands in the 264 hour samples of similar strength to the controls.  There are slightly 
stronger bands in the 48 hour and 384 hour timepoints.  There is moderate expression 
of Brachyury in the 168 hour timepoint. 
 
The levels of the markers of DE (CXCR4 and coexpression of FoxA2 and Sox17) are 
generally higher than those seen in previous in vitro differentiation experiments. 
Figure 3.3.18A:
































































ried out on 
A.  The ma
 and BRAC
wo days in


















 shown).  A
















s with the 
the experim
el as it wa
gives stron
f SOX17 w
 (OCT4 = 3








































































Figure 3.3.20: Expression of key markers in mES cells cultured in monolayer for two 
days then aggregated for five days then in monolayer for a further nine days evaluated 
by immunocytochemistry (enzymatic activity). All images at 400X magnification 
 
 
Figure 3.3.20 shows the expression of key differentiation markers evaluated by 
enzymatic immunocytochemistry.  The two timepoints are following the initial two 




following the five day EB phase.  Secondary antibody and negative control images are 
included for each timepoint along with the DE markers SOX17, FOXA2 and GATA4 
and the ectodermal marker NESTIN.  There is no staining in any of the control 
conditions at either timepoint.  After 48 hours some expression of SOX17 and 
FOXA2 is present – indicated by several areas of positive (brown) staining.  There is 
no expression of GATA4 or NESTIN.  After 192 hours there is continued positive 
staining for SOX17 and FOXA2 and positive expression of GATA4.  There is still no 
evidence of NESTIN expression. 
 
 
Table 3.3.1:  Table summarising all the expression data for the selected differentiation 
markers from in vitro experiments four, five, six and controls.  The selected markers 
were Oct4 and Nanog for undifferentiated cells, Sox17, FoxA2, CXCR4 and GATA4 
for (definitive) Endoderm, Brachyury for Mesoderm and Nestin for Ectoderm.  
Expression of RNA expression was evaluated by RTPCR whilst expression of 
protein expression was evaluated by (fluorescence or enzymatic) 
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Table 3.3.1 shows a summary of the expression of the selected markers from in vitro 
experiments four, five and six along with selected controls.  Where the expression of a 
particular marker was not assessed it will read N/A.  RNA levels are given as 
negative, where no expression was observed in any samples, then very weak where 
some very faint bands were seen, then weak where faint bands appeared in most 
samples.  With these samples expression was equivocal to a degree.  Values of 
positive, where bands were present in (almost) all samples, moderate, where stronger 
bands were seen and strong, were very bright bands were seen all indicate that the 
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The experiments carried out in this section were aimed at replicating the results 
reported from a number of published studies [D’Amour et al 2005, MacClean et al 
2007, Kubo et al 2004, Tada et al 2005, Yasunaga et al 2005] where DE had been 
generated from both human and murine ES cells in vitro.  This study aimed to do this 
for the first time using the CEE mES cell line available in our laboratory [Buttery et al 
2001, Gothard et al 2010]. 
 
In the above studies low serum and SR culture conditions were used.  In experiment 
one (Section 3.2.1i and 3.3.1) the attachment and proliferation of the CEE mES cell 
line in these conditions was investigated.  There were some problems regarding the 
proliferation of the cells in some of the experimental conditions.  Using CEE mES 
complete media (used for maintaining the mES cells in proliferation culture), that 
contained 10% FCS, cells attached to the plates and then expanded suggesting the 
cells could proliferate in the absence of a feeder layer. In the differentiation media(s) 
where the serum concentration was lower (≤ 2%) this did not occur.  The cells could 
be cultured in a feeder free environment for a sufficient time period intended for the 
differentiation experiments so it was not the absence of a feeder layer or the ECM 
components it provides that caused the cell attachment problems. 
 
The lack of proliferation, due to cell death, in the differentiation conditions indicated 
that the mES cells would not grow in serum free/low serum conditions (it is known 
that other researches within the Tissue Engineering group at Nottingham University 
have encountered similar results when conducting similar experiments) and as a 
consequence it was not possible to evaluate the extent to which the cells had 
differentiated.  It was decided to try using SR media in future and to reduce the 
seeding density of mES cells (to avoid them reaching confluency prior to the end of 
the experiment). 
 
Following the issues with cell growth in low serum media observed in experiment one 
culture conditions using SR supplemented media were investigated in experiment two 
 
(Section 3.2.1ii and 3.3.2).  The two control conditions (CEE mES complete media, 
LIF+/) that contained 10 % serum (FCS) showed greater proliferation in cell number 
over the course of the experiment than the experimental conditions, where 10% SR 
was used. This was largely due to very low cell attachment following cell seeding in 
the differentiation conditions. There was also some loss of cells throughout the 
experiment and the combination of these two factors left very few surviving cells in 
the differentiation conditions. The seeding density may have been reduced too much 
from the previous experiment but the major problem seemed to be in the initial 
attachment of the mES cells to the culture surface. 
 
It was concluded that in further experiments the initial conditions when the mES cells 
are transferred to the culture plates must favour their adherence. The differentiation 
media would then be introduced once the cells had adhered. The key conclusions from 
these experiments were that: 
 
 CEE mES cells will not readily attach and proliferate in the absence of serum. 
 
 It is crucial to ensure that the CEE mES cells to adhere to the culture plate at 
the start of the differentiation experiments. 
 
 CEE mES cells will proliferate in feeder free culture on gelatine or collagen 
IV coated plates for at least six days. 
 
 Plates should be seeded with cells in maintenance media (containing serum) to 
allow initial adherence before culturing in low serum conditions 
(differentiation media). 
 
These conclusions were investigated further in a series of optimisation experiments, 
termed experiment three, (Section 3.2.1iii and 3.3.3) before any future differentiation 
experiments were conducted. 
 
Culture vessel treatment: mES cells were seeded on either gelatin or Collagen IV 
coated TCP in 10% (v/v) FCS containing media to see if using a different matrix 
component to aid cell attachment made any difference to the poor cell attachment 
 
observed in earlier experiments.  Gelatin is a mix of a number of irreversibly 
hydrolysed Collagens and is therefore a nonspecific aid for cell attachment whilst 
Collagen IV consists of six polypeptide chains and is a specific (unaltered) ECM 
component that is found exclusively in basement membranes where it plays an 
important role in cell adhesion [Khoshnoodi et al 2008].  No significant differences 
were observed between the mES cells seeded on gelatin coated TCP or those seeded 
on collagen IV coated TCP. This suggested that the poor attachment and proliferation 
observed in the initial experiments above was not due to the cell culture vessel and its 
(gelatin) coating.   
 
Media composition: The attachment and rate of proliferation of mES cells cultured 
(feeder free) in 10% FCS was compared to that in 10% SR media on gelatin coated 
TCP.  No significant differences were observed between the rate of proliferation and 
total cell number when the mES cells were cultured in either 10% (v/v) FCS or 10% 
(v/v) SR (a chemically defined alternative to serum that contains heated treated serum 
components required for cell maintenance but does not contain any bioactive proteins 
such as growth factors and hormones, etc). Having shown that the mES cells would 
not attach and proliferate in low serum conditions 10% (v/v) SR was used in some of 
the culture conditions in further experiments as an alternative to both high and low 
serum conditions. 
 
Seeding density: mES cells were seeded in CEE mES complete media (10% FCS, 
LIF) at various cell densities between 1 x 104 and 2.5 x 105 cells/ml on gelatin coated 
TCP.  The initial (total) number of cells that attached increased with increasing 
seeding density. The optimum seeding density for these experiments was between 5 x 
104 and 1 x 105 cells/ml based on an experiment of between nine – 16 days duration.  
The actual seeding density chosen for future experiments was decided depending on 
the planned duration of the experiment. 
 
Media composition: The proliferation of mES cells was investigated in a range of 
different media formulations including low (1%) and normal (10%) FCS levels, serum 
and SR, and DMEM and αMEM.  The CEE mES cells proliferated at different rates 
in the different media compositions tested although growth was observed in all 
conditions with the exception of the low serum conditions. Greater cell numbers were 
 
observed when cultured in 10% (v/v) FCS (CEE mES complete media, LIF+/) after 
72 hours compared with the 10% (w/v) SR media and the αMEM media. αMEM 
was used as it contains the antioxidant ascorbic acid (Vitamin C) which is thought to 
aid attachment by limiting the peroxidation of a range of lipid membrane components 
including αTocopherol (Vitamin E) facilitating greater interactions between cell 
surface molecules and the tissue culture vessel surface [Smith et al 2002]. 
 
However, the number of cells attaching was comparable in all conditions. Cell 
numbers in all conditions were sufficient for the generation of RNA samples and 
preparation of samples for immunocytochemical analysis.  These optimisation 
experiments showed that the CEE mES cell line would proliferate on gelatin coated 
TCP in a range of media formulations but that if low serum conditions were used the 
cells would not proliferate.  Gelatin coated TCP along with DMEM based media 
formulations containing 10% (v/v) FCS or SR were taken forward for use in future 
experiments.  
 
In experiment four (Section 3.2.1iv and 3.3.4) CEE mES cells were seeded in nine 
different conditions designed to investigate the effects of aggregation into EBs, 
treatment with the growth factor ActA and serum levels on the specification of DE.  
The levels of key marker expression in the RTPCR analysis show some marked 
differences between the different culture conditions. Although cell attachment and 
proliferation occurred in all the conditions the quality of RNA samples generated 
varied considerably which may have been an indicator that some conditions more 
favourable for cell growth and differentiation than others. The cells seemed to show 
the sensitivity to low serum levels that had been previously observed in experiments 
one and two in the culture conditions where SR was used but this conflicted with what 
has been reported in the literature where mES cells (although not CEE mES cells) had 
been successfully differentiated in media containing SR [Kubo et al, 2004]. 
 
The RTPCR analysis showed upregulation of DE markers when ActA was added to 
the culture media. The coexpression of FoxA2 and Sox17 along with the expression 
of CXCR4 indicates that DE formation was favoured in these conditions compared to 
conditions where ActA was not present.  This corresponds with the upregulation of 
DE markers seen following ActA treatment of mES cells in the literature [Kubo et al 
 
2004, Tada et al 2005, Yasunaga et al 2005].  As detailed in Sections 1.6 and 3.1.1 
ActA is a member of the TGFβ superfamily of growth factors.  It triggers a signal 
pathway that prompts SMADs 3 and 4 to enter the nucleus where they join 
transcriptional complexes.  These complexes then mediate the expression of various 
genes including those responsible for DE specification during development [Abe et al 
1996]. 
 
Oct4 was expressed throughout the time course of the experiment suggesting that 
either an undifferentiated population of cells remained or that the differentiating cells 
retained some undifferentiated characteristics [Nichols et al 1998].  Some expression 
of Oct4 has been reported in adult stem cell populations suggesting that Oct4 
expression is retained as cells differentiate further [Lee et al 2010].  The cells that had 
been aggregated into EBs showed slightly elevated levels of differentiation markers 
expressed, in some instances, at earlier timepoints in comparison with those that had 
been cultured in monolayer. 
 
Whilst none of the differentiation conditions in this experiment directed the cells to 
differentiate towards the DE fate with great efficiency, the variations in marker 
expression observed suggest that the culture conditions investigated, particularly 
addition of ActA and aggregation into EBs, did influence the differentiation of the 
mES cells. Further experiments incorporated extended culture times to increase the 
time that cells were exposed to the factors hypothesised to induce differentiation (see 
sections 3.2.1v).  These conclusions agreed with those from the literature [Kubo et al 
2004, Tada et al 2005, Yasunaga et al 2005] where the addition of growth factors and 
the subsequent activation of specific signalling pathways promoted the differentiation 
of mES cells towards the DE fate shown by the coexpression of FoxA2 and Sox17 
and the expression of CXCR4.  Some of the techniques employed in the literature 
involved selective stages based on positive expression of CXCR4 and ECadherin 
[Yasunaga et al 2005] or CXCR4 alone (using hES cells) [D’Amour et al 2005] to 
achieve a purer population of DE cells. 
 
In experiment five (Section 3.2.1v and 3.3.5) CEE mES cells were seeded in five 
different conditions designed to investigate further the effects of aggregation into EBs 
and treatment with the growth factor ActA on the specification of DE.  Following the 
 
poor outcome of low serum and SR conditions in the earlier experiments all 
conditions were supplemented with 10% (v/v) FCS.  The proliferation of the cells was 
monitored by eye through the course of the experiment to ensure sufficient cells were 
present for the generation of samples for analysis (by RTPCR and 
immunocytochemistry).  The cells in all the culture conditions attached and then 
proliferated throughout the time course of the experiment. 
 
The cells that had been aggregated (3 days as EBs) prior to monolayer culture began 
to express the selected DE markers, FoxA2, Sox17 and CXCR4, but the fact that there 
was an apparent reduction in the level of expression later in the experiment (when in 
monolayer culture for 9 days) suggested that extending the aggregation time might 
have aided DE differentiation [Abe et al 1996]. In the literature aggregation/culture 
times of 2.5 days followed by up to 7.5 days in monolayer in the presence of ActA 
induced expression of hepatic markers [Kubo et al, 2004].  In this study there was 
little difference between the ActA treated aggregates and those with no ActA. This 
could mean that the concentration of ActA was insufficient to exert an effect or that 
the culture duration needed to be extended to increase the exposure time of cells to the 
growth factor or that the effectiveness of the growth factor is reduced in a 3D 
environment.   
 
ActA disperses by passive diffusion in culture [Gurdon et al, 1994] so may have been 
unable to penetrate to the core of larger aggregates. Greater differences were apparent 
between the cells treated with ActA and those that had not been treated in the 
monolayer only conditions. This could mean that the differentiation initiated by 
aggregating the cells was not supported further with growth factor treatment. It also 
suggested that the differentiation effects of the growth factor treatment and of 
aggregation were not combinatorial. In condition three, where the cells went from 
monolayer to aggregation then back to monolayer culture, the DE markers were 
expressed at a fairly constant level until the terminal samples which showed a slight 
increase in expression. Again this suggested that an extension to the duration of the 
experiment might prove worthwhile. 
 
The expression of Brachyury in a number of culture conditions suggested that some 
mesodermal differentiation was taking place alongside any differentiation towards 
 	
DE. The same observations have been reported in the literature [Kubo et al 2004, 
Tada et al 2005].  The two germ layers have been shown to arise from a common 
precursor known as the mesendoderm [Tada et al 2005] and are therefore closely 
related. The ectodermal marker Nestin was expressed at low levels in some of the 
conditions. There was no real pattern to this expression but the strongest bands were 
observed in conditions were ActA was absent indicating that the ectodermal lineage 
was not favoured by ActA treatment. 
 
The immunocytochemical analysis provided few clear conclusions although 
expression of the selected DE markers was present in a number of the samples. In the 
later timepoints (216, 288 or 336 hours dependant on which culture condition) high 
background interference, shown in the secondary antibody controls, made analysis 
difficult. However in the earlier timepoints coexpression of FOXA2 and SOX17 was 
seen in conditions one and two, where ActA was present, and to a lesser extent in 
condition five, where the cells had been aggregated without ActA treatment. ActA 
treatment and aggregation appeared to support the expression of the DE markers at 
the protein level. This corresponds with the results in the literature [Kubo et al 2004, 
Tada et al 2005, Yasunaga et al 2005].   
 
OCT4 expression was observed in all conditions although it was strongest in 
condition four, where the cells were in monolayer culture and had no differentiation 
stimuli. The cells had retained the greatest pluripotent character in the culture 
condition where factors to induce differentiation were absent but some pluripotent 
marker expression remained in all conditions (as with the RTPCR analysis). The 
mesodermal/mesenodermal marker BRACHYURY was also expressed at the protein 
level. Its expression was strongest in the conditions were ActA was absent 
(conditions four and five).  This conflicts with some observations in the literature that 
suggested that ActA can induce upregulation of mesodermal markers [Kubo et al 
2004, Tada et al 2005]. 
 
The immunocytochemical results and the RTPCR analysis point towards the same 
general conclusions, namely that both ActA treatment and aggregation favour DE 
specification when compared with the monolayer controls under 10% FCS conditions 
with the CEE mES cell line. However the differentia
 

DE lineages as mesodermal markers are also in evidence.  As previously stated most 
of the studies in the literature involved a selection stage to purify the population of 
DE cells [Yasunaga et al 2005, D’Amour et al 2005, MacClean et al 2007] but such 
selection proved difficult in these experiments because of the lack of robustness of the 
cells when subjected to FACS. 
 
In experiment six (Section 3.2.1vi and 3.3.6) a modified version of the most 
promising culture condition from experiment five (condition three – two days in 
monolayer, 3 days as EBs then a further nine days in monolayer with Acta present 
throughout) was run (Section 3.2.1vi and 3.3.6).  Extending the aggregation phase by 
48 hours (2 days in monolayer then 5 days as EBs followed by a further 9 days in 
monolayer with ActA present throughout) resulted in clear RTPCR coexpression of 
all three selected DE markers, FoxA2, Sox17 and CXCR4, at the 168 hour (post 
aggregation phase) timepoint.  
 
As previously observed the marker expression then decreased when the cells were 
reseeded in monolayer (despite continued exposure to ActA) before gradually 
increasing by the end of the culture period at the 384 hour timepoint. The same 
pattern was also seen for the mesodermal/mesendodermal marker Brachyury. 
Expression of the pluripotency marker Oct4 was maintained at a consistent level 
through to the 168 hour timepoint after which it began to fall. Oct4 was still expressed 
in the terminal 384 hour timepoint but at a noticeably reduced level. 
 
Western blot analysis showed that the DE markers were being expressed at the protein 
level. However the resolution of the data produced meant it was difficult to say 
whether a marker was present at greater levels in one sample than another, only 
whether it was present or absent. The selected DE markers, FOXA2 and SOX17, were 
expressed but the cells also expressed OCT4, suggesting a retention of some 
pluripotent character or that some of the cell population had not differentiated, and 
BRACHYURY, indicating some mesodermal differentiation. 
 
The enzymatic immunocytochemical analysis also showed the expression of FOXA2, 
SOX17 and GATA4 indicating that specification of DE was occurring. There was no 
 




A number of the variables examined through the course of these experiments seem to 
induce cells to differentiate towards the DE fate.  However the process appeared to be 
far from efficient. The sensitivity of the CEE mES cell line to serum levels even when 
SR was used proved an obstacle to fully investigating the range of culture conditions 
that favour DE specification. The ultimate conclusions from this chapter of work are: 
 
Aggregating the cells into EBs promoted differentiation when compared to cells 
cultured in monolayer but did not specifically favour DE specification. In many cases 
when cells were reseeded in monolayer culture after an aggregation phase the strength 
of differentiation marker expression reduced. This phenomenon was still observed 
when the aggregation phase was extended from three to five days in duration. 
 
ActA treatment seems to favour the specification of DE when compared to control 
conditions but the induction effect was not comprehensive or particularly strong. DE 
markers were generally expressed at elevated levels after ActA treatment but markers 
of other fates, particularly mesoderm (see below) were sometimes present [Kubo et al 
2004, Tada et al 2005]. The pluripotent marker Oct4 [Nichols et al 1998] was also 
still expressed although occasionally at reduced levels. 
 
Some differentiation towards mesoderm occurred in the conditions that favour DE 
specification. This was perhaps unsurprising as the two germ layers arise from a 
common precursor [Tada et al 2005]. There was little evidence of any ectodermal 
differentiation in the conditions that most favoured DE formation.  
 
Whilst germ layer specification is an important stage in establishing cell lineages 
during development the cells are still some way from being fully differentiated into 
specific cell types and a level of maturation is still required.  These in vitro techniques 
(specifically a five day EB phase in ActA+, 10% (v/v) FCS media) will be used 
further in Chapter 4 to investigate the ability to enhance DE differentiation from the 
 
CEE mES cell line with subsequent coculture (following in vitro DE differentiation) 
of the CEE mES cells with early stage embryonic chick gut tissue with the ultimate 
aim of further differentiating the CEE mES cells towards the intestinal progenitor/ISC 
fate.  Coculture with specific embryonic tissue types has been shown to induce 
differentiation towards specific cell lineages [Sugie et al 2005, Fair et al 2003, Van 
Vranken et al 2005] with the target cell lineage dictating the choice of tissue e.g. to 
produce pulmonary epithelium mES cells were cocultured with pulmonary 








As cell differentiation moves further down the developmental pathway the signals that 
control its differentiation become more complex both in terms of the number of 
factors involved as well as spatial and temporal levels of control [Chadwick and 
Marsh 1992, Kaufmann 2005, Tickle 2003].  As a consequence this pattern of 
signalling becomes increasingly difficult to replicate in vitro making it a challenge to 
expose cells to further differentiation stimuli.  A number of studies have shown that 
coculturing pluripotent cells with ex vivo early embryonic tissue explants or cells 
(from a variety of different species) can direct undifferentiated cells towards a 
particular fate as discussed below. 
 
To further differentiate cells towards a particular tissue/cell population or to maintain 
a particular cell type a complex network of signalling interactions is usually involved.  
These can be hard to reproduce in vitro for a variety of reasons including the number 
of signalling factors involved to the spatial nature of the signals.  As previously stated 
the intestinal progenitor niche is maintained in the base of the Crypts of Lieberkuhn 
by a complex range of signals (Section 1.2.1, Figures 1.5 and 1.6) that act in a 
spatially dependant manner.  A number of signalling factors are involved that do not 
originate from the same source.  The strengths of the different signals therefore vary 
depending on the physical location of where they overlap (dependant on the methods 
by which the signalling factors diffuse) and these variations can produce different 
responses in the receptor cells. 
 
To prompt ES cells towards a particular developmental fate it stands to reason that 
they must be exposed to the signals from the location in the embryo where they arise 
and this can direct the choice of tissue for coculture.  This has been demonstrated 
with a number of target cell types.  A number of the studies detailed below also 
included an initial in vitro differentiation step (involving growth factor treatments 
and/or aggregation into EBs) before the coculture stage, usually targeting a specific 
germ layer.  This mirrors the process that would occur in normal development as 
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differentiation into specific cell and tissue types would occur following the 
specification of the three germ layers (endoderm, mesoderm and ectoderm) at 
gastrulation [Kaufmann 2005, Chadwick and Marsh 1992]. 
 
Photoreceptor cells have been generated by coculturing mES cells with embryonic 
chick retina [Sugie et al 2005].  In this study mES cells were initially aggregated into 
EBs for four days, by the hanging drop method, and treated with retinoic acid in vitro 
for a further four days to initiate differentiation towards the neural fate.  The cells 
were then sorted by selection for markers of neural differentiation and the positive 
cells were cocultured with (day six) embryonic chick retinal tissue for 10 days.  At 
the end of the coculture period the mES derived cells were assessed for the 
expression of Rhodopsin, a key functional protein found in photoreceptor cells, by 
immunohistochemistry with approximately one fifth staining positive.  The expression 
of the photoreceptor specific transcription factor crx and the rod photoreceptor 
markers IRBP and recoverin was assessed by RTPCR.  These all showed increased 
expression in the cocultured cells versus controls [Sugie et al 2005]. 
 
Culturing mES cells with cardiac mesoderm has been shown to promote 
differentiation towards the hepatic fate [Fair et al 2003].  Cardiac mesoderm would be 
found proximal to hepatic endoderm during embryonic development and it is 
therefore likely that the two areas share signalling interactions.  GFPlabelled mES 
cells were cocultured with embryonic chick cardiac mesoderm for up to four days.  
The cells were then analysed for the expression of markers of the hepatocyte fate.  It 
was shown that the cells in coculture were positive for the expression of the early 
endodermal/hepatic markers Sox17α, GATA4 and HNF3β compared to control cells 
when assessed by RTPCR after one day.  After two and four days the hepatic 
markers αfetoprotein and albumin also showed upregulated mRNA expression [Fair 
et al 2003]. 
 
Coculturing mES cells with pulmonary mesenchyme was found to promote 
differentiation towards the pulmonary epithelial fate [Van Vranken et al 2005].  mES 
cells that had been aggregated into EBs were cocultured with pulmonary 
mesenchymal tissue from day 11.5 or 13.5 embryonic mice for five or 12 days.  The 
cells were then analysed for the expression of markers of pulmonary epithelium.  The 
 
cocultured cells showed upregulation of the epithelial markers cytokeratin and 
TTF1.  Expression of Surfactant protein C, a marker of type II pneumocytes, was 
detected in some of the cocultured cells.  These markers were not expressed in the 
experimental controls [Van Vranken et al 2005]. 
 
Coculturing mES cells with five day postnatal rat auditory hair cells or auditory 
neurons promoted differentiation into bipolar neurons following an initial in vitro 
treatment with RA to induce ectodermal/neural differentiation [Coleman et al 2007].  
EBs and dissociated cells were cocultured with auditory neurons for seven days and 
with auditory hair cells for three days.  The most successful technique involved the 
coculture of intact EBs with hair cell explants which gave the highest number of 
neuronlike cells (by morphological assessment) that expressed neurofilament protein 
when evaluated by immunolabelling [Coleman et al 2007]. 
 
Introduction into the AortaGonadMesonephros (AGM) microenvironment induced 
haematopoietic activity in (labelled) mES cells [Krassowska et al 2006].  EBs that had 
been generated by the hanging droplet method were cocultured with a number of 
stromal cell lines and samples were collected at defined timepoints.  The 
haematopoietic activity of the sampled cells was assessed using the CFUA and the 
HPPCFC (colony forming) assays [Krassowska et al 2006]. 
 
Tissue derived cells also seem able to promote stem cell differentiation.  Cynomolgus 
monkey ES (cES) cells cultured with (day 14) embryonic mouse liver derived cells 
differentiated into hepatocyte like cells [Saito et al 2006].  The expression of AFP, 
albumin, α1antitrypsin and HNF4α were upregulated in the cocultured cells 
compared to controls when evaluated by RTPCR.  The cocultured cells also showed 
expression of Cytochrome P450 7A1, a putative marker for endoderm derived 
hepatocytes, whilst the controls did not.  Immunocytochemical analysis showed an 
increased number of ALBUMIN positive cells in the cocultured cells compared to 
controls.  The cocultured cells also showed some functional activities associated with 
hepatocytes, namely urea synthesis and glycogen storage [Saito et al 2006]. 
 
Some studies have used intact embryos from a variety of species rather than specific 
tissue explants or cells to induce the differentiation of SCs towards a target cell fate.  
 
Culturing hMSCs within whole rodent or murine embryos has been shown to be able 
to initiate differentiation towards kidney cell types [Yokoo et al 2005].  The embryos 
were excised at embryonic day 9.5 for the mice and embryonic day 11.5 for the rats.  
Bone derived hMSCs were injected into the embryos which were then cultured ex 
vivo for four days.   
 
At this point the metenephroi (the third stage of kidney development) were dissected 
and cultured in vitro for a further six days.  The hMSCs were then extracted and 
analysed for the expression of a number of markers of early kidney development 
including aquaporin1, parathyroid hormone receptor 1 and glomerular epithelial 
protein 1 by RTPCR.  Based on increased levels of marker expression compared to 
controls the hMSCs cultured with rodent embryos appeared to take the initial 
differentiation steps towards the kidney fate during the whole embryo culture with 
further differentiation occurring during the organ culture phase [Yokoo et al 2005]. 
 
ES also differentiated according to the microenvironment in which they were 
transplanted in vivo [Kudo et al 2007].  mES cells seeded into the intestinal 
environment following radiation damage contributed to the repair and repopulation of 
the intestinal epithelium (see Section 1.4) [Kudo et al 2007]. 
 
The chicken is a model organism for genetic and developmental studies and therefore 
much is known about its molecular biology and development including a fully 
sequenced genome.  These closely resemble mammalian processes so it is 
hypothesised that inducing signals in the chick will have the desired effect on the 
murine (and human) cells [Bellairs and Osmond 2005, Chadwick and Marsh 1992].  
Embryonic chick tissue was used in conjunction with mES in a number of the studies 
discussed above [Sugie et al 2005, Fair et al 2003].  However, there are sufficient 
differences to allow for molecular analysis of the murine cells following coculture 
without any chick nucleic acid or protein giving false positive results (i.e. it is 
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The experiments in this chapter sought:  
 
 To ascertain if it was feasible to excise and maintain ex vivo embryonic chick 
gut tissue for sufficient time to carry out the proposed coculture protocols. 
 
 To transfect CEE mES cells with a GFP expressing plasmid. 
 
 To establish if mES cells could be introduced to, cultured within and then 
extracted from ex vivo chick gut tissue explants. 
 
To coculture CEE mES cells, some of which had been through the in vitro 
differentiation protocols detailed in Chapter Three, with embryonic chick gut tissue 
and to evaluate the effects of this coculture on stem cell differentiation to the 
definitive endoderm and intestinal precursor lineages.  Cell differentiation was 
assessed at the RNA level by RTPCR and the proteomic level by 








Fertilised chicken eggs were obtained at one day postfertilisation (Henry Stewart & 
Company  Ltd, Lincolnshire, UK) and stored at 12°C until required.  The eggs were 
then incubated at 37ºC for six days.  The top of the egg was then gently cracked open 
and a sufficient part of the shell removed to allow access around the embryo (Figure 
4.2.1A).  A small volume of PBS was pipetted in and the membrane was then pierced 
to allow the PBS to drain through to aid in detaching the embryo from the membrane 
(Figure 4.2.1B).  The membrane was then cut around the embryo which was then 
lifted out of the shell and placed in a Petri dish.  Any membrane remaining attached to 
the embryo was then trimmed away and the embryo was cleaned with PBS (Figure 
4.2.1C).  The head and the heart were then removed, the embryo pinned down and an 
incision made along the ventral side.  The endodermal tissues, including the early 
intestine were then excised [Bellairs and Osmond 2005]. 
 
Embryonic chick tissue was chosen for a number of reasons.  Embryonic chicks are 
far easier to obtain & store than (mammalian) species that give birth to live young.  
Fertilised eggs can be obtained from a specialist supplier in large numbers and can be 
kept at 8  12°C in a chilled unit for a few days (where development is arrested) 
before being transferred to an incubator at 37°C until they reach the desired stage of 
development.  In addition, during the first half of development (up to 10 days as the 
eggs would take approximately 21 days to hatch) work can be carried out without the 




Tissue explants were washed in PBS and then fixed by 4% (w/v) formalin treatment 
for 20  30 minutes at room temperature.  The tissue samples were then processed 
overnight using a Leica TP1020 tissue processor that dehydrates the tissues through a 


















ced.  C – 
en a series 
before fina
en embedd
 chilled to 
d Stevens 1
moval of th






















g a Leica 
x to harden
tevens and 







 and then w
Heath 2006
 The top o
 and the me






















Tissue explants were washed in PBS and then fixed with 4% (w/v) formalin treatment 
for 20 minutes.  The samples were mounted in OCT embedding matrix (Cellpath, 
UK).  The blocks were set by immersion in isopentane cooled by immersion in liquid 
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Polylysine slides (VWR, 6310107) were soaked in acetone (or methanol) for two 
minutes and then air dried to ensure that the slides were clean.  A 2% (v/v) solution of 
3Aminopropyltriethoxysilane (APES) in acetone was made by adding 2 ml APES 
(SigmaAldrich, A3648) to 98 ml Acetone.  This solution was used on the day it was 
made and was subsequently discarded.  The (dry) slides were soaked in the 2% (v/v) 
APES solution for two minutes.  The slides were then washed twice in distilled water 
and then dried completely in a 37ºC oven and allowed to cool.  The slides were then 




Wax embedded samples were sectioned (5  10 Xm thickness) using a Leica RM2165 
Microtome.  The sections were transferred to a 50°C water bath to stretch the wax and 
then mounted onto an APES coated slide.  The slides were placed on a hot plate set at 
65°C to melt the wax and remove any air bubbles.  The slides were allowed to cool 
and then the mounted samples were stored at room temperature. 
 
Cryoembedded samples were sectioned (5  10 Xm thickness) using a Bright 
Instrument Company 5030 Cryostat.  The interior of the instrument was chilled to 
30°C to keep the samples frozen whilst the sample blocks are stored in dry ice when 
removed from the 80°C freezer to keep them as cold as possible.  Sections were 
mounted on an APES coated slide and placed at room temperature to allow the 
embedding matrix to melt and dry to the slide.  The mounted samples were then 
stored at 20°C until required. 
 
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The tissue explants were tested for markers to ensure that intestinal tissue was being 
excised.  Mounted tissue sections were stained by fluorescence 
immunohistochemistry (see Section 2.2.7) using an antibody raised against the 
expressed protein for CDX2, a marker of early intestinal lineages (Cell Signalling 
Technology, USA, 3977S) [Traber and Silberg 1996].   
 
RNA samples were prepared from whole chicks, freshly excised tissue and from 
tissue explants that had been cultured ex vivo for up to 10 days (three and seven days 
in batch A then three, seven and 10 days in batch B  see Section 2.2.1) by digestion 
with dispasecollagenase (see Section 4.2.11).   
 
These samples were evaluated for the expression of GAPDH, a ubiquitously 
expressed ‘housekeeping’ gene, and cdx2 by RTPCR analysis (as described in the 
Sections 2.2.5 and 2.2.6).  Details of the primer pairs can be found in the table below 
(Table 4.2.1).  Please note these primers were designed against chicken (Gallus 





Tissue explants were washed with PBS and then transferred to nontissue culture 
treated six well plates in DMEM + 10% (v/v) FCS that had been prewarmed to 37°C.  
The tissue was then maintained in culture for up to 25 days with fresh media added as 
required, usually every day.  Samples were prepared for RTPCR analysis of key 
marker expression after three, seven and 10 days (see Sections 2.2.5, 2.2.6 and 
Section 4.2.6). Samples were fixed and prepared for sectioning and histological 
staining after one, four, six and eight days in culture (see Section 4.2.8).  Livedead 
analysis was also carried out after three, five, six, eight, 10, 20 and 25 days in culture 
(see Section 4.2.9). 
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Wax embedded sections or cryosections mounted on slides of explanted tissue that 
had been maintained in ex vivo culture for between zero (freshly explanted tissue) and 
 
eight days were stained with H & E [Bancroft and Stevens 1982, Young, Lowe, 
Stevens and Heath 2006] to allow examination of the tissue architecture.  Reagent 
recipes can be found in Section 6.4. 
 
The wax sections were rehydrated by immersion through the following sequence of 
solvents: Xylene for three x one minute, 100%, 90%, 70% and 50% (v/v) Industrial 
Methylated Spirit (IMS) for one minute each and then H2O for one minute.  The slides 
were immersed in Haematoxylin for five  10 minutes then rinsed with H2O to remove 
any excess stain.  The slides were then immersed in Scott’s Tap Water substitute for 
two minutes.  The slides were then washed with H2O and then dehydrated through the 
following sequence of solvents: 50%, 70% and 90% (v/v) IMS for one minute each.  
The slides were then dipped in 1% (w/v) Alcoholic Eosin for three seconds.  The 
dehydration sequence was then completed by further solvent immersions: 100% IMS 
two x two seconds and Xylene two x five seconds.  The slides were then air dried and 
the sections mounted using Distyrene, Plastisier and Xylene (DPX) (Sigma) under a 





The required amount of Livedead working solution was made up from a Livedead® 
cell viability/cytotoxicity kit (Molecular Probes, L3224).  Ethidium D1 homodimer 
(Eth D1, 20 µl of 2 mM) was added to 9.975 ml PBS (final concentration 4 XM) and 
vortexed thoroughly.  Calcein AM (5 µl of 4 mM) was then added to the working 
solution (final concentration 2 XM) and vortexed thoroughly. 
 
The media was aspirated from the tissue in culture and the tissue washed three times 
with PBS.  Enough live/dead working solution to cover the tissue was applied and 
incubated for 30  40 minutes at room temperature.  The livedead working solution 
was then removed and the tissue was washed three times with PBS.  The tissue was 
then covered with UV mountant (DABCO) and visualised using a Nikon Eclipse 
fluorescence microscope (excitation/emission 495/515 nm Calcein AM (green = live 





LB broth was supplemented with Ampicillin to a final concentration of 30 Xg/ml (150 
ul of 100 mg/ml stock in 500 ml).  10 ml of this media was aliquoted into a universal 
and inoculated with a scraping from a glycerol stock of the bacteria carrying the 
GFP/Puromycin resistance expressing plasmid (VS01 – see Figure 4.1.2).  This 
culture was incubated in a shaking incubator at 37ºC for two  three hours.  This 
allowed the bacteria to start growing in a small and concentrated environment.  The 
contents of the universal were transferred into a large conical flask containing the 
remainder of the media.  This was incubated overnight in the shaking incubator at 
37°C. 
 
The medium was cloudy the following day indicating the bacteria had grown.  The 
culture was aliquoted into 50 ml centrifuge tubes and spun at 2000 g for 10  15 
minutes.  The supernatant was removed.  The pellets were stored at 20°C until 
required. 
 
The minimum concentration of Puromycin required to kill mES cells not carrying the 
plasmid was determined by carrying out a kill curve – untransfected cells were 
cultured in media (DMEM + 10% FCS + 1% AB/AM + 1% LGlut + 5 x 10³ units/ml 
LIF) containing 0.05 – 3 Xg/ml Puromycin in a gelatin coated 24 well TCP plate 
(Figure 4.2.2) for several days and observed throughout.  A control was cultured in 
Puromycin free media.  The kill curve was carried out in triplicate. 
 
The plasmid was prepared and purified using an RNeasy® MaxiKit (Qiagen, Cat no 
12162).  The plasmid yield was then quantified using a Nanodrop Spectrophotometer. 
The plasmid was linearised by digestion with PstI restriction enzyme overnight at 
37°C.  The linearised plasmid was checked by electrophoresis on an agarose gel 
(Figure 4.2.2). 
 
CEE mES cells at passage number 20 in suspension at 1 x 107 cells/ml (400 Xl) and 
plasmid suspension at 20 Xg/ml (250 Xl) were mixed with  PBS (150 Xl, Gibco, Cat no 
10010) to give a total reaction volume of 800 Xl.  This was transferred to a cuvette 
and placed in a Multiporator.  A charge of 450 V was then passed across the cuvette 
 
for 500 Xs [Bushman F, 2002, Lateral DNA Transfer  Mechanisms and 





Figure 4.2.2: Kill curve plate layout 
 
 
The reaction mix was then diluted out in cell culture media and transferred to six well 
tissue culture treated plates.  The media contained Puromycin at 1 Xg/ml (as 
determined by the kill curve – Figure 4.3.5  7).  The electroporated cells were 
cultured under Puromycin selection for 14 days on gelatin coated TCP six well plates 
to ensure only cells that had been transfected would survive.  The surviving cells were 
then transferred into ordinary mES cell proliferative culture conditions.  The cells’ 





Tissue explants were washed with PBS and then transferred to nonTCP treated six 
well plates containing DMEM + 10% (w/v) FCS.  The explants were then injected 
 
with 100 µl of mES or GFPmES cells in suspension (some of which had been pre
treated in vitro with ActA), at 1 x 106 cells/ml, using a fine hypodermic needle and 
syringe.  The tissuecell cocultures were then incubated at 37ºC, 5% (v/v) CO2 in air 
for up to seven days.  In the optimisation experiments the live cocultures were 
examined under a fluorescent microscope to establish if the injected GFPmES cells 
remained associated with the tissue mass; some of the (intact) celltissue cocultures 
were embedded and sectioned as above and examined using a fluorescence 
microscope.  The sections were examined using a Nikon Eclipse Fluorescence 
microscope before H and E staining as it was found that H and E staining produced 
high levels of background fluorescence in the GFP emission wavelength.  Therefore 
the fields of view for the two images produced (GFP vs H and E staining) were 
slightly offset (see Section 4.3, Figure 4.3.7). 
 
At the end of the coculture period the tissue explants were broken down using a 
dispasecollagenase digestion media (DMEM, 1% (v/v) FCS, 1% (w/v) AB/AM, 1% 
(w/v) LGlut, 75 U/ml collagenase XI, 20 µg/ml dispase).  The explants were 
transferred to fresh nonTCP six well plates containing the digestion media and 
incubated for two  three hours at 37°C on a shaker.  RNA samples were prepared 
from the cell suspension as described in Section 2.2.1 and analysed by RTPCR as 
described in Section 2.2.5 and 2.2.6.  Protein samples were prepared as described in 
Section 2.2.3 and analysed by western blotting as described in Section 2.2.8.  Samples 
were prepared for immunocytochemistry as described in Section 4.2.14 and analysed 
as described in Section 2.2.7. 
 
These experiments were conducted a number of times as there was a limit to the 
number of samples that could be run at any one time.  These experiments were termed 
batch A – F. In Batch A naïve GFPmES cells were injected into six intact embryonic 
chick gut tissue explants. In Batch B naïve GFPmES cells were injected into six 
intact embryonic chick gut tissue explants whilst GFPmES cells that had been 
aggregated into EBs and ActA treated in vitro (treatment based on condition three in 
Chapter Three, Section 3.2.1v and 3.3.5 consisting of two days in monolayer followed 
by a five day EB phase with a further nine days in monolayer in ActA+, 10% (v/v) 
FCS media throughout) were injected into a further six intact embryonic chick gut 
tissue explants. In Batch C naïve GFPmES cells were injected into six intact 
 	
embryonic chick gut tissue explants. In Batch D naïve GFPmES cells were injected 
into five intact embryonic chick gut tissue explants whilst GFPmES cells that had 
been aggregated into EBs and ActA treated in vitro were injected into a further four 
intact embryonic chick gut tissue explants. In Batch E mES cells were injected into 
nine intact embryonic chick gut tissue explants. In Batch F mES cells were injected 
into nine intact embryonic chick gut tissue explants and cocultured for six days. 
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Tissue explants were washed with PBS and then broken down using a dispase
collagenase digestion media as described above (Section 4.2.10).  The dissociated 
cells were then resuspended and seeded in nonTCP six well plates in DMEM + 10% 
(v/v) FCS.  GFPmES cells in suspension (100 Xl at 1 x 106 cells/ml), some of which 
had been pretreated in vitro with ActA, were intermixed with the dissociated gut 
cells using a fine hypodermic needle and syringe.  The cellcell cocultures were then 
incubated at 37ºC & 5% (v/v) CO2 in air for up to seven days.  RNA samples were 
prepared from the cell suspension as described in Section 2.2.1 and analysed by RT
PCR as described in Section 2.2.5 and 2.2.6.  Protein samples were prepared as 
described in Section 2.2.3 and analysed by western blotting as described in Section 
2.2.8.  Samples were prepared for immunocytochemistry as described in Section 
4.2.14 and analysed as described in Section 2.2.7. 
 
This experiment was run in parallel to intact tissue cocultures as part of the 
experiment termed batch D.  In Batch D naïve GFPmES cells were used to set up 
five cocultures with cells derived from embryonic chick gut tissue explants and co
cultured for seven days whilst GFPmES cells that had been aggregated into EBs and 
ActA treated in vitro (treatment based on condition three in Chapter Three, Section 
3.2.1v and 3.3.5 consisting of two days in monolayer followed by a five day EB phase 
with a further nine days in monolayer in ActA+, 10% (v/v) FCS media throughout) 
were used to set up four cocultures with cells derived from embryonic chick gut 







The mES cells used in the coculture experiments (Batches A – D inclusive) had been 
stably transfected with a GFP expressing plasmid (see Chapter 3A).  The cell 
suspension (from batches A  C) produced by the dispasecollagenase digest was 
sorted for positive expression of GFP using BeckmanCoulter Altra Flow Sorter 
instrument prior to sample preparation (see Section 2.3).  The sorting parameters were 
optimised using a positive and negative control sample to ensure all negative cells 
were excluded.  The sorted cells were then either returned to monolayer culture or 
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The cell suspension produced from the dispasecollagenase digest was pelleted by 
centrifugation at 200 g for five minutes and washed three times with PBS.  The cells 
were then fixed by treatment with 4% (w/v) formalin for 20 minutes at room 
temperature.  The cells were then washed three times with PBS and resuspended at 
high density in a small volume of PBS.  Between 10  20 Xl of this cell suspension 
was placed on an APES coated polylysine microscope slide and spread to cover an 
area approximately 5 mm in diameter.  The slides were then allowed to air dry in 




Primers were designed as described in the general methods section.  The selected 
markers were Lgr5/GPR49 [Barker et al 2007], Msi1 [Potten et al 2003], both of 
which are markers of ISC, CD133 [Kania et al 2005], a marker commonly associated 
with ASC populations known to be expressed in colonic stem cells [Samuel et al 
2008] & Epi Ant [Engelhardt et al 1993].  As described previously the selected marker 
for undifferentiated cells was Oct4 & GAPDH primers were used as a ubiquitously 
expressed control to confirm the RT stage of the reaction had worked (Table 4.2.1A).  
Primers were also designed for chick cdx2 and chick GAPDH (Table 4.2.1B).   
 
 
Table 4.2.1A: RTPCR primer pair details for chicken markers of interest. 
 
 





Where coculture batches A  D were analysed only the enzymatic method (see 
Section 2.2.9) was used as the samples contained GFP labelled cells.  For batches E  
H unlabelled cells were used so both fluorescent and enzymatic techniques were 
employed (see Section 2.2.9). The expression of the ISC marker LGR5, the DE 









Before the explanted tissue could be used in the coculture experiments it was 
necessary to confirm that the tissue being excised was the developing intestinal tissue.  
Therefore the tissue was examined at the molecular level for the expression of key 
marker genes and corresponding proteins. 
 
Day six/stage 20 tissue was used because work carried out and general information 
[Bellairs and Osmond 2005] showed that it was at this stage that the early intestine 
had formed a tissue mass of appropriate size and morphology. This was confirmed by 
histological and immunohistochemical staining of whole embryo sections.  Day six 
chick tissue was also used in one of the studies in the literature [Sugie et al 2005].  
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Sections of wax embedded (day six) embryonic chick gut tissue displayed strong 
expression of the intestinal marker CDX2 when evaluated by fluorescence 
immunohistochemistry (Figure 4.3.1).  Figure 4.3.1A shows H & E staining of a 
whole (day six) embryonic chick section with the area from which tissue was excised 
circled.  Figures 4.3.1B and C show the secondary antibody control (i.e. sections 
incubated with PBS in place of the primary antibody but with secondary antibody to 
determine if any positive signal was given by nonspecific binding).  The DAPI 
staining clearly shows that material was present but there was no strong signal in the 
FITC channel.  There was moderate background interference in the FITC channel but 
no areas of strong positive staining.  This indicated that there was minimal non
specific binding of the tagged secondary antibody.  Figures 4.3.1D – G show the 
images of the primary antibody staining from two representative sections.  The DAPI 
images show all the cells present in this area of the section whilst the FITC channel 
illustrate expression of the target protein, CDX2, which was expressed in both 
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Before the cells could be cocultured with the tissue explants the viability of the tissue 
in ex vivo culture was investigated.  The tissue explants were placed in culture for up 
to 25 days and analysed for signs of necrosis and degradation.  By eye observations 
were made and samples were collected for histology, immunohistochemistry and RT






Figure 4.3.2 shows the levels of RNA expression of the ubiquitous marker, GAPDH, 
and the intestinal marker, cdx2 by chick gut tissue explants cultured ex vivo for 0, 3, 7 
and 10 days.  This data supported the immunohistochemical results shown in Figure 
4.3.1 and also demonstrated that the explanted tissue not only survived in culture but 
also maintained RNA expression.  The top two rows in Figure 4.3.2 show the results 
from the first batch of this experiment.  Stronger GAPDH bands were achieved from 
whole chick explants than the other samples due to the varied levels of GAPDH 
expression in different tissues.  GAPDH expression was maintained throughout the 
time course without any significant difference in the strength of the bands from the 
samples prepared from tissue samples immediately after excision or those from tissue 
that had been in culture for seven days. 
 
This was also true for the intestinal marker cdx2 although one of the three replicates at 
the seven day timepoint showed no expression.  In the second batch of the experiment 
(the lower two rows in Figure 4.3.2) there was some reduction in the strength of the 
GAPDH bands over the (longer) time course but expression was still maintained 
although more variation between replicates was apparent than in batch A.  Cdx2 
expression also appeared reduced in the later timepoints, again with more variation 
between replicate samples.  Some of this corresponded to the variation in the GAPDH 
bands (day 10 samples) and therefore may have been caused by reduced efficiency of 
the RT reactions but some did not (day seven samples).  The variation could also have 
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Figure 4.3.5: Kill curve. Light microscopy images showing mES and SNL cell growth 
at x Xg/ml Puromycin after 24 hours. mES and inactivated SNL feeder layer cells 
were cultured alone and mES cells on a feeder layer of inactivated SNL cells. A: mES 
No Puromycin. B: SNL No Puromycin. C: mES+SNL No Puromycin. D: mES 3 
Xg/ml Puromycin. E: SNL 3 Xg/ml Puromycin. F: mES+SNL 3 Xg/ml Puromycin. 
 
 
After 96 hours little difference was observable between mES cells in the control 
(Figure 4.3.6A) and in 0.05 Xg/ml Puromycin (Figure 4.3.6B).  Far fewer cells 
remained viable in 0.1 Xg/ml Puromycin and 0.5 Xg/ml (Figure 4.3.6C and D) but live 
cells were still present.  At the highest concentrations of Puromycin used, 1 Xg/ml and 
3 Xg/ml, >95% of the cells were dead (Figure 4.3.6E and F).  The inactivated SNLs 
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Figure 4.3.11 shows cross sections of cocultures that had been fixed, cryo
preserved/embedded and sectioned following seven days in culture.  For each 
sample two images are displayed; the left hand images (Figure 4.3.11A and C) are 
fluorescent images scanning for GFP, the right hand images (Figure 4.3.11B and 
D) are H & E stains to show the extent of the tissue on the sample slide.  Whilst in 
Figure 4.3.10 above only GFP signal from cells on or near the surface of the 
explants is detected these sections show the extent to which the GFP positive mES 
cells were distributed within the chick tissue.  The fluorescent and H and E images 
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Batch A naïve GFPmES cells were injected into six intact embryonic chick gut 
tissue explants and cocultured for seven days.  In Batch B naïve GFPmES cells 
were injected into six intact embryonic chick gut tissue explants and cocultured 
for seven days whilst GFPmES cells that had been aggregated into EBs and Act
A treated in vitro were injected into a further six intact embryonic chick gut tissue 
explants and cocultured for seven days. In Batch C naïve GFPmES cells were 
injected into six intact embryonic chick gut tissue explants and cocultured for 
seven days. In both batches A and B expression of GAPDH was observed but the 
bands produced were weaker than were produced in most reactions.  There were 
no bands produced with any other primer pair which may have been a reflection 
of the poor quality of the RNA samples generated postFACS or may simply have 







Figure 4.3.13 shows the results of the RTPCR analysis of the RNA samples 
generated from coculture experiment (batch) D.  Naïve GFPmES cells were 
injected into five intact embryonic chick gut tissue explants whilst GFPmES cells 
that had been aggregated into EBs and ActA treated in vitro (treatment based on 
condition three in Section 3.2.1v and 3.3.5 consisting of two days in monolayer 
followed by a five day EB phase with a further nine days in monolayer in ActA+, 
10% (v/v) FCS media throughout) were injected into a further four intact 
embryonic chick gut tissue explants and cocultured for seven days.  Naïve GFP
mES cells were also used to set up five cocultures with cells derived from 
embryonic chick gut tissue explants and cocultured for seven days whilst GFP
mES cells that had been aggregated into EBs and ActA treated in vitro  were used 
to set up four cocultures with cells derived from embryonic chick gut tissue 
explants and cocultured for seven days. 
 
Figure 4.3.13A shows the results from GFPmES cells cocultured with intact 
tissue explants, Figure 4.3.13B shows the results of GFPmES cells cultured with 
 

dissociated embryonic chick gut cells whilst Figure 4.3.13C shows the control 
mES cells that had not been cocultured.  In both the intact explants and 
dissociated cell experiments samples one and two were with ActA treated cells 
whilst samples three  five were with naïve GFPmES cells.  The ‘scores’ assigned 
to these bands are summarised in tabular form in Figure 6.3.6 in Section 6.3. 
 
No significant expression was observed for any of the markers in the chick tissue 
controls with the exception of GAPDH.  The sequence homology between species 
is higher for GAPDH than for the marker genes used so some expression was not 
unexpected.  The expression of GAPDH in the chick tissue controls was 
noticeably weaker than in other samples.  The exception is control sample B1 
where the GAPDH expression was stronger (& weak expression is observed in a 
number of the marker genes).  This was probably due to contamination with 
murine cells as the other two controls showed no expression of the markers.  Oct4 
expression was observed in all the samples but at relatively low levels.  The levels 
of Oct4 expression were reduced in the experimental samples when compared to 
the controls.  Moderate expression of FoxA2 was seen in all the samples but 
expression of Sox17 was less consistent.  FoxA2 expression was comparable 
between the intact explant and dissociated cell cocultures but Sox17 expression 
was stronger in the dissociated cell samples.  Moderate expression of Brachyury 
was seen in all the samples but was stronger in the dissociated cell samples than 
the intact explant samples.  There was no expression of CXCR4 or Nestin in either 
condition. 
 
Moderate expression of Lgr5 was seen in both conditions.  There was weak 
expression of CD133 and Epi Ant in all the samples with the dissociated cell 
samples showing stronger bands than the intact explants.  There was no 
expression of Msi1 in either condition.  None of the ISC markers selected showed 
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Figure 4.3.15 shows the results from the RTPCR analysis of the RNA samples 
generated in coculture experiments (batch) E (Figure 4.3.15A) and F (Figure 
4.3.15B). In Batch E naïve (unlabelled) mES cells were injected into nine intact 
embryonic chick gut tissue explants and cocultured for 7 days. In Batch F naïve 
(unlabelled) mES cells were injected into nine intact embryonic chick gut tissue 
explants and cocultured for six days. Control samples from mES cells that had 
not been cocultured are also shown (Figure 4.3.15C). 
 
GAPDH expression was seen in the two chick tissue controls but at a lower level 
than in the samples.  This was believed to be due to the especially high degree of 
interspecies sequence homology for this gene (as detailed above).  No other 
markers were expressed in the controls. 
 
Oct4 expression was seen in every sample however it was reduced in the 
experimental samples when compared to the controls.  Also Oct4 expression was 
higher in batch E than in batch F.  Strong expression of FoxA2 but no expression 
of Sox17 was apparent in batch E whilst in batch F FoxA2 expression was weaker 
but Sox17 was also weakly expressed.  Very weak bands for Sox17 and FoxA2 
were just visible in the controls.  Moderate expression of Brachyury was present 
in both conditions.  Weak expression of Nestin was observed batch E but was not 
present in batch F.  There was no expression of CXCR4 in either condition. 
 
Moderate expression of Lgr5 was present in both batches as was strong expression 
of CD133.  There was no expression of Msi1 in batch E but weak expression was 
observed in batch F.  There was no expression of Epi Ant in either condition.  The 
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the brightfield image showed a good number of cells in the field of view with 
these cells mostly being found in clusters.  The clusters of cells in the bottom left 
hand quadrant gave strong FITC signal and those in the top left hand quadrant 
gave moderate signal indicating the presence of LGR5 protein.  Although LGR5 
expression was extensive it was not expressed in every cell. 
 
In sample B2, where naïve mES cells had been cocultured with an intact 
embryonic chick gut tissue explant for seven days, (Figure 4.3.16i, panels D  F) 
the brightfield image (at lower magnification than B1) showed large clusters of 
cells.  The large cluster of cells in the bottom right hand quadrant gave a moderate 
FITC signal indicating the presence of LGR5 protein but the other clusters of cells 
did not appear to express LGR5 protein (at a detectable level). 
 
In sample B5, where naïve mES cells had been cocultured with an intact 
embryonic chick gut tissue explant for seven days,  (Figure 4.3.16ii, panels G  I) 
the brightfield image showed that most of the cells in this sample were towards 
the centre of the field of view.  The FITC signal was weaker than the previous 
samples.  This could have reflected lower levels of LGR5 protein expression or 
may have been an experimental or imaging artefact. 
 
The positive control samples (Figure 4.3.16iii, panels J  L) were sections of 
embryonic mouse intestinal tissue mounted on a slide and stained with antiLGR5 
antibody.  The brightfield and DAPI images showed that almost all the field of 
view contained tissue.  Strong FITC signal was obtained across the sample with 
some very strong signal in some areas.  In the secondary control sample there 
were large numbers of cells present as illustrated by the brightfield image (Figure 
4.3.16iii, panel M) and the DAPI stain (Figure 4.3.16iii, panel N) but no FITC 
signal was present indicating that there was no nonspecific binding of the 
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view was also entirely filled with cells.  There were a number of small patches of 
low FITC signal generally to the left hand side of the image (Figure 4.3.17F) 
indicating areas where LGR5 protein was expressed. 
 
In sample B4, where naïve mES cells had been cocultured with an intact 
embryonic chick gut tissue explant for six days, (Figure 4.3.17G  I) the field of 
view was largely full of cells, although there were none in the top left hand corner.  
There were a number of patches of low FITC signal in the bottom half of the 
image (Figure 4.3.17I) indicating areas of LGR5 protein expression.   
 
The three experimental samples shown all exhibited some expression of LGR5 
protein however there was considerable variation in the apparent distribution and 
strength of this expression with sample A5 showing stronger expression than the 
other two samples. 
 
The positive control sample (Figure 4.3.17J  L) was a section of embryonic 
mouse intestinal tissue mounted on a slide and stained with antiLGR5 antibody.  
The brightfield image shows that almost all the field of view contained tissue.  
Strong FITC signal was obtained across the sample with some very strong signal 
in some areas.  In the secondary control sample there were large numbers of cells 
present as illustrated by the brightfield image (Figure 4.3.17M) and the DAPI 
stain (Figure 4.3.17N) but no FITC signal was present indicating that there was no 
nonspecific binding of the antibodies.  Please note that the controls are common 




































































































































































expression of the pluripotency marker OCT4.  This corresponded with the RNA 
expression observed in the RTPCR analysis. 
 
 
Figure 4.3.19: Representative images illustrating the expression of key (germ 
layer) markers in mES derived cells following coculture with (day six) 
embryonic chick gut tissue for seven days. Cells were fixed and dried on glass 
slides before being stained by immunofluorescence. Light images (top) show the 
location of the cells on the slide, fluorescent images showing positive primary 
FITC antibody staining. 
 
Table 4.3.2:  Table summarising all the expression data for the selected 
differentiation markers from all the coculture experiments (and controls) detailed 
above.  The selected markers were Oct4 for undifferentiated cells, Lgr5, Msi1, 
CD133 and EpiAnt for Intestinal progenitor cells/ISC, Sox17, FoxA2 and CXCR4 
for (definitive) Endoderm, Brachyury for Mesoderm and Nestin for Ectoderm.  
Expression of RNA expression was evaluated by RTPCR whilst expression of 
protein expression was evaluated by fluorescence immunocytochemistry 
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of positive, where bands were present in (almost) all samples, moderate, where 
stronger bands were seen and strong, were very bright bands were seen all 
indicate that the selected marker was definitely expressed.  Protein levels are 











The mES cells were successfully stably transfected with GFP.  GFP expression 
was retained after several passages in monolayer culture and after the cells were 
aggregated into EBs indicating that GFP expression was likely to be retained if 
the cells were subjected to the in vitro differentiation protocols detailed in Chapter 




It was established embryonic day six was the optimal point in development at 
which to extract tissue based upon observations of the size and development of the 
target tissue.  This was supported by previous observations of chick development 
[Bellairs and Osmond 2005].  Embryonic day six tissue was also used in co
culture experiments in the literature [Sugie et al 2005].  At this point of 
development the endodermal organs were distinguishable and could be excised.  
Any earlier in development and the embryo was too small to reliably excise the 
correct tissue, any later and the early developmental signals might have been lost. 
 
Antibody staining of the excised tissue was positive for the selected intestinal 
marker, CDX2, indicating that the gut tissue was being excised during the embryo 
dissections [Traber and Silberg 1996].  The tissue extracted at embryonic day six 
appeared to remain viable in culture for between six and eight days but some signs 
of degradation, such as loss of shape and colour changes, were visible at the latter 
stages of culture.  H & E staining revealed the formation of small lesions in the 
tissue at days six and eight.  Livedead staining showed the tissue remained 
viable, in part, for up to 25 days.  However significant increases in the amount of 
dead tissue occurred beyond 10 days of culture.  Studies in the literature generally 
used a coculture period of between four and 12 days [Sugie et al 2005, Fair et al 
2003, Van Vranken et al 2005].  The tissue explants continued to express the cdx2 
 
transcript [Traber and Silberg 1996] after 10 days in ex vivo culture although there 
was some reduction when compared to freshly excised tissue. 
 
When mES cells were injected into embryonic chick gut tissue explants in ex vivo 
culture they were retained in sufficient numbers within the tissue mass for at least 
seven days to then be analysed for markers of differentiation.  Studies in the 
literature generally used a coculture period of between four and 12 days [Sugie et 
al 2005, Fair et al 2003, Van Vranken et al 2005] and this combined with the 
survival time of the tissue explants in ex vivo culture a coculture period of seven 
days was targeted.  It was decided therefore to coculture CEE mES cells with the 




Although the data generated from batches A  C (naïve and ActA pretreated 
GFPmES cells cocultured ex vivo with (day six) embryonic chick gut tissue for 7 
days) was limited, because of the poor quality RNA samples not producing any 
bands in the RTPCR analysis, it was still possible to glean some useful 
information with regard to planning further experiments.  FACS recovered a good 
number of cells, sufficient to generate RNA samples for analysis.  However the 
process of sorting had a detrimental effect on the viability of the cells; this 
resulted in very poor samples being generated for analysis and prevented further 
culture of the cells and as a consequence no meaningful data was generated.  This 
was also true for the control batch of cells that had not been cocultured prior to 
FACS. 
 
It was shown that the PCR primers being used in the RNA sample analysis were 
species specific, with the exception of the highly conserved GAPDH, which meant 
that it would be possible to analyse the mES cells following coculture without 
separating them from the chick tissue derived cells; this approach was used for 
subsequent experiments.  Using the existing GAPDH primers made it harder to 
equalise loading in the PCR reactions (because the chick RNA present contributed 
to the strength of the GAPDH bands).  However as the samples were used for an 
endpoint comparison rather than multiple timepoints through the course of the 
 
experiment the data collected still clearly indicated where expression of the 
selected ISC markers had been initiated. 
 
In coculture experiment batch D (naïve and ActA pretreated GFPmES cells co
cultured ex vivo with either intact embryonic (day six) chick gut tissue explants or 
dissociated cells derived from the same for 7 days) the lack of expression in the 
chick only controls confirmed that the primers were species specific and therefore 
all the expression in the experimental samples was of murine origin eliminating 
the possibility of false positives.  The control cells that were cultured on either 
TCP plates or noncell culture treated plates showed no significant differences in 
marker gene expression suggesting that the noncell culture treated plates used in 
the coculture experiments had no effect on the differentiation of the cells. 
 
In the RTPCR analysis the germ layer marker expression indicated that DE cell 
fates were present (FoxA2 and Sox17 positive) although mesendoderm/mesoderm 
(Brachyury positive) were also present in all samples (expression was stronger in 
dissociated cell cocultures compared with intact explants) [Kubo et al 2004, Tada 
et al 2005].  This was true for both intact explant and dissociated cell cocultures.  
The expression of the ISC marker Lgr5 [Barker et al 2007] suggested that 
differentiation towards the intestinal epithelial progenitor had occurred.  
Expression of CD133 [Kania et al 2005] and weak expression of EpiAnt 
[Engelhardt et al 1993] also suggested that differentiation towards the desired cell 
fate was occurring in some cell populations although Msi1 expression was not 
present. 
 
In comparison only CD133 (of the selected ISC markers) was expressed in the 
control samples.  CD133 is expressed in a range of ASC populations (as detailed 
in Section 1.2.3) [Yin et al 1997, Corbeil et al 2000, Shmelkov et al 2005, Kordes 
et al 2007, Samuel et al 2008] and this expression could be accounted for by the 
random differentiation of the mES cells in the control samples.   Oct4 expression 
was maintained indicating that some undifferentiated cells may remain or that the 
differentiating cells continue to express Oct4.  The level of Oct4 expression was 
reduced when compared to the (no coculture) controls which supports the 
conclusion that the cells are differentiating.  Some expression of Oct4 has been 
 
reported in adult stem cell populations suggesting that Oct4 expression is retained 
as cells differentiate further [Lee et al 2010]. 
 
When the ActA pretreated and naïve GFPmES cells are compared following co
culture it can be seen that the germ layer markers e.g. FoxA2 and Brachyury are 
expressed at slightly elevated levels in the ActA treated samples than the naïve 
cells.  This pattern is reversed when examining the ISC marker Lgr5 [Barker et al 
2007] in the intact explants although in the dissociated cells the Lgr5 and CD133 
bands are slightly stronger in the pretreated cells.  Overall there is no significant 
difference between the cells treated with ActA in vitro prior to coculture and 
naïve mES cells following seven days coculture with intact chick gut explants or 
dissociated cells derived from the same. 
 
The RTPCR analysis of the RNA samples generated in coculture batches E and 
F (naïve mES cells cocultured ex vivo with intact embryonic (day six) chick gut 
tissue explants for six days (Batch F) or seven days (Batch E)) showed a high 
degree of similarity between the results from both experiments (and with the 
previous data) indicating that the experiments were giving reproducible results.  
The germ layer marker expression showed that DE specification had occurred 
(FoxA2 and Sox17 positive) and some expression of the 
mesendodermal/mesodermal marker Brachyury was present (see Section 1.6 and 
Section 3.1) [Tada et al 2005, Kubo et al 2004]. 
 
The selected ISC markers (see Section 1.2.3) were expressed although there was 
slight variation between the cells cocultured for seven days (Batch E) and the 
cells cocultured for six days (Batch F).  In both batches the strong expression of 
Lgr5 and CD133 was a good indicator that ISC like cells were being specified 
[Barker et al 2007, Kania et al 2005].  Msi1 was also expressed in batch F which 
further supported this conclusion [Potten et al 2003].  No EpiAnt expression was 
seen but this may be because the cells had not yet differentiated to the point of 
expressing this specialised tissue marker [Engelhardt et al 1993]. 
 
The immunocytochemical analysis showed that the cells were expressing the ISC 
marker LGR5 at the protein level [Barker et al 2007], as did the western blot 
 
analysis.  In the western blot the coculture sample produced a weaker band than 
the positive control sample.  This supported the RTPCR data in indicating that 
(some of) the cells were differentiating towards the ISC fate. 
 
0(0(0$$	
Whilst the protocol proved to be a viable method for initiating the expression of 
ISC markers not all of the mES cells differentiated towards the ISC fate.  The 
panel of differentiation markers were expressed in most of the cocultured cell 
samples but there were signs that some cells remained undifferentiated and that 
some other fates may have been specified (see Table 4.3.2). 
 
 The CEE mES cells were successfully transfected with the GFP encoding 
VS01 plasmid. 
 
 The desired embryonic chick tissue could be successfully explanted and 
maintained in ex vivo culture for six – seven days.  Sufficient injected cells 
are retained within the tissue explant during coculture. 
 
 There were no apparent differences in DE/ISC gene/protein expression 
between the cells treated in vitro with ActA and naïve mES cells 
following seven days coculture with intact chick gut explants or 
dissociated cells derived from the same. 
 
 There were no differences in DE/ISC gene/protein expression between the 
GFPmES cells and the unlabelled mES cells when differentiated using the 
coculture protocol. 
 
 The coculture seemed to induce the expression of the key ISC marker 
Lgr5 [Barker et al 2007] at the RNA level in a reproducible manner.  This 
is supported by consistent LGR5 expression at the protein level. 
 
 The coculture methodology used supported the differentiation of naïve 
mES cells to differentiate towards an ISClike fate at a molecular level.  
 
Similar results have been reported in the literature with different tissue 
types and target cell lineages [Sugie et al 2005, Fair et al 2003, Van 
Vranken et al 2005].  However not all the cells were differentiated or fully 
differentiated towards the intestinal progenitor fate. 
 
When the studies in the literature (see Section 4.1.1) are examined it can be seen 
that whilst they all share the central concept of culturing undifferentiated cells 
with tissue from early in development to produce specific cell lineages the 
assessment of cell differentiation is generally limited to the molecular level.  For 
example, to produce photoreceptor cells [Sugie et al 2005] a two stage 
differentiation protocol was used with in vitro treatment of mES cells with RA 
followed by selection of cells positive for neural (ectodermal) markers which were 
then cocultured with embryonic chick retinal tissue.  This resulted in about 20% 
of the cocultured cells expressing retinal markers, such as Rhodopsin, but no 
functional evaluation was conducted. 
 
The production of hepatocytes from mES cells by coculture with cardiac 
mesoderm alone [Fair et al 2003] also assessed cells differentiation at the 
molecular level only with cocultured cells showing upregulation of hepatic 
markers, such as AFP, when compared to controls.  Generating pulmonary 
epithelium by coculturing of mES cells with pulmonary mesenchyme [Van 
Vranken et al 2005] produced an upregulation of pulmonary epithelial markers, 
such as cytokeratin, when compared to controls but no functional tests were 
conducted. 
 
Whilst the cells that had been cocultured with embryonic chick gut tissue 
expressed ISC markers at the molecular level for the cells to be useful for tissue 
engineering applications they must also have the functional characteristics of the 
ISC.  The cells generated by the techniques outlined in Chapters Three and Four 







Although it is possible to generate cells that exhibit the molecular profile of 
particular differentiated cell types from mES cells, the true test of how successful 
the process has been is to assess their ability to mature such that they display 
physiological and functional characteristics of the desired cell type/lineages.     
Therefore the aim of this Chapter was to investigate if the cells generated in 
Chapters Three and Four could differentiate and mature further to give rise to 
fully differentiated intestinal epithelial cells.  This could be assessed by using a 
model system that had been described for investigation of epithelial barrier 
formation [Beltinger et al 1999]. For the cells to have potential in tissue 
engineering applications, such as generating in vitro models of disease or for drug 
absorption studies,  this model system needs to demonstrate the fundamental 
barrier functional properties expected of the intestinal epithelium.   
 
Other GI epithelial functions include digestion (enzymes and suchlike are secreted 
by the intestinal epithelium) and digestive transit (waves of contraction in the 
smooth muscle surrounding the intestine known as peristalsis move material along 
the GI tract), (selective) nutrient absorption (into the capillaries that permeate the 
intestinal wall, see Figure 5.1.1A) and immune defence (there is a large 
population of microorganisms present in the gut).  A number of these functions 
including nutrient absorption and immune defence are dependent on the integrity 
of the epithelial cell layer and could therefore be investigated in the proposed 
model.  An intact epithelial cell layer acts as a barrier between the intestinal lumen 
and the underlying tissue and blood capillaries.  Assessing the extent to which the 
ES derived cells can form an intact epithelial layer is a good initial test of their 
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electrical resistance of the epithelial layer; an intact epithelial layer will provide 
more resistance to the passage of an electrical current as charged molecules will 
not be able to pass across it as readily. 
 
A simple coculture model using ISEMF cells with either HCA7 or T84 colonic 
epithelial cell lines was established (see Section 5.2, Figure 5.2.2) and certain 
physiological characteristics were examined [Beltinger et al 1999].  Cocultures 
were established on Transwell cell culture inserts (as detailed in Section 5.2.1) 
with ISEMF cells seeded on the exterior surface of the membrane with either 
HCA7 or T84 cells seeded on the interior surface.  The TER across the 
membrane was then measured using an Epithelial Voltometer (EVOM) that 
measured in Ohms (a) per cm2.   
 
TER provides a measure of the electrical resistance across a membrane (see 
Figure 5.1.2).  An intact epithelial layer will present a significant barrier to the 
passage of an electrical current and will therefore have a higher TER than an 
incomplete epithelial layer or negative control samples [Madara et al 1992].  TER 
values have also been used to assess tissue engineered GI tissue [Choi et al 1998].  
The TER of control inserts that had no cellular component and that had been 
seeded with ISEMF cells only was also evaluated.  The inserts (membrane) gave 
TER readings of 12 (± 0.5) a/cm2 whilst the inserts seeded with ISEMF cells only 
gave TER values of 10.5 (± 0.4) a/cm2.  This indicates that the ISEMF cell layer 
alone did not contribute to the TER of the system. 
 
Membranes with a confluent layer of HCA7 cells only gave TER values of 140 
(± 12.4) a/cm2 whilst those with both ISEMF and HCA7 cell layers gave TER 
values of 246.7 (± 20.4) a/cm2.  To determine if this increase in TER was caused 
by factors secreted by the ISEMF cells the TER of HCA7 cells incubated in 
ISEMFCM or unconditioned media were compared.  HCA7 cells in 
unconditioned media (0.1% FCS in DMEM) gave similar TER values as 
previously of 138 (± 11.4) a/cm2 whereas those incubated in ISEMFCM gave 
TER values of 180.7 (± 7.1) a/cm2.  This supports the idea that it is factors 
secreted by the ISEMF cells that contribute to an increase in the TER rather than 
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The same pattern was not seen in T84 cells where the dual cell samples showed 
10fold upregulated transport activity compared with the controls.  This activity 
was mediated by the cyclooxygenase enzymes COX1 and COX2.  Suppression 
of the COX enzymes reversed the downregulation of transport activity in HCA7 
cells.  The differences between HCA7 and T84 cells were explained by the 
different expression of the Cox enzyme transcripts in each cell line; HCA7 cells 
expressed the Cox transcripts whilst T84 cells did not.  This explains why in the 
presence of COX positive ISEMF cells transport activity increases in T84 cells 
[Beltinger et al 1999].  The use of an ISEMF layer along with the epithelial cell 
line in the TMCC system gave a more accurate model of the properties of the 
intestinal epithelium. 
 
Monolayers of T84 (intestinal epithelial) cells were cultured in monolayer on 
collagen coated permeable supports [Nash et al 1987].  These monolayers were 
then used to study the transmigration of polymorphonuclear leukocytes in the 
presence of a chemotactic gradient (of formyl methionyl leucyl phenylalanine) 
and the effects that this had on the ability of the epithelial monolayer to maintain 
its barrier function.  The chemical treatment reduced the TER of the epithelial 
layer which permitted greater transmigration of leukocytes.  Normal TER levels 
were restored following removal of the chemical agents [Nash et al 1987]. 
 
It is important to represent all of the tissue/cell components of the intestinal wall 
in any model as it is not just the epithelial layer that is important in maintaining 
the function of the intestinal lining [Powell et al 1999(1)].  Myofibroblasts play an 
important role in the intestinal wall where they secrete a number of growth 
factors, ECM components and inflammation response mediators [Powell et al 
1999(1)].  The role of ISEMFs in Crohn’s disease was examined [Powell et al 
1999(2)].  ISEMFs play an important role in wound repair in the intestine with 
factors they secrete stimulating epithelial proliferation and hence restitution 
(where healthy tissue grows into the space left by an injury).  They also help 
facilitate some of the active transport mechanisms by which nutrients are absorbed 
from the gut lumen into the bloodstream [Powell et al 1999 (2)].  For a model 




A similar model was used to examine the effect of the immune response to 
microbial agents on the intestinal mucosa (particularly the role of subepithelial 
myofibroblasts) with reference to Crohn’s disease [Willemsen et al 2002].  Sub
epithelial myofibroblasts and T84 intestinal epithelial cells were seeded on 12mm 
Transwell inserts in a similar fashion as shown in Figure 5.1.1B (with controls 
where myofibroblasts were not present).  This model was then used to investigate 
if excessive exposure to microbial factors could induce early symptoms of 
Crohn’s disease by initiating an ‘excessive’ immune response.  Leukocytes or 
cytokines were then introduced into the models to simulate an immune response 
to a microbial agent.  This reduced the integrity of the epithelial barrier (assessed 
by monitoring TER and molecule movement (flux) across the membrane) but the 
effects were less marked in the model where myofibroblasts were present 
suggesting that they play a role in maintaining epithelial integrity.  It appeared this 
role was facilitated by the secretion of growth factors by the myofibroblasts 
[Willemsen et al 2002]. 
 
A potential use for ES derived intestinal epithelial progenitors would be as a 
substitute for the T84 cell line in a model such as the one used in this study.  IPS 
derived cells might also be useful in such a model as it would allow for the 
generation of disease models where cells from patients suffering from e.g. 
Crohn’s disease could be compared with unaffected cells.  This might allow the 
identification of initiating environmental factors as well as the study of the 
disease’s progression. 
 
Passage of labelled molecules has also been used to assess tissue engineered GI 
tissue in rats [Tait et al 1995].  Nutrient transport was assessed using labelled 
(C14) glucose.  The results were compared with those from age matched control 
tissue samples and the level of activity was found to be similar [Tait et al 1995].  
Transport of DGlucose is a sodium dependant process mediate by the neomucosa 
and will not occur in a normal fashion unless a functional epithelial barrier is 
present.  By comparing the uptake of D[U14C] glucose in animals that had 
received engineered intestinal tissue with a control group of animals that had only 
native tissue the nutrient uptake properties of the engineered tissue could be 
 
assessed.  The rate of glucose uptake was comparable in both groups of animals 
[Tait et al 1995]. 
 
Some of the techniques used have also been used to assess mucosal repair in vivo 
following damage to the intestinal epithelium [Blikslager et al 2007].  TER 
measurements were used to assess the rate and extent to which the barrier function 
of the intestinal epithelium was restored following injury.  This occurs via a 
mechanism called restitution where healthy tissue surrounding a wounded area 
grows into the space restoring the epithelial cell population.  Measuring the TER 
at various timepoints following intestinal injury indicate show quickly the 




The aims in this chapter were to establish if the cells that had been through the 
differentiation protocols in Chapter Four could mature further into functional 
intestinal epithelial cells (and generate an epithelial barrier) in a simple model 
system. 
The experiments in this chapter evaluated if the cells produced by the 
methodologies described in Chapters Three and Four displayed some of the 
physical and functional characteristics of an (intestinal) epithelial layer (and 
ultimately would be able to generate a functional epithelial barrier).  Transwell 
cell culture inserts with Polyethylene Terephthalate (PET) membranes were used 
as the basis for the model.  The membranes represented the basement membrane, 
in this instance of the intestinal epithelium (see Figure 5.1.1 and Section 1.2.1, 
Figure 1.3) [Paulsson et al 1992, Stanley et al 1982].  These were seeded with 
ISEMFs on the gelatin coated exterior surface that represented the surrounding 
connective tissue that supports the intestinal epithelium (see Figure 5.1.1).  The 
interior of the membrane was seeded with the mES derived cells to see if they 
could form an epithelial layer [Beltinger et al 1999].  The following properties 
were then examined (see Section 5.2 for full experimental details. 
 
 
 To investigate the integrity of the putative epithelial cell layer (cultured in 
monolayer) the TER across the membrane was measured. 
 
 To investigate the passage of nutrients across the putative epithelial cell 
layer the permeability of the membrane to (fluorescently labelled) protein 
was measured. 
 
 These characteristics were used to infer whether the cells were organising 
into a structure that would perform the functions expected of an epithelial 
layer such as controlling/blocking the passage of material across the layer.  
Other components in the model were designed to replicate the other tissue 
structures that interact with the epithelial layer in the intestine (see Figure 
5.1.1). 
 
 The intestinal epithelium contains a number if distinct structures and cell 
types with characteristic morphologies.  To observe if any of these 
structures, such as tight junctions, or cell types were present the cells were 
examined in high resolution using TEM as well as light microscopy to 












Cell culture Transwell inserts for 12 well plates with 1.5 cm2 PET membranes 
with 0.45 Xm pores (BD, 353180) were coated by plasma deposition of PAA 
using a plasma chamber [Zelzer et al 2008] (Figure 5.2.1) to aid cell attachment to 
the membrane exterior surface [Harsch et al 2000].  Plasma is a fourth state in 
which matter can exist, where gaseous particles are highly ionised, first described 
by Sir William Crookes in 1879 (although the name ‘Plasma’ was first used by 
Irving Langmuir in 1928).  Whilst plasmas share some properties with matter in a 
gaseous state (such as no defined physical shape) they also have some very 
distinctive properties (such as the ability to form ‘structures’ under the influence 
of a magnetic field) [Crookes 1897, Langmuir 1928].   
 
Figure 5.2.1: Plasma chamber equipment set up for plasma coating 
To coat the Transwell inserts with the PAA plasma the inserts were placed into 
the plasma chamber which was then sealed.  The Transwell inserts were first 
 
‘Oxygen etched’ by the addition of oxygen at 300 mTorr with an input power of 
20W for three minutes.  PAA (in its plasma form) was then added to the chamber 
at 250 mTorr.  PAA was deposited at 3.8 Angstroms (Å)/second to a thickness of 
1.008 kÅ for Batch A and 2.9 Å/second to a thickness of 1.009 kÅ for Batch B.  
Each deposition treatment took between five and eight minutes. 
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A population of ISEMF cells was provided by Michelle Jackson of the Wolfson 
Digestive Diseases Centre, Queens Medical Centre, Nottingham. These cells had 
been isolated from adult human intestine as detailed below [Mahida et al 1997].  
Samples of human adult colonic mucosa were obtained from resection specimens 
from patients undergoing partial colectomy for carcinoma.  These samples were 
taken at least 5 cm away from the tumour site and histologically abnormal 
samples were excluded.  Ethical approval was obtained in 2003 – R&D 
GM050303 and ethics Q2050309, Nottingham City Hospitals Trust. 
 
Mucosal samples were separated from the underlying submucosa by dissection 
and cut into 1 cm long strips.  The mucosal samples were incubated with 1 mM 
dithiothreitol (DTT) for 15 minutes at room temperature.  After washing with 
calcium and magnesium free HBSS the mucosal strips were incubated on a plate 
shaker at 37˚C in 1 mM EDTA for a 90 minute period; the 1 mM EDTA was 
replaced every 30 minutes.  After treatment with EDTA, the mucosal strips (that 
were now denuded of epithelium) were thoroughly washed with HBSS with Ca2+ 
and Mg2+.  Mucosal strips were cut into approximately 1 cm lengths and were 
subsequently cultured at 37˚C, 5% CO2 in air, in RPMI 1640 media (100 ml total 
volume) supplemented with 10% (v/v) FCS and 1% (w/v) Penicillin
StreptomycinAmphotericin, (100 µg Streptomycin, 250 ng Amphotericin B and 
1000 units Penicillin B, Sigma, UK). 
 
During culture, lamina propria lymphocytes, macrophages and eosinophils 
migrated via basement membrane pores and appeared both in the suspension and 
adherent to the culture dish.  The cells in suspension were removed every 24 to 72 
hour culture period for the first week and twice weekly subsequently.  The 
 
denuded mucosal tissue was maintained in culture for up to four weeks, at which 
point ISEMFs migrated from the tissue and populated the culture dish.  Lamina 
propria was transferred into fresh culture dishes until no more ISEMFs migrated 
from the tissue. 
 
The ISEMF cells that migrated out of the tissue were transferred to fresh T75 TCP 
culture flasks (Nunc, UK) and were maintained in ISEMF media (DMEM 
supplemented with 10% (v/v) FCS, 2 mM LGlut and 1% (w/v) Penicillin
StreptomycinAmphotericin, (100 µg Streptomycin, 250 ng Amphotericin B and 
1000 units Penicillin B) in a humidified atmosphere at 37°C and 5% CO2 in air. 
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Once c.80% confluent, ISEMF cells were washed with 5 ml PBS and detached 
from the cell culture flask by treatment with prewarmed 0.25% (v/v) 
Trypsin/0.02% (w/v) EDTA (3 ml).  The cell suspension was transferred to a 
centrifuge tube where the Trypsin was inactivated by serum following the addition 
of ISEMF media.  The cells were pelleted by centrifugation at 200 g for five 
minutes.  The supernatant was removed and the cells were resuspended in ISEMF 
media and counted using an improved Neubauer haemocytometer.  The 
concentration was adjusted to 1 x 105 cells/ml by adding an appropriate amount of 
ISEMF media.   
 
Transwell cell culture inserts that had been plasma coated (see section 5.2.1i) 
were inverted in a large Petri dish so that the exterior membrane surface faced 
upwards.  This surface had been coated with 0.1% (w/v) Gelatin solution for two 
hours, then washed thoroughly with PBS and allowed to dry.  ISEMF cell 
suspension (150 Xl) was aliquoted onto the membrane and the Transwell inserts 
were incubated in a humidified atmosphere at 37°C, 5% (v/v) CO2 in air overnight 
to allow the cells to adhere (Figure 5.2.2).  PBS (2 ml) was added to each Petri 
dish to ensure the atmosphere remained humidified.  Following overnight 
incubation it was established that the cells had adhered to the exterior of the 
membrane by observation under a light microscope.  The Transwell inserts were 
then turned and placed in 12 well (nontissue culture treated) plates.  ISEMF 
 
media (1.5  2 ml) was added to the outer/lower chamber with 500 Xl  1 ml media 
being added to the inner/upper chamber.  The Transwell inserts were cultured for 
a further six  seven days to allow the ISEMF cells to proliferate on the membrane 
exterior [Beltinger et al 1999]. 
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Both mES cells and GFPmES cells were differentiated towards the intestinal 
precursor fate by ex vivo coculture as described in Chapter Four, Section 4.2.10.  
In brief the cells were injected into day six embryonic chick gut tissue explants in 
ex vivo culture for 7 days in mES complete media (LIF).  Following coculture 
the cells were sorted to isolate the mES derived cells from the chick tissue.  Some 
of these cells were sorted by FACS as described in the Section 2.2.10 whilst some 
of the cells were sorted by centrifugation. 
 
Remaining tissue was removed by sucrose density centrifugation.  Following 
enzymatic digestion the coculture samples were placed in a 5% (w/v) sucrose 
solution and centrifuged at 150 g for two minutes in a 15 ml centrifuge tube.  
Whilst the enzymatic digest of the tissue explants following coculture reduced 
the tissue to smaller pieces the tissue was not broken down to single cells. The 
remaining multicell clusters are much greater in mass than the single murine 
cells.  This mass differential means that when centrifuged in a viscous matrix the 
cells separated according to density.  The upper portion of the supernatant (and 
the single CEE mES cells therein) was removed and the single cells washed 
thoroughly with PBS.  These cells were then resuspended in ISEMF media and 
seeded onto the interior membrane surface of Transwell cell culture inserts that 
had been seeded with ISEMF cells (as described above) at 5 x 104 cells/ml in 12 
well tissue culture plates (Figure 5.2.2).  The plates were incubated in a 
humidified atmosphere at 37°C, 5% CO2 in air.   
Controls were also set up using undifferentiated mES and GFPmES cells on 
ISEMF seeded inserts and Transwell inserts with ISEMF cells alone.  Plasma 
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days) and the data gathered was used to determine if significant differences 
existed between the controls and the experimental samples. 
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FITCBSA (5 mg, Autogen Bioclear, ABXK14) conjugate was reconstituted in 1 
ml PBS.  This was then added to protein freeDMEM (PFDMEM) at 0.1% (v/v).  
A 1% (w/v) solution of unlabelled BSA was also made up in PFDMEM.  The 
media was removed from the seeded Transwell cell culture inserts and the upper 
and lower chambers washed twice with PFDMEM.  BSA (1% (w/v)) in PF
DMEM (800 Xl) was added to the lower chamber with 300 Xl being added to the 
upper chamber.  The Transwell inserts were returned to the incubator for 30 
minutes.  This allowed the protein levels on either side of the membrane to 
equilibrate and ensured there was no osmotic gradient across the membrane/cell 
layers. 
 
After equilibration, an additional 700 Xl 1% (w/v) BSA in PFDMEM was added 
to the lower chamber (total volume 1.5 ml) whilst 200 Xl of 0.1% (w/v) FITC
BSA in PFDMEM was added to the upper chamber (total volume 500 Xl) giving 
a final concentration of 0.04% (w/v) in the upper chamber and 0.01% (w/v) in the 
total volume of media.  The Transwell inserts were then returned to the incubator.  
Every 30 minutes for the following two hours 200 Xl of media was removed from 
the lower chamber following gentle agitation by pipetting.  This was immediately 
replaced with 200 Xl of 1% (w/v) BSA in PFDMEM.  After the two hour time 
point was complete the Transwell inserts were rewashed twice in PFDMEM and 








































flat bottomed black 96 well plate and comparing this to a standard curve of FITC
BSA in PFDMEM using a KC4 plate reader. The fluorescence excitation and 
emission maxima for FITC are Excitation 495 nm and Emission 525 nm. 
 
The standard curve was generated by making up nine standard solutions of FITC
BSA in PFDMEM between 0  1% (w/v).  The standard solutions of FITCBSA 
in PFDMEM used were 1%, 0.5%, 0.25%, 0.125%, 0.0625%, 0.03125%, 
0.015625%, 0.0078125% and 0%.  The fluorescence of these solutions was then 
measured and plotted against the concentration of FITCBSA on a graph to 
produce a standard curve.  The concentrations of the ‘unknown’ samples were 





Some images of the seeded Transwell inserts were obtained through the course of 
the experiment by light microscopy using a Nikon Eclipse microscope and 
camera. 
Following 21 days of culture the samples were fixed in 3% (v/v) Glutaraldehyde 
in 0.1 M Cacodylate buffer for 24 hours.  Sample processing, embedding, 
sectioning and TEM imaging was carried out in the Advanced Microscopy Unit, 
Medical School, QMC, Nottingham.  The inserts were washed in 0.1 M 
Cacodylate buffer then treated with 1% (v/v) aqueous Osmium Textroxide for one 
hour.  The inserts were washed for five x one minute in H2O and then dehydrated 
with two x 15 minute washes in 50% (v/v) Ethanol.  The inserts were then stored 
in 70% (v/v) Ethanol before being cut in half.  The cut inserts were then washed 
two x 10 minutes in 70% (v/v) Ethanol.  The samples were then further dehydrated 
through the following stages: two x 15 minutes 90% (v/v) Ethanol, three x 20 
minutes 100% Ethanol then two x 15 minutes 100% Propylene Oxide (carried out 
in a glass vessel).   
 
Resin was prepared by mixing 25 ml Araldite CY212 resin, 15 ml Agar 100 resin 
and 55 ml Dodecenyl Succinic Anhydride (DDSA) then adding 2 ml Dibutyl 
 
phthalate and 1.5 ml Dimethyl phthalate (DMP) 30.  The mixture was stirred and 
then polymerised by incubation at 60°C for 48 hours.  The samples were then 
infiltrated with resin firstly using a 1:3 mix of resin and Propylene Oxide for four 
hours then with 1:1 resin/Propylene Oxide for 24 hours and finally 100% resin for 
2.5 hours.  The samples were then placed in a mould and incubated at 60°C for (at 
least) 48 hours.  Sections were cut using a Microtome and mounted on APES 
coated slides on copper grids.   
 
The sections were then stained with 50% (v/v) Methanolic Uranyl Acetate 
(Saturated Uranyl Acetate (UA) in distilled water mixed 1:1 with 100% 
Methanol).  A few drops of Methanolic UA were placed on each section and left 
for 10 minutes in the dark.  The samples were then washed once in 50% (v/v) 
Methanol then three times in UltraPure™ water; for each wash the sample was 
briefly immersed in the liquid at least ten times.  Excess liquid was removed from 
the sample by blotting with filter paper.  The samples were then placed in 0.1 mg 
Lead Citrate dissolved in NaOH for 30 seconds then washed three times in 
UltraPure™ water as before.  The samples were blotted again and allowed to dry 
and then stored in the dark in a sealed container until they were imaged.   
 
Detailed images were obtained via TEM using a FEI Tecnai 12 BioTWIN electron 
microscope with a Soft Imaging System, Megaview III camera [Bancroft and 







Table 5.3.1 and Figure 5.3.1 (see Section 6.3 for supplementary graphs 6.3.8 and 
6.3.9) show the TER readings obtained from experimental and control seeded cell 
culture inserts.   The negative control samples, where the inserts had not been 
seeded with any cells, showed a slight decrease in TER, from 175 (±7) to 143 (±4) 
a, through the course of the experiment but generally were very consistent.   The 
ISEMF controls, where only the exterior surface of the insert membrane had been 
seeded, showed very little change in TER through the experiment from 185 (±0) 
a at the start to 173 (±18) a at day 21 with the reading never lower than 165 (±7) 
a.   TER measured in the mES controls, the undifferentiated controls for batch A, 
were fairly constant up to day 12, having been 190 a initially and 185 a at day 
12, but the TER then fell at day 14 (165 a) and 16 (150 a) before rising back to a 
similar level (200 a) for the final two timepoints.   The GFPmES controls, the 
undifferentiated controls for batch B, showed a decrease in TER (190 to 150 a) 
over the whole time course but this was not a consistent trend throughout. 
 
Experimental batch A, where the inserts had been seeded with mES cells that had 
been through the differentiation protocol where naïve mES cells were injected into 
intact day six embryonic chick gut tissue explants and cocultured for seven days 
(detailed in Chapter Four) but that had not been sorted using FACS, gave 
consistent TER readings throughout the time course (175 (±13) a initially, 176 
(±11) a at day 21).   However there was some variation between individual 
samples as shown in Supplementary Figure 6.3.3.   Experimental batch B, where 
the inserts had been seeded with GFPmES cells that had been through the 
differentiation protocols detailed in Chapter Four that had been sorted by FACS, 
also gave consistent readings throughout with a slight increase in TER at the end 
of the time course (157 (±14) a initially, 173 (±13) a at day 21).   As with batch 
A there was some variation between the individual samples as shown in 
Supplementary Figure 6.3.4 but the SD values show the variation was less in 
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disparity was less than at 13 days.   The distribution of protein crossover was 
fairly even through the incubation with ISEMF1 having a slight majority in the 
initial 60 minutes.   The negative controls showed almost identical results to the 




Figures 5.3.3i  iv (panels A  P) show the TEM images generated from the 
embedded membrane samples following 21 days of culture.   Panels A  H show 
images from the mES samples, panels I  K show the images from the mES 
controls, panels L  O show the images from the GFPmES samples and panel P 
shows the GFPmES controls.  The images generally show the membrane with 
any cells associated with it although some of the images focus on specific cell 
structures and the membrane is not shown. 
    
Figure 5.3.3i panel A shows a single rounded cell that has detached from the 
membrane. Morphologically this cell resembles an undifferentiated ES cell and 
was around 1 Xm across.   Figure 5.3.3i B shows a number of cells (and 
surrounding cellular detritus) that have detached from the membrane.   These cells 
also displayed the rounded morphology characteristic of undifferentiated cells.  
Figure 5.3.3i C and D show an ISEMF cell attached to the membrane, C shows 
the whole cell whilst D is at higher magnification.   The cell had the expected 
elongated myofibroblast morphology.  These images were of an insert that had 
been seeded with mES cells that had been cocultured with day six embryonic 
chick gut tissue for seven days prior to seeding. 
 
Figure 5.3.3ii E, F, G and H showed a single cell attached to the membrane, E 
showed the whole cell whilst F, G and H were at higher magnification.   The cell 
had a rectangular morphology and a variety of cellular structures could be seen 
including some dark granules and lighter spaces.  The cell was also much larger 
than the one observed in Figure 5.3.3i (around 4 Xm across) and had a more 
rectangular morphology.  These images were of an insert that had been seeded 
with mES cells that had been cocultured with day six embryonic chick gut tissue 
 
for seven days prior to seeding.   Figure 5.3.3iii I, J and K showed another ISEMF 
cell associated with the membrane, I showed the whole cell whilst J and K were at 
higher magnification. The cell had the expected elongated myofibroblast 
morphology.  These images were of an insert seeded with undifferentiated mES 
cells (mES control). 
 
Figure 5.3.3iii L and 5.3.3iv M showed a single cell associated with the 
membrane, L showed the whole cell whilst M was at higher magnification.   The 
cell had a square morphology although the corners are rounded and was very large 
(around 10 Xm across).   As with the cell shown in panel E there were a number of 
dark granules present in the cell.   Figure 5.3.3iv panel N shows an ISEMF cell 
attached to the membrane that had the expected elongated myofibroblast 
morphology.  These images were of an insert that had been seeded with GFPmES 
cells that had been cocultured with day six embryonic chick gut tissue for seven 
days prior to seeding. 
 
Figure 5.3.3iv O showed the cellular detritus of a lysed cell that appeared to have 
been associated with the membrane.  This showed that some damage may have 
occurred to the cells during sample processing for TEM.   This image was of an 
insert that had been seeded with GFPmES cells that had been cocultured with 
day six embryonic chick gut tissue for seven days prior to seeding. Figure 5.3.3iv 
P showed part of an ISEMF cell attached to the membrane although the cell is 
partly obscured by part of the sample mounting (the dark black area).  This image 
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underlying ISEMF cell layer.   These images show that the underlying ISEMF cell 
layer had remained attached but had not achieved confluence.  
 
Panels D and F show the top layer of mES cells (that had been cocultured with 
embryonic day six chick gut tissue for seven days prior to seeding) where the 
seeded cells had formed a near confluent monolayer.   Figure 5.3.4ii panels G  J 
show the same images from the cocultured GFPmES cell (that had also been co
cultured prior to seeding) seeded inserts (batch B).   The ISEMF cells (panels G 
and I) in these inserts were sparse and had not reached the same degree of 
membrane coverage as in batch A.   The cocultured cells (Figure 5.3.4ii panels H 







As detailed in Section 5.1 the Transepithelial resistance (TER) across a cell layer 
provides an indication of the integrity of an epithelial barrier.  If solution/media 
(and the salts/charged molecules within) were able to freely permeate across the 
barrier the TER would be low (<200 a) and would not change significantly 
through the course of the experiment. In this instance an epithelial barrier was not 
being formed as the cells were not interacting with their neighbours or forming 
tight junctions    If the TER rises through the initial part of the experiment (the 
first seven  10 days) until reaching a steady level (>1000 a) this would indicate 
that as the cells seeded on the membrane grew to confluence they also began to 
interact cell to cell e.g. by forming tight junctions [Beltinger et al 1999, Blikslager 
et al 2007].  A more integrated (epithelial) barrier was formed and this prevented 
the easy passage of charged molecules (and hence electrical current) from one 
side of the barrier to another; this caused an increase in resistance. 
 
Tight junctions are strong interactions between the membranes of adjacent cells 
[Denker and Nigam 1998] and when formed create an (almost) impermeable 
barrier.  They link the Actin cytoskeletons of neighbouring cells via a number of 
membrane protein complexes with the most common proteins being Claudins 
[Furuse et al 1999] and Occludins [McCarthy et al 1996].  This barrier is critical 
to the functions of the intestinal epithelium as active transport mechanisms are 
required to cross it allowing the exclusion of microorganisms (immune defence) 
and the selective absorption of nutrients. 
 
The TER values for the cocultured cells showed no significant differences from 
the TER readings for the control cells and negative controls with the ratio between 
them oscillating around 1:1 over the course of the experiment.  If the samples 
were behaving in a significantly different manner from the controls you would 
expect to see this ratio change with a specific trend as the experiment progressed.  
If a genuine epithelial barrier had been formed the TER in the experimental 
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samples (and hence the ratio to the controls where the TER remained constant) 
would have risen steadily through the early part of the experiment as the epithelial 
layer formed before levelling off when an intact barrier was present.  Tissue 
engineered intestine was compared with native tissue (see Section 1.5) following 
transplantation into rats.  Initially (prior to transplantation) the engineered 
constructs had a lower TER than intact tissue but by end of the experiment the 
engineered tissue displayed comparable TER readings with the native tissue [Choi 
et al 1998]. 
 
The controls, particularly the negative control where there was no cellular 
component, were expected to remain at fairly steady levels, as they did.  The 
ISEMF cell layer on the exterior membrane surface contributed little to the TER 
as the ISEMF controls gave similar readings to the negative controls.  This 
corresponds with what was reported in the literature [Beltinger et al 1999].  This 
supports the hypothesis that it was only the formation of an intact epithelial layer 
along with its associated interactions, such as tight junctions [Denker and Nigam 
1998] and associated structural proteins [Furuse et al 1999, McCarthy et al 1996] 
that would have produced a significant change in the TER.  In retrospect the 
inclusion of a positive control where inserts were seeded with an epithelial cell 
type, such as HCA7 or T84 [Beltinger et al 1999, Nash et al 1987, Willemsen et 
al 2002], would have provided an additional useful comparison. 
 
One of the key functions of the intestinal epithelium is the absorption of nutrients 
from the intestinal lumen into the blood stream.  This absorptive function is based 
upon concentration gradients but the epithelial layer restricts the loss of ‘useful’ 
molecules out of the circulation.  This is reliant on a number of mechanisms 
including being a simple barrier to molecule diffusion as well as active transport 
mechanisms. 
 
It would have been expected to see diffusion of the FITCBSA across the cell
membrane barrier in the TMCC system in both the experimental and control 
samples.  If an epithelial layer was formed in the experimental samples this would 
have regulated the passage of the labelled protein between the two liquid volumes 
on either side of the membrane. Therefore in the experimental samples the 
 
passage of the labelled FITCBSA should have occurred at a slower rate 
compared with the controls assuming that an epithelial layer was formed.  The 
level of labelled protein should have equilibrated in all samples eventually but it 
should have reached equilibrium in the controls before the experimental samples. 
 
The membrane permeability of the negative controls, which were identical at the 
two timepoints as there was no cellular component in these samples, gave very 
similar results throughout the experiment.  This indicates that the results from 
both incubations could be compared with confidence.  In a few samples the 
amount of FITCBSA was at a higher percentage than the initial concentration but 
this could be explained by errors/variations from the standard curve and the plate 
reader (the limits of sensitivity of the plate reader and the standard curve must be 
considered when analysing these results).  There was no significant change in the 
membrane permeability between the two timepoints which, whilst expected for 
the control samples where passage of the labelled protein was uninhibited 
[Beltinger et al 1999], indicates that there was no formation of an epithelial barrier 
layer in the experimental samples.   
 
An established epithelial barrier should have slowed the passage of the labelled 
protein across the membrane in comparison with the controls.  This is supported 
by the poor correlation between some of the experimental replicates.  Once again 
a positive control using an epithelial cell type would have been useful; it has been 
shown that intestinal epithelial cell lines cocultured with ISEMF cells prove a 
significantly greater barrier to the passage of (labelled) molecules such as 3H
Mannitol than membrane only or ISEMF only controls [Beltinger et al 1999]. 
 
An identifying feature of intestinal epithelium is the distinct cell types that are 
found within the tissue.  These cell types (see Section 1.2.1, Figure 1.4) have 
unique morphologies and structures that can be identified visually.  The 
examination of the samples under the microscope (by light microscopy and by 
Transmission Electron Microscopy, TEM) was carried out to assess the 
architecture of the cells within the samples and to determine if any of them 
display the characteristic morphology of intestinal epithelial cell types as well as 
 
looking for characteristic cellcell interactions found in epithelial cell layers, 
particularly tight junctions [Denker and Nigam 1998]. 
 
The sample processing for the TEM imaging seems to have had a deleterious 
effect on the samples.  Whilst some of the ISEMF cells seemed to have remained 
associated with the membrane the majority cells seeded on the interior side of the 
membrane seemed to have detached during processing (suggesting that they were 
strongly associated with the membrane).  A few single cells were observed some 
of which had dissociated from the membrane.  These cells were small and had a 
rounded morphology characteristic of unattached, dead cells.  It is possible that a 
population of undifferentiated cells were still present following the coculture 
with embryonic chick gut tissue and that these cells more readily dissociated from 
the membrane during sample processing for TEM. 
 
Some cells were observed still associated with the membrane and these cells were 
often larger with a more rectangular morphology and noticeable internal 
architecture.    Absorptive enterocytes are the most common cell type in the 
intestinal epithelium and have a rectangular morphology whilst all the cell types 
in the intestinal epithelium, particularly the Paneth cells and Goblet cells, have 
large internal structures (see Section 1.2.1) [Crosnier et al 2006]. 
 
No tight junctions were observed in any of the samples as those cells that were 
observed were always solitary and therefore could not interact with any 
neighbouring cells.  There was also no evidence of the tissue morphology of the 
intestinal epithelium such as microvillous structures.  The density of cells would 
suggest that an epithelial layer and its associated architecture were unlikely to 
have been formed (although this may have been a consequence of the cells being 
lost during the TEM processing).  These cells had been observed (by light 
microscopy) throughout the experiment (as seen in Figure 5.3.5) including at the 
termination of the experiment when the samples were fixed.  This suggests that 
(some of) the cells might have been lost during sample processing (see below) but 
if the cells association with the insert membrane had been strong (as would be 
expected if an epithelial layer had been formed) then it is unlikely that the cells 
would have detached so easily. 
 
 
The TEM facility reported that during the processing and embedding phase 
‘something’ detached from the interior of the inserts and this may account for the 
loss of these cells.  If the cells had not attached well to the interior of the 
membrane this would explain the ease with which they were lost during 
processing in comparison to the ISEMF cells that remained associated with the 
exterior membrane surface.  The two sets of experimental samples using mES or 
GFPmES that had been through the coculture differentiation protocol (batch A = 
mES cells, batch B = GFPmES cells) were seeded with ISEMF cells from 
different flasks that originated from different tissue sources which may therefore 
have been proliferating at different rates.  This could explain the differences 
observed (by light microscopy) in the number of ISEMF cells in different 
samples.   
 
1(0(*$$	
The data collected indicates that the putative ISClike cells did not form into an 
epithelial layer in the model system.  The cells did not display the morphological 
or functional characteristics of intestinal epithelium. 
 
 There was no significant change in the TER through the course of the 
experiment.  This indicates that an epithelial layer and its associated tight 
junctions were not being formed. 
 
 The membrane permeability assay showed that the cells grown on the 
Transwell inserts (in all conditions) did not form a barrier to FITCBSA.  
There were no significant changes through the course of the experiment 
which supports the conclusion that FITCBSA could pass across the 
membrane as readily at the end of the experiment as at the start indicating 
that an epithelial layer had not been formed. 
 
 The TEM images provide little information due to the loss of the cells 
during sample processing.  Those cells that were present displayed some 
interesting cellular architecture but were so infrequent that making a 
 
positive identification of the cells found in the intestinal epithelium 
[Crosnier et al 2006] was impossible.  Nothing resembling the 
characteristic cellular architecture, such as microvilli, of the intestinal 









A number of the variables examined through the course of these experiments 
seem to induce cells to differentiate towards the DE fate.  However the process 
appeared to be far from efficient. The sensitivity of the CEE mES cell line to 
serum levels even when SR was used proved an obstacle to fully investigating the 
range of culture conditions that favour DE specification. The ultimate conclusions 
from this chapter of work are: 
 
 Aggregating the cells into EBs promoted differentiation when compared to 
cells cultured in monolayer but did not specifically favour DE 
specification. In many cases when cells were reseeded in monolayer 
culture after an aggregation phase the strength of differentiation marker 
expression reduced. This phenomenon was still observed when the 
aggregation phase was extended from three to five days in duration. 
 
 ActA treatment seems to favour the specification of DE when compared 
to control conditions but the induction effect was not comprehensive or 
particularly strong. DE markers were generally expressed at elevated 
levels after ActA treatment but markers of other fates, particularly 
mesoderm (see below) were sometimes present [Kubo et al 2004, Tada et 
al 2005]. The pluripotent marker Oct4 [Nichols et al 1998] was also still 
expressed although occasionally at reduced levels. 
 
 Some differentiation towards mesoderm occurred in the conditions that 
favour DE specification. This was perhaps unsurprising as the two germ 
layers arise from a common precursor [Tada et al 2005]. There was little 
evidence of any ectodermal differentiation in the conditions that most 




Whilst the protocol proved to be a viable method for initiating the expression of 
ISC markers not all of the mES cells differentiated towards the ISC fate.  The 
panel of differentiation markers were expressed in most of the cocultured cell 
samples but there were signs that some cells remained undifferentiated and that 
some other fates may have been specified (see Table 4.3.2). 
 
 The CEE mES cells were successfully transfected with the GFP encoding 
VS01 plasmid. 
 
 The desired embryonic chick tissue could be successfully explanted and 
maintained in ex vivo culture for six – seven days.  Sufficient injected cells 
are retained within the tissue explant during coculture. 
 
 There were no apparent differences in DE/ISC gene/protein expression 
between the cells treated in vitro with ActA and naïve mES cells 
following seven days coculture with intact chick gut explants or 
dissociated cells derived from the same. 
 
 There were no differences in DE/ISC gene/protein expression between the 
GFPmES cells and the unlabelled mES cells when differentiated using the 
coculture protocol. 
 
 The coculture seemed to induce the expression of the key ISC marker 
Lgr5 [Barker et al 2007] at the RNA level in a reproducible manner.  This 
is supported by consistent LGR5 expression at the protein level. 
 
 The coculture methodology used supported the differentiation of naïve 
mES cells to differentiate towards an ISClike fate at a molecular level.  
Similar results have been reported in the literature with different tissue 
types and target cell lineages [Sugie et al 2005, Fair et al 2003, Van 
Vranken et al 2005].  However not all the cells were differentiated or fully 




The data collected indicates that the putative ISClike cells did not form into an 
epithelial layer in the model system.  The cells did not display the morphological 
or functional characteristics of intestinal epithelium. 
 
 There was no significant change in the TER through the course of the 
experiment.  This indicates that an epithelial layer and its associated tight 
junctions were not being formed. 
 
 The membrane permeability assay showed that the cells grown on the 
Transwell inserts (in all conditions) did not form a barrier to FITCBSA.  
There were no significant changes through the course of the experiment 
which supports the conclusion that FITCBSA could pass across the 
membrane as readily at the end of the experiment as at the start indicating 
that an epithelial layer had not been formed. 
 
 The TEM images provide little information due to the loss of the cells 
during sample processing.  Those cells that were present displayed some 
interesting cellular architecture but were so infrequent that making a 
positive identification of the cells found in the intestinal epithelium 
[Crosnier et al 2006] was impossible.  Nothing resembling the 
characteristic cellular architecture, such as microvilli, of the intestinal 
epithelial cell types was apparent. 
 
$$	
Overall this work has shown that coculturing pluripotent mES cells with 
embryonic chick gut tissue can induce limited differentiation towards the ISC fate 
with increased expression of the selected ISC markers observed when compared 
to controls.  Pretreating the cells with growth factors in vitro did not seem to 
enhance this differentiation but there was scope for these techniques to be refined.  
Following the differentiation protocols the cells did not display the desired 
 
physiological characteristics but again there was scope to refine these techniques, 
particularly with regard to selecting cells positive for the expression of the chosen 
molecular markers.  These techniques show promise but do require some further 
development.  Ideas for how this work might be refined, expanded upon and taken 









The sensitivity of the CEE mES cell line to FACS proved a major technical hurdle 
in a number of experiments.  Whilst a number of factors that might have caused 
this such as temperature, duration of time out of ‘normal’ culture conditions, the 
stress of passing through the FACS machine and comparison with other mES cell 
types have been investigated the cost of using the FACS facility and time 
limitations meant that no adequate explanation for this sensitivity could be found.  
Establishing why the cells display this sensitivity, and hopefully finding a solution 
to the problem, would allow considerable refinement of the differentiation 
protocols at a number of stages. 
 
Following the in vitro differentiation stage detailed in Chapter Three cells could 
be selected by positive expression of DE cell surface markers, such as CXCR4 
[D’Amour et al 2005, Yasunaga et al 2005].  Secondly, labelled murine cells 
could be easily separated from chick derived cells following ex vivo coculture 
detailed in Chapter Four.  The cells could then be selected by positive expression 
of ISC cell surface markers, such as LGR5/GPR49 [Barker et al 2007], before 
being seeded in the TMCC experiments carried out in Chapter Five. 
 
The coculture protocols were technically difficult to carry out and there were 
some parts of the process that proved ‘rate limiting’ particularly the egg/embryo 
dissection stage.  If embryonic gut tissue cells could be isolated and grown in 
continuous culture this would provide an easier way of supplying cells for co
culture.  It would need to be established if the cells continue to produce the same 
molecular signals in this form as they do as intact explants/freshly isolated cells. 
 
Extending the concept above further it might be possible to use cells/tissue 
explants to condition media that could then be used in the further differentiation of 
ES cells (or other multipotent cells) towards the intestinal epithelial progenitor 
fate [Maxson and Burg 2008, Kang et al 2009].  This would remove some of the 
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more time consuming stages of the coculture protocols.  Using gut cells from 
continuous cell culture or conditioned media rather than tissue explants would 
also permit the extension of the time the ES cells could be cultured under 
differentiation conditions as the degradation of the tissue explants would no 
longer be a limiting factor.  It would also reduce the number of animals required 
for the experiments.  Media could be conditioned using embryonic murine gut 
tissue; this would give species specific signalling factors (a consideration that 
would also be important in transferring the techniques to hES cells).  Using 
conditioned media might also permit an expansion in the number of cells used in 
the differentiation protocols as this would not be limited by the number of cells 
that could be injected into a tissue explant. 
 
These protocols could be transferred to produce different types of cells.  Injecting 
ES cells into other embryonic tissue explants, such as the liver or the kidney, 
could be combined with in vitro DE specification to produce a range of target cell 
types.  This could be expanded to incorporate mesoderm (e.g. muscle) and 
ectoderm (e.g. skin) derived tissues.  A number of studies have already been 
conducted exploring the potential of coculture of ES cells with early embryonic 
tissues [Sugie et al 2005, Fair et al 2003, Van Vranken et al 2005, Coleman et al 
2007] and some have employed in vitro growth factor treatments [Sugie et al 
2005, Coleman et al 2007] or aggregation into EBs [Van Vranken et al 2005] prior 
to the coculture stage as discussed in Section 4.1. 
 
The different parameters within the differentiation protocols could be varied or in 
some cases combined.  For example intact EBs could be used in coculture with 
embryonic chick gut tissue.  EBs could be generated in vitro and cultured for 
around five days (to initiate differentiation) before being injected into embryonic 
chick gut tissue explants in ex vivo culture [Van Vranken et al 2005].  The length 
of the culture periods in the in vitro differentiation stage could be varied e.g. 
would extending the length of the EB phase of culture to from five to seven days 
increase the expression of DE markers.  Resources permitting, the concentration 
of ActA growth factor could be increased (from 10 ng/ml) to concentrations of up 
to 100 ng/ml.  Other factors such as LY294002 (an inhibitor of the enzyme PI3K) 
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
[MacClean et al 2007] could also be used to replace/compliment the effects of 
ActA.    
 
There are a number of different methods by which EBs can be generated in 
addition to the suspension culture method detailed in Section 2.1.4, such as the 
hanging droplet technique [Kurosawa 2007].  These methodologies could be 
compared to the existing protocol to see if they are more suited for generating DE 
and its derivatives.  Ideally this would involve an expanded version of the 
experiments detailed in Section 3.2.1iv – 3.2.1vi and 3.3.4 – 3.3.6, where the 
different variables are all explored in parallel. 
 
If the results in Chapter Five had been more significant it would have been 
necessary to repeat the experiments with the inclusion of a greater range of 
controls.  A positive control using an epithelial cell line, such as HCA7, seeded 
on the interior surface of the cell culture inserts would definitely have been 
included.  These cells would have been expected to produce a functional epithelial 
barrier and would therefore give an indication of what changes in TER and 
membrane permeability occur as the epithelial barrier is formed [Beltinger et al 
1999, Blikslager et al 2007]. 
 
Investigating the expression of a range of markers, such as tight junction 
associated proteins [McCarthy et al 1996, Furuse et al 1999] and markers of 
various intestinal epithelial cell lineage markers (see Section 1.2.3), and 
comparison with positive controls would also provide a further assessment of 
whether the cells were functioning as ISC.  This study could be further expanded 
by examining the TER and membrane permeability (of FITCBSA) of excised gut 
tissue explants in ex vivo culture [Tait et al 1995, Choi et al 1998].  This might 
also provide interesting observations as to how the values change as the tissue 
degrades with time and the epithelial barrier loses integrity – the reverse scenario 
of what you would hope to observe in the experimental samples. 
 
Further imaging of the seeded Transwell inserts could be carried out.  The light 
microscopy imaging carried out in Chapter Five allowed observation of the cells 
during the culture period but only in 2D whilst the TEM imaging gave high 
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magnification images of individual cells.  Sectioning of the inserts at the 
conclusion of the experiment and staining with e.g. H & E would show if any 
cellular organisation/tissue structures were evident (see Section 1.2.1) [Crosnier et 
al 2006].   
 
Such sections would also be suitable for antibody staining for markers of 
intestinal epithelial cell types (see Section 1.2.3) such as LGR5 (Intestinal Stem 
Cells) [Barker et al 2007], CDX2 (a key transcription factor for correct intestinal 
patterning during development) [Beck et al 1999], Epithelial Antigen (a cell 
surface marker found throughout epithelial layers) [Engelhardt et al 1993] and 
specific markers for Goblet Cells (Periodic Acid Schiff or Dolichos Biflorus 
Agglutinin), Enteroendocrine Cells (Synaptophysin or Chromogranin A) and 
Paneth Cells (Lysozyme or Periodic Acid Schiff expressed at the base of the 
Crypts of Lieberkuhn). 
 
More extensive molecular analysis of the cells could be carried out throughout the 
differentiation protocols.  Techniques such as Microarray analysis could 
quantitatively assess the expression of many thousands of genes. Differentiating 
cells could be compared to undifferentiated ES cells to highlight the changes in 
gene expression induced by the differentiation protocols and to normal intestinal 
epithelium to assess the full extent to which the cells are differentiating towards 
the target cell type.  Microarray analysis would also allow comparisons of the 
gene expression of cells that had been through different differentiation protocols 
e.g. cells that had been ActA treated and cocultured versus cells that had only 
been cocultured.  This would facilitate the identification of the most ‘efficient’ 
way to differentiate the cells towards the desired target type. 
 
If the sensitivity to FACS was resolved it would allow quantification of what 
percentage of the cells were differentiating towards a particular fate using a 
labelled antibody against an endodermal surface marker such as CXCR4 
[D’Amour et al 2005, Yasunaga et al 2005].  As mentioned above, this would also 
allow selection of the differentiated fraction of the cell population for use in 
further experiments.  The same process could be repeated using intestinal stem 
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cell surface markers, such as LGR5 [Barker et al 2007], to select the desired 
fraction of the cell population following the coculture differentiation protocol. 
 
The molecular/viability analysis carried out on the chick tissue explants could also 
be expanded.  Further stains, such as Alamar blue (Resazurin) [Anoopkumar
Dukie et al 2005, O’Brien et al 2000] are available as alternatives to LiveDead 
solution for assessing the viability of tissue in culture.  A more extensive analysis 
of the RNA and protein expression of the tissue through ex vivo coculture could 
also have been carried out. 
 
The CEE mES cell line used in these studies has been successfully differentiated 
towards osteogenic fates [Gothard et al 2010] but did not readily differentiate 
towards DE under the selected conditions.  Other mES cell lines that have 
previously been differentiated towards endodermal fates could be substituted in 
these experiments [Tada et al 2004, Kubo et al 2004, Yasunaga et al 2005].  Using 
feederindependent mES cell lines rather than the feeder dependant CEE mES cell 
line might eliminate the attachment issues encountered in the early experiments in 
Chapter Three. 
 
This might also provide an indication as to whether transferring the techniques to 
hES cells (please see below) is likely to prove successful; if results cannot be 
replicated in different mES cell lines it would suggest a reduced likelihood that 
the results would be replicated in ES from a different species.  Other mES cell 
lines might not display the same sensitivity to serum levels shown by the CEE 
mES cell line which would allow the full effects of serum concentration on the 
differentiation of the cells to be investigated [Kubo et al 2004, Tada et al 2005, 
Yasunaga et al 2005, D’Amour et al 2005]. 
 
If the differentiation protocols could be refined then the research could be 
developed further to encompass further objectives.  Collaborating with researches 
producing scaffolds for GI tissue engineering would provide the opportunity to 
show that the derived cells would work in a complete tissue engineering strategy.  
The cells would be seeded on a suitable scaffold and placed in 3D/in vivo culture 
and allowed to proliferate (see Section 1.4) [Choi and Vacanti 1997].  The 
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scaffold would be designed to reproduce the morphology of intestinal tissue.  
Potentially such constructs could be used for disease modelling, drug absorption 
studies and ultimately clinical applications. 
 
All current strategies for intestinal epithelial engineering involve the use of 
isolated adult crypts (see Section 1.4) [Flint et al 1991, Evans et al 1992].  The 
supply of such material is limited and this would limit the potential scope for 
clinical use of tissue engineered intestine (much in the same way that organ 
replacement therapies are current limited by the number of suitable donors).  
Using an ES (or an IPS) derived cell source would address this issue as ES cells 
can be readily cultured in large numbers in vitro.  Using ES derived cells would 
also allow the observation of disease progression in conditions such as Crohn’s 
disease.  Intestinal models could be established with both ‘normal’ and Crohn’s 
patient derived cells and the effects of microbial and dietary factors [Nash et al 
1987, Willemsen et al 2002] in terms of inducing Crohn’s disease could be 
investigated by examining the normal cells compared to the model with cells 
known to have a tendency towards the disease. 
 
Once proof of principle had been established using mES cells the next step would 
be to transfer the techniques to hES cells.  For any tissue engineered material to 
have clinical potential it would need to be human tissue.  Studies in the literature 
have shown that the DE inducing effects of ActA on mES cells [Kubo et al 2004, 
Tada et al 2005, Yasunaga et al 2005] are comparable to those on hES cells 
[D’Amour et al 2005].  Given the potential that IPS cells [Takahashi and 
Yamanaka 2006, Yu et al 2007, Takahashi and Yamanaka 2007, Duan et al 2011] 
(see Section 1.3) have to provide a patient specific cell source it would also be 
useful to see if the differentiation protocols had the same effects in them as in 
‘conventional’ ES cells.  This would be a critical step in developing tissue 
engineered intestine that was of clinical use. 
 
Whilst they were only produced as a technical step to facilitate the coculture 
experiments, further characterisation of the GFPmES cells could be carried out.  
Although they continued to form EBs and express Oct4 following transfection 
with the VS01 plasmid a more extensive molecular analysis would be required to 
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establish that the transfection had not caused any significant alterations to the cells 
molecular character (at both the nucleic acid and protein level).  This could 
include Microarray experiments to compare the full gene expression profile of the 
transfected cells with the unaltered ES cell line.  The ability of the cells to 












This section contains summary tables and supplementary information for data 






Evidence in the literature suggests that low serum concentrations and the presence 
of ActA induces mES cells to differentiate towards the DE lineage in culture with 
greater efficiency than as EBs in standard cell culture media [D’Amour et al 2005, 
MacClean et al 2007, Kubo et al 2004, Tada et al 2005, Yasunaga et al 2005].  
This experiment aimed to show that these results could be achieved using the CEE 
mES cell line.  Complete (CEE mES) cell culture media contains around 10% 
FCS so the initial experiment aimed to establish if the CEE mES cell line could 
tolerate low serum (2% or lower) conditions and to observe any discernible effects 
on their differentiation under these conditions. 
 
Figure 3.3.1A shows that the cells rapidly reached a confluent state in the CEE 
complete cell culture media (10% FCS, LIF+, see Section 3.2.1i) with large single 
colonies formed by 24 hours.  The cells continued to proliferate rapidly and by the 
end of the experiment a confluent monolayer had formed.  The cells maintained a 
rounded morphology and did not appear to change in size, remaining 
approximately 60  80 Xm in diameter. 
 
Figure 3.3.1B shows that the cells grew fairly rapidly in the SNL media (10% 
FCS, LIF, see Section 3.2.1i) over the first 24 hours, but not at the same rate as in 
CEE complete cell culture media, and then appeared to proliferate faster for the 
duration of the experiment.  By the end of the experiment a confluent monolayer 
had formed.  Although it was unobservable at 120 hours, at 48, 72 and 96 hours 
some of the cells appeared to have grown larger and altered their morphology.  
Some elongated cells were visible in the photos from these timepoints. 
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Figure 3.3.1: Representative Light microscopy images of CEE mES cells cultured 
in A  CEE complete cell culture media (10% FCS, LIF+) control for 120 hours, B 
 SNL media control for 120 hours (10% FCS, LIF), C – Differentiation media 
without ActA for 120 hours and D  Differentiation media with 10 ng/ml ActA 
for 120 hours. 
 
In Figure 3.3.1C some cells appeared to adhere to the surface of the wells but 
many did not resulting in early loss of cell numbers in the differentiation media 
without ActA.  Proliferation was also minimal.  Although some cell clusters were 
apparent by 120 hours they appeared to be unattached to the culture plate.  Figure 
3.3.1D illustrates that cell growth was minimal and that only a small fraction of 
the cells adhered to the well surface in the differentiation media plus ActA.  
Some cells appeared enlarged and spread out at 48  72 hours but by the end of the 
experiment these cells were no longer observable. 
 
When cultured under low serum conditions the CEE mES cell line did not 
proliferate or adhere as it did when cultured in CEE complete cell culture media 
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(10% FCS, LIF+/) resulting in almost total cell death and therefore no samples 





The presence of ActA in serum replacement (SR) media rather than low serum 
has been previously shown to promote differentiation to the DE fate without 
having a negative effect on cellular attachment and proliferation [D’Amour et al 
2005, Kubo et al 2004, Tada et al 2005, Yasunaga et al 2005].  In this study, the 
ability to culture CEE mES cells in SR media was assessed.  In addition, the effect 
of using different ECM components to coat the culture vessel was also 
investigated. 
 
Figure 3.3.2A shows that the cells attached to the well surface but did not reach a 
confluent monolayer (it should be noted that a large number of cells had not 
attached at 48 hours and were removed with the first media change hence the 
apparent reduction in cell number from 48  72 hours) in CEE complete cell 
culture media on gelatin coated TCP.  Surviving cells remained small and rounded 
in morphology and formed multicellular aggregates.  Similarly, Figure 3.3.2B 
shows that the cells attached to the plate surface in CEE complete cell culture 
media on Collagen IV coated TCP.  There was a significant loss of cells between 
72 and 96 hours but those that remained were able to become established in 
culture. 
 
Figure 3.3.2C shows the cells attached to the culture plate and proliferated until 72 
hours after seeding SNL media on Gelatin coated TCP.  After this point there was 
a large reduction in cell number.  The cells that survived showed altered (usually 
elongated) morphologies and were generally larger in size.  Figure 3.3.2D shows 
the cells proliferated slowly for the first 72 hours but a significant number showed 
changes in morphology at 72 hours in SNL media on Collagen IV coated TCP.  
From 72  96 hours the cells proliferated rapidly but from 96  120 hours there 
was a significant loss of cells.  The cells that proliferated at a faster rate (and then 
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Table 6.3.3: Summary table of the RTPCR band strength data from experiment 




Table 6.3.4: Summary table for RTPCR band strength data from experiment five 




Table 6.3.5: Summary table for experiment six RTPCR data. Summary tables for 






Table 6.3.6: Summary table showing PCR band strength ‘scores’ for coculture 
experiment (batch) D. 
 
 
Table 6.3.6B: Summary table showing PCR band strength scores for coculture 
experiment culture vessel controls. 
 
 
Table 6.3.7: Summary table of average PCR band strength ‘scores’ for coculture 








Figure 6.3.3: Graph showing TER values in mES derived cell seeded inserts and 




Figure 6.3.4: Graph showing TER values in GFPmES derived cell seeded inserts 
and controls over 21 days in culture. 
 	
Table 6.3.8: Summary table of the ratios of the average TER readings from the 
experimental samples (batch A or B) and the various control conditions 
throughout the time course of the culture. 
 
Table 6.3.9: Summary tables for membrane permeability study. Values given are 
% FITCBSA based upon the standard curve (Figure 5.3.3A). Where 0 values are 


















439.5 ml DMEM (Gibco, UK) 
50 ml FCS (10% (v/v), Sigma, UK) 
5 ml Antibiotics & Antimycotics (1% (v/v), Sigma, UK) 
5 ml (200 mM) LGlutamine (1% (v/v), final conc 2mM) (Sigma, UK) 




99.95 ml SNL complete media (see above) 
50 Xl LIF (stock concentration 1 x 106 units/ml, working concentration 500 




70 ml DMEM (Gibco, UK) 
20 ml FCS (20% (v/v), Sigma, UK) 




97.9 ml DMEM (Gibco, UK) 
1 ml Antibiotics & Antimycotics (1% (v/v), Sigma, UK) 
1 ml (200 mM) LGlutamine (1% (v/v), final conc 2mM) (Sigma, UK) 
100 Xl (10 mM) βMercaptoethanol (0.1% (v/v), final conc 10 XM, Sigma, UK) 
 
'::$.	$	-
97.7 ml DMEM (Gibco, UK) 
1 ml Antibiotics & Antimycotics (1% (v/v), Sigma, UK) 
1 ml (200 mM) LGlutamine (1% (v/v), final conc 2mM) (Sigma, UK) 
100 Xl (10 mM) βMercaptoethanol (0.1% (v/v), final conc 10 XM, Sigma, UK) 
200 Xl FCS (0.2% (v/v), Sigma, UK) 
 
'::$.	$	
95.9 ml DMEM (Gibco, UK) 
1 ml Antibiotics & Antimycotics (1% (v/v), Sigma, UK) 
1 ml (200 mM) LGlutamine (1% (v/v), final conc 2mM) (Sigma, UK) 
100 Xl (10 mM) βMercaptoethanol (0.1% (v/v), final conc 10 XM, Sigma, UK) 






87.9 ml DMEM (Gibco, UK) 
1 ml Antibiotics & Antimycotics (1% (v/v), Sigma, UK) 
1 ml (200 mM) LGlutamine (1% (v/v), final conc 2mM) (Sigma, UK) 
100 Xl (10 mM) βMercaptoethanol (0.1% (v/v), final conc 10 XM, Sigma, UK) 
10 ml Serum replacement (10% (v/v), Sigma, UK) 
 
'::$."$	
96.75 ml DMEM (Gibco, UK) 
1 ml FCS (1% (v/v), Sigma, UK) 
1 ml Penicillin & Streptomycin (1% (v/v), final concentrations: 100 U/ml 
Penicillin; 100 µg/ml Streptomycin, Sigma, UK) 
0.25 ml Gentamycin solution (0.25% (v/v), final concentration 25 µg/ml 
Gentamycin, Sigma, UK) 
1 ml (200 mM) Lglutamine (1% (v/v) final concentration 2 mM, Sigma, UK) 
6 mg collagenase XI (6% (w/v) final concentration 75 U/ml, Sigma, UK) 
2 mg dispase I (2% (w/v), final concentration 20 µg/ml, 0.12 U/ml, Sigma, UK) 
Note: dissolve the enzymes in an aliquot of the 100 ml DMEM and filter sterilise 




445 ml DMEM (Gibco, UK) 
 	
50 ml FCS (10% (v/v), Sigma, UK) 
5 ml (200 mM) LGlutamine (1% (v/v), final conc 2 mM, Sigma, UK) 
100 µg Streptomycin (0.002% (w/v), final conc 200 ng/ml, Sigma, UK) 
250 ng Amphotericin B (0.005% (w/v), final conc 500 ng/ml, Sigma, UK) 
1000 units/ml Penicillin B (Sigma, UK) 
 
'::$:('C-+,7.)
99.9 ml DMEM (Gibco, UK) 
100 Xl FITCBSA solution (Sigma, UK) 
 
'::$'C-+,7.)
100 ml DMEM (Gibco, UK) 




1 g Eosin (Nustain, UK). 





20 g NaHCO3 (Sigma, UK). 
3.5 g MgSO4 (Sigma, UK). 





199 ml H2O. 
20.6 g Sucrose (Sigma, UK). 
584 mg NaCl (Sigma, UK). 
120 mg MgCl2 (Sigma, UK). 
952 mg HEPES (Sigma, UK). 
1 ml Triton X100 (Sigma, UK). 
Note: once the solution had been made up the pH was adjusted to 7.2 by the 
addition of small amounts of HCl or NaOH. The pH was measured using a 
Mettler Toledo pH meter.  All solutions where a specific pH is given were 





20 mg DABCO. 
20 ml PBS. 
6%"+	0E,
 	
2 ml DABCO stock solution. 





999.9 ml H2O. 
2.42 g TrisHCl (Sigma, UK). 
8.76 g NaCl (Sigma, UK). 




9.975 ml PBS. 
25 Xl Eth D1. 






Following imaging the bands obtained were (subjectively) scored on a scale of 
one – seven based upon relative size (pixel count) and brightness (pixel intensity).  
 	
A guideline to these scores is shown below.  If no band was visible then a score of 
zero was assigned. 
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